0001140361-18-036080.txt : 20180809 0001140361-18-036080.hdr.sgml : 20180809 20180809171126 ACCESSION NUMBER: 0001140361-18-036080 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 48 CONFORMED PERIOD OF REPORT: 20180630 FILED AS OF DATE: 20180809 DATE AS OF CHANGE: 20180809 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VirnetX Holding Corp CENTRAL INDEX KEY: 0001082324 STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794] IRS NUMBER: 770390628 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-33852 FILM NUMBER: 181006285 BUSINESS ADDRESS: STREET 1: 308 DORLA COURT STREET 2: SUITE 206 CITY: ZEPHYR COVE STATE: NV ZIP: 89448 BUSINESS PHONE: (831) 438-8200 MAIL ADDRESS: STREET 1: 308 DORLA COURT STREET 2: SUITE 206 CITY: ZEPHYR COVE STATE: NV ZIP: 89448 FORMER COMPANY: FORMER CONFORMED NAME: PASW INC DATE OF NAME CHANGE: 20001109 FORMER COMPANY: FORMER CONFORMED NAME: PACIFIC SOFTWORKS INC DATE OF NAME CHANGE: 19990322 10-Q 1 form10q.htm 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2018

☐

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number: 001-33852

VirnetX Holding Corporation

(Exact name of registrant as specified in its charter)

Delaware		77-0390628
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification Number)

308 Dorla Court, Suite 206 Zephyr Cove, Nevada		89448
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (775) 548-1785

Former name, former address and former fiscal year, if changed since last report:

Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐		Accelerated filer ☒
Non-accelerated filer ☐	(Do not check if a smaller reporting company)	Smaller reporting company ☐

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act. Yes ☐ No ☒

The number of shares outstanding of the Registrant’s Common Stock as of August 6, 2018, was 62,622,325.

SPECIAL NOTE REGARDING FORWARD LOOKING STATEMENTS

We have included or incorporated by reference in this Quarterly Report on Form 10-Q (including in the section entitled Management’s Discussion and Analysis of Financial Condition and Results of Operations), and from time to time we may make statements that may constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are based upon our current expectations, estimates, assumptions and beliefs concerning future events and conditions and may discuss, among other things, anticipated future performance (including sales and earnings), expected growth, future business plans and costs and potential liability for environmental-related matters. Any statement that is not historical in nature is a forward-looking statement and may be identified by the use of words and phrases such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “will be,” “will continue,” “will likely result in,” and similar expressions. These statements include our beliefs and statements regarding general industry and market conditions and growth rates, as well as general domestic and international economic conditions. Readers are cautioned not to place undue reliance on forward-looking statements. Forward-looking statements are necessarily subject to risks, uncertainties and other factors, many of which are outside our control, which could cause actual results to differ materially from such statements and from our historical results and experience. These risks, uncertainties and other factors include, but are not limited to those described in Item 1A - Risk Factors of this Quarterly Report on Form 10-Q and elsewhere in the Quarterly Report and those described from time to time in our future reports filed with the Securities and Exchange Commission. Readers are cautioned that it is not possible to predict or identify all the risks, uncertainties and other factors that may affect future results and that the risks described herein should not be considered to be a complete list. Any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

AMONG OTHERS, THE FORWARD LOOKING STATEMENTS THAT APPEAR IN THIS QUARTERLY REPORT THAT MAY NOT OCCUR INCLUDE STATEMENTS THAT:

WE HAVE BEEN AWARDED DAMAGES IN THE AMOUNT OF $439.7 MILLION IN THE “APPLE I” LITIGATION. WE HAVE ALSO RECEIVED A JURY VERDICT IN THE AMOUNT OF $502.6 MILLION IN DAMAGES IN THE “APPLE II” LITIGATION AND WE HAVE REQUESTED THAT THE DAMAGES IN APPLE II LITIGATION BE ENHANCED DUE TO APPLE’S WILLFUL INFRINGEMENT. TAKEN TOGETHER, THESE STATEMENTS MAY IMPLY THAT WE MAY SOON RECEIVE OVER $900 MILLION IN CASH. HOWEVER, (1) APPLE HAS APPEALED THE AWARDS IN BOTH OF THE APPLE I AND APPLE II LITIGATIONS AND THE COURT’S OR JURY’S DECISIONS MAY BE REVERSED OR AMENDED UPON APPEAL, (2) THE COURT MAY NOT AWARD US ENHANCED DAMAGES IN THE APPLE II LITIGATION, OR (3) WE MAY BE UNSUCCESSFUL IN OUR APPEAL OF CERTAIN ACTIONS BY THE PATENT TRIAL AND APPEALS BOARD THAT HAVE BEEN INITIATED BY APPLE OR OTHER PARTIES -- IF ANY OF THESE OCCUR, THEY MAY HAVE THE AFFECT OF THWARTING ENTIRELY, OR REDUCING AND DELAYING PAYMENTS TO US. THE CONTINUATION OF THESE LITIGATIONS IS DISTRACTING TO OUR MANAGEMENT AND EXPENSIVE, AND THIS DISTRACTION AND EXPENSE MAY CONTINUE.

WE HAVE UNDERTAKEN ACTIVITIES TO COMMERCIALIZE OUR PRODUCTS AND PATENT PORTFOLIO IN AND OUTSIDE THE UNITED STATES. THESE STATEMENTS MAY IMPLY THAT THE WORLDWIDE MARKET FOR OUR COMMERCIALIZED PRODUCTS IS LARGE AND WILL RESULT IN SIGNIFICANT FUTURE REVENUES FOR US. HOWEVER, COMMERCIALIZATION OF PRODUCTS SUCH AS OURS ARE SUBJECT TO SIGNIFICANT OBSTACLES AND RISKS, INCLUDING BUT NOT LIMITED TO A PERCEPTION BY SOME POTENTIAL PARTNERS AND CUSTOMERS THAT THEY SHOULD AWAIT THE OUTCOME OF THE APPLE I AND APPLE II LITIGATIONS BEFORE ENTERING OR CONSIDERING TO ENTER ANY AGREEMENT WITH US, AND THAT OR OTHER FACTORS MAY LEAD US TO BE UNSUCCESSFUL IN OBTAINING FURTHER LICENSING AGREEMENTS OR MAKING ARRANGEMENTS OR ENTERING CONTRACTS WHICH CREATE SIGNIFICANT FUTURE REVENUES FOR US.

EXCEPT AS REQUIRED BY LAW, WE UNDERTAKE NO OBLIGATION TO UPDATE OR REVISE ANY FORWARD-LOOKING STATEMENT AS A RESULT OF NEW INFORMATION, FUTURE EVENTS OR OTHERWISE.

VIRNETX HOLDING CORPORATION

INDEX

		Page
PART I — FINANCIAL INFORMATION		1
	Item 1 —Condensed Consolidated Financial Statements.	1

	Condensed Consolidated Balance Sheets at June 30, 2018 (unaudited) and December 31, 2017	1
	Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2018 and 2017 (unaudited)	2
	Condensed Consolidated Statements of Comprehensive Loss for the three and six months ended June 30, 2018 and 2017 (unaudited)	2
	Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2018 and 2017 (unaudited)	3
	Notes to Condensed Consolidated Financial Statements	4
	Item 2 —Management’s Discussion and Analysis of Financial Condition and Results of Operations	14

	Item 3 —Quantitative and Qualitative Disclosures About Market Risk	19

	Item 4 —Controls and Procedures	19

PART II — OTHER INFORMATION		20
	Item 1 —Legal Proceedings	20

	Item 1A —Risk Factors	22

	Item 6 —Exhibits	32

SIGNATURES		33
EXHIBIT INDEX		34

Index

PART I — FINANCIAL INFORMATION

ITEM 1. - FINANCIAL STATEMENTS.

VIRNETX HOLDING CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share amounts)

	As of June 30, 2018			As of December 31, 2017
	(unaudited)
ASSETS

Current assets:

Cash and cash equivalents	$	3,968		$	3,135
Accounts receivables		2			—
Investments available for sale		724			1,453
Prepaid expenses and other current assets		864			591
Total current assets		5,558			5,179

Prepaid expenses, non-current		1,796			1,989
Property and equipment, net		17			7
Total assets	$	7,371		$	7,175

LIABILITIES AND STOCKHOLDERS’ EQUITY

Current liabilities:

Accounts payable and accrued liabilities	$	2,966		$	414
Accrued payroll and related expenses		219			2,175
Income tax liability		399			393
Deferred revenue, current portion		—			1,500
Total current liabilities		3,584			4,482

Deferred revenue, non-current portion		—			1,000
Other liabilities		140			140
Total liabilities		3,724			5,622

Commitments and contingencies (Note 4)		—			—

Stockholders’ equity:

Preferred stock, par value $0.0001 per share Authorized: 10,000,000 shares at June 30, 2018 and December 31, 2017, Issued and outstanding: 0 shares at June 30, 2018 and December 31, 2017		—			—
Common stock, par value $0.0001 per share: Authorized: 100,000,000 shares at June 30, 2018 and December 31, 2017, Issued and outstanding: 62,292,808 shares and 59,051,978 shares, at June 30, 2018 and December 31, 2017, respectively		6			6
Additional paid-in capital		190,724			177,076
Accumulated deficit		(187,070	)		(175,516	)
Accumulated other comprehensive loss		(13	)		(13	)
Total stockholders’ equity		3,647			1,553

Total liabilities and stockholders’ equity	$	7,371		$	7,175

See accompanying notes to condensed consolidated financial statements.

Index

VIRNETX HOLDING CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

(in thousands, except per share amounts)

	Three Months Ended						Six Months Ended
	June 30, 2018			June 30, 2017			June 30, 2018			June 30, 2017
Revenue	$	16		$	396		$	22		$	771
Operating expense:
Research and development		1,186			957			2,191			1,873
Selling, general and administrative		5,292			3,250			11,901			6,615
Total operating expense		6,478			4,207			14,092			8,488
Loss from operations		(6,462	)		(3,811	)		(14,070	)		(7,717	)
Interest income, net		12			13			20			31
Loss before taxes		(6,450	)		(3,798	)		(14,050	)		(7,686	)
Provision for income tax		—			—			(5	)		(5	)
Net loss	$	(6,450	)	$	(3,798	)	$	(14,055	)	$	(7,691	)
Basic and diluted loss per share	$	(0.10	)	$	(0.07	)	$	(0.23	)	$	(0.13	)
Weighted average shares outstanding basic and diluted		61,532			58,195			60,835			58,170

VIRNETX HOLDING CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited)

(in thousands)

	Three Months Ended						Six Months Ended
	June 30, 2018			June 30, 2017			June 30, 2018			June 30, 2017
Net loss	$	(6,450	)	$	(3,798	)	$	(14,055	)	$	(7,691	)
Other comprehensive income (loss):
Change in equity adjustment from foreign currency translation, net of tax		—			—			—			(1	)
Change in unrealized gain on investments, net of tax		(1	)		—			—			(4	)
Total other comprehensive income gain (loss)		(1	)		—			—			(5	)
Comprehensive loss	$	(6,451	)	$	(3,798	)	$	(14,055	)	$	(7,696	)

See accompanying notes to condensed consolidated financial statements.

Index

VIRNETX HOLDING CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

(in thousands)

	Six Months Ended June 30, 2018			Six Months Ended June 30, 2017
Cash flows from operating activities:
Net loss	$	(14,055	)	$	(7,691	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation		10			15
Stock-based compensation		2,008			1,715
Changes in assets and liabilities:
Prepaid expenses and other assets		(80	)		(13	)
Accounts payable and accrued liabilities		2,552			(1,362	)
Accrued payroll and related expenses		(1,923	)		(1,303	)
Accounts receivables		(2	)		—
Income tax liability		6			(1	)
Deferred revenue		—			(750	)
Net cash used in operating activities		(11,484	)		(9,390	)
Cash flows from investing activities:
Purchase of investments		(924	)		(756	)
Proceeds from sale or maturity of investments		1,635			5,760
Net cash provided by investing activities		711			5,004
Cash flows from financing activities:
Proceeds from sale of common stock		11,639			—
Payments of taxes on restricted stock units		(33	)		(29	)
Net cash provided by (used in) financing activities		11,606			(29	)
Net change in cash and cash equivalents		833			(4,415	)
Cash and cash equivalents, beginning of period		3,135			6,627
Cash and cash equivalents, end of period	$	3,968		$	2,212

Non-cash transactions
Deferred revenue reclassified to retained earnings – ASC 606 adoption	$	2,500		$	—

See accompanying notes to condensed consolidated financial statements.

Index

VIRNETX HOLDING CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share amounts)

(Unaudited)

Note 1 — Business Description

VirnetX Holding Corporation, which we refer to as “we”, “us”, “our”, “the Company” or “VirnetX”, is engaged in the business of commercializing a portfolio of patents. We seek to license our technology, including GABRIEL Connection Technology™, to various original equipment manufacturers, or OEMs, that use our technologies in the development and manufacturing of their own products within the IP-telephony, mobility, fixed-mobile convergence and unified communications markets. Since 2012 we had revenues from settlements of patent infringement disputes whereby we received consideration for past sales of licensees that utilized our technology, where there was no prior patent license agreement, as well as license agreement revenues from settlements providing licensing for the continued use of our technology (see “Revenue Recognition”).

Our portfolio of intellectual property is the foundation of our business model. We currently own approximately 185 total patents and pending applications, including 70 U.S. patents/patent applications and 115 foreign patents/validations/pending applications. Our patent portfolio is primarily focused on securing real-time communications over the Internet, as well as related services such as the establishment and maintenance of a secure domain name registry. Our patented methods also have additional applications in the key areas of device operating systems and network security for Cloud services, Machine-to-Machine (“M2M”), communications in areas including “Smart City,” “Connected Car” and “Connected Home.” All our U.S. and foreign patents and pending patent applications relate generally to securing communications over the internet and as such, cover all our technology and other products. Our issued U.S. and foreign patents expire at various times during the period from 2019 to 2024. Some of our issued patents and pending patent applications were acquired by our principal operating subsidiary, VirnetX, Inc., from Leidos, Inc. (“Leidos”) (f/k/a Science Applications International Corporation, or SAIC) in 2006 and we are required to make payments to Leidos based on cash or certain other values generated from those patents in certain circumstances. The amount of such payments depends upon the type of value generated and certain categories are subject to maximums and other limitations.

Note 2 — Basis of Presentation and Summary of Significant Accounting Policies

Unaudited Interim Financial Information

The accompanying Condensed Consolidated Balance Sheet as of June 30, 2018, the Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2018 and 2017, the Condensed Consolidated Statements of Comprehensive Loss for the three and six months ended June 30, 2018 and 2017, and the Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2018 and 2017 are unaudited. These unaudited interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”). In our opinion, the unaudited interim condensed consolidated financial statements include all adjustments of a normal recurring nature necessary for the fair presentation of our financial position as of June 30, 2018, our results of operations for the three and six months ended June 30, 2018 and 2017, and our cash flows for the six months ended June 30, 2018 and 2017. The results of operations for the three and six months ended June 30, 2018 are not necessarily indicative of the results to be expected for the year ending December 31, 2018.

These unaudited interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2017, filed with the SEC on March 16, 2018.

Use of Estimates

We prepare our condensed consolidated financial statements in accordance with U.S. GAAP. In doing so, we have to make estimates and assumptions that affect our reported amounts of assets, liabilities, revenues, and expenses, as well as related disclosure of contingent assets and liabilities. In some cases, we could reasonably have used different accounting policies and estimates. In some cases, changes in our accounting estimates are reasonably likely to occur. Accordingly, actual results could differ materially from our estimates. To the extent that there are material differences between these estimates and actual results, our financial condition or results of operations will be affected. We base our estimates on past experience and other assumptions that we believe are reasonable under the circumstances, at the time they are made, and we evaluate these estimates on an ongoing basis. We refer to accounting estimates of this type as critical accounting policies and estimates, which we discuss further below.

Basis of Consolidation

The condensed consolidated financial statements include the accounts of VirnetX Holding Corporation and our wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated.

Index

Reclassifications

Certain prior period amounts were reclassified to conform to the current year’s presentation. None of these reclassifications had an impact on reported operating expenses, operating income or net income for any of the periods presented.

Revenue Recognition

Most of our revenue historically has been derived from licensing and royalty fees from contracts with customers which often spanned several years. We account for revenue in accordance with Accounting Standards Update (“ASU”) No.2014-09, Revenue from Contracts with Customers “Topic 606”, which we adopted on January 1, 2018 using the modified-retrospective method (see Note 8 – Effects of Adopting ASU Topic 606). Prior to January 1, 2018 we recognized revenue in accordance with previous guidance as described in our Annual Report on Form 10-K for the year ended December 31, 2017.

A performance obligation is a promise in a contract to transfer a distinct good or service to the customer in accordance with Topic 606. A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. Our revenue arrangements may consist of multiple-element arrangements, with revenue for each unit of accounting recognized as the product or service is delivered to the customer.

With the licensing of our patents, performance obligations are generally satisfied at a point in time as work is complete and our patent rights are transferred to our customers. We generally have no further obligation to our customers regarding our technology.

Certain contracts may require our customers to enter into a hosting arrangement with us and for these arrangements revenue is recognized over time, generally over the life of the servicing contract.

Deferred revenue

From 2013 to 2016, we received contractual payments totaling $10,000. In accordance with our revenue recognition policy, we deferred and then recognized revenue over the life of the contract, but not ahead of collection. We recognized $375 and $750 of revenue, related to this contract during the three and six months ended June 30, 2017. On January 1, 2018, we adopted Topic 606 and applied the modification retrospective approach as discussed above.

Earnings Per Share

Basic earnings per share are computed by dividing earnings available to common stockholders by the weighted average number of outstanding common shares during the period. Diluted earnings per share are computed by dividing net income by the weighted average number of shares outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued.

Concentration of Credit Risk and Other Risks and Uncertainties

Our cash and cash equivalents are primarily maintained at two major financial institutions in the United States. A portion of those balances are insured by the Federal Deposit Insurance Corporation. During the six months ended June 30, 2018 we had funds which were uninsured. We do not believe that we are subject to any unusual financial risk beyond the normal risk associated with commercial banking relationships with major financial institutions. We have not experienced any losses on our deposits of cash and cash equivalents.

Prepaid Expenses

Prepaid expenses at June 30, 2018 include the current portion of prepaid rent for a facility lease for corporate promotional and marketing purposes. From inception, the prepayment totaling $4,000 is being amortized over the 10-year term of the lease. The unamortized non-current portion of the prepayment is included in Prepaid expenses, non-current on the condensed consolidated balance sheet.

Impairment of Long-Lived Assets

On an annual basis, we identify and record impairment losses on long-lived assets when events and changes in circumstances indicate that the carrying amount of an asset might not be recoverable. Recoverability is measured by comparison of the anticipated future net undiscounted cash flows to the related assets’ carrying value. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the projected discounted future net cash flows arising from the asset.

Index

Fair Value of Financial Instruments

Fair value is the price that would result from an orderly transaction between market participants at the measurement date. A fair value hierarchy prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). Level 2 measurements utilize either directly or indirectly observable inputs in markets other than quoted prices in active markets.

Our financial instruments are stated at amounts that equal, or approximate, fair value. When we estimate fair value, we utilize market data or assumptions that we believe market participants would use in pricing the financial instrument, including assumptions about risk and inputs to the valuation technique. We use valuation techniques, primarily the income and market approach, which maximizes the use of observable inputs and minimize the use of unobservable inputs for recurring fair value measurements.

Mutual Funds: Valued at the quoted net asset value of shares held.

U.S. Government and U.S. Agency Securities: Fair value measured at the closing price reported on the active market on which the individual securities are traded.

The following tables show the adjusted cost, gross unrealized gains, gross unrealized losses and fair value of our securities by significant investment category as of June 30, 2018, and December 31, 2017.

	June 30, 2018
	Adjusted Cost		Unrealized Gains		Unrealized Losses		Fair Value		Cash and Cash Equivalents		Investments Available for Sale
Cash	$	2,056	$	-	$	-	$	2,056	$	2,056	$	-

Level 1:
Mutual funds		1,087		-		-		1,087		1,087		-
U.S. government securities		80		-		-		80		-		80
U.S. agency securities		1,468		1		-		1,469		825		644
		2,635		1		-		2,636		1,912		724
Total	$	4,691	$	1	$	-	$	4,692	$	3,968	$	724

	December 31, 2017
	Adjusted Cost		Unrealized Gains		Unrealized Losses			Fair Value		Cash and Cash Equivalents		Investments Available for Sale
Cash	$	1,972	$	—	$	—		$	1,972	$	1,972	$	—

Level 1:
Mutual funds		616		—		—			616		616
U.S. agency securities		2,001		—		(1	)		2,000		547		1,453
		2,617		—		(1	)		2,616		1,163		1,453
Total	$	4,589	$	—	$	(1	)	$	4,588	$	3,135	$	1,453

New Accounting Pronouncements

In June 2018, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2018-07, Compensation—Stock Compensation (“Topic 718”)—Improvements to Nonemployee Share-Based Payment Accounting. The amendments in this update expand the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. The amendments specify that Topic 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor’s own operations by issuing share-based payment awards. The amendments in this update are effective for public business entities for fiscal years beginning after December 15, 2018, including interim periods within that fiscal year and early adoption is permitted. We adopted the ASU effective June 30, 2018, which had no material impact on our financial position or statement of operations.

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments-Credit Losses (“Topic 326”). The purpose of this ASU is to require a financial asset measured at amortized cost basis to be presented at the net amount expected to be collected. Credit losses relating to available-for-sale debt securities should be recorded through an allowance for credit losses. This ASU is effective for interim and annual reporting periods beginning after December 15, 2019. We are evaluating the impact this guidance will have on our financial position and statement of operations.

Index

In February 2016, FASB issued ASU No. 2016-02, Leases (“Topic 842”). Topic 842 requires an entity to recognize right-of-use assets and lease liabilities on its balance sheet and disclose key information about leasing arrangements. For public companies, Topic 842 is effective for annual reporting periods beginning after December 15, 2018, including interim periods within that reporting period, with early adoption permitted. We are evaluating the impact this guidance will have on our financial position and statement of operations.

In May 2014, the FASB issued ASU No. 2014-09 Revenue from Contracts with Customers (“Topic 606”). As amended, Topic 606 supersedes prior revenue recognition requirements including most industry-specific revenue recognition guidance. In summary, the core principle of Topic 606 is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. On January 1, 2018 we adopted this standard which resulted in a $2,500 decrease in accumulated deficit and a $2,500 decrease in deferred revenue in our consolidated balance sheet (see Note 8 — Effects of Adopting ASU Topic 606).

Note 3 - Income Taxes

We had income tax expense of $0 and $5 for the three and six-months ended June 30, 2018 and 2017, respectively, as a result of minimum tax payments. During the three and six-month period ended June 30, 2018 and 2017, we had net operating losses (“NOLs”) which generated deferred tax assets for NOL carryforwards. We provided valuation allowances against the net deferred tax assets including the deferred tax assets for NOL carryforwards. Valuation allowances provided for our net deferred tax assets increased by approximately $7,400 and $3,747 for the six months ended June 30, 2018 and 2017, respectively.

In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of the deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Based on the available objective evidence, management believes it is more likely than not that the net deferred tax assets at June 30, 2018 will not be fully realizable. Accordingly, management has maintained a full valuation allowance against its net deferred tax assets at June 30, 2018. The valuation allowance carried against our net deferred tax assets was approximately $41,000 and $34,000 at June 30, 2018 and December 31, 2017, respectively.

At June 30, 2018, we have federal and state net operating loss carryforwards of approximately $103,000 and $117,000, respectively, expiring beginning in 2027 and 2028, respectively.

In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers, (“Topic 606”) which amends revenue recognition principles and provides a single set of criteria for revenue recognition among all industries. We adopted the new standard effective January 1, 2018 under the modified retrospective method. Under the modified retrospective method, we recognized deferred revenue of $2,500 through retained earnings. The tax provision is prepared based on the assumption that the Company will file accounting method change form 3115 with 2018 tax return to reflect the adoption of Topic 606.

Our tax years for 2005 and forward are subject to examination by the U.S. tax authority and various state tax authorities. These years are open due to net operating losses and tax credits remaining unutilized from such years.

Our policy is to recognize interest and penalties accrued on uncertain tax positions as a component of income tax expense. As of June 30, 2018, we had accrued immaterial amounts of interest and penalties related to the uncertain tax positions.

Note 4 — Commitments and Related Party Transactions

We lease our offices under an operating lease with a third party expiring in October 2019. We recognize rent expense on a straight-line basis over the term of the lease.

We lease the use of an aircraft from K2 Investment Fund LLC (“LLC”) for business travel for employees of the Company. We incurred approximately $75 and $683 compared to $213 and $472 in rental fees and reimbursements to the LLC during the three and six months ended June 30, 2018 and 2017, respectively. Our Chief Executive Officer and Chief Administrative Officer are the managing partners and control the equity interests of the LLC. We entered into a 12-month non-exclusive lease with LLC for use of the plane at a rate of $8 per flight hour, with no minimum usage requirement. The agreement contains other terms and conditions normal in such transactions and can be cancelled by either us or LLC with 30 days’ notice. The lease renews on an annual basis unless terminated by the lessor or lessee. Neither party has exercised their termination rights.

Note 5 — Stock-Based Compensation

We have a stock incentive plan for employees and others called the VirnetX Holding Corporation 2013 Equity Incentive Plan (the “Plan”), which has been approved by our stockholders. In May 2017, the Board approved an amendment and restatement of the Plan to, among other things, increase the shares reserved under the Plan by 2,500,000 shares (the “Plan Amendment”). Our stockholders approved of the Plan Amendment at the 2017 Annual Meeting of Stockholders held on June 1, 2017. The Plan provides for grants of 16,624,469 shares of our common stock, including stock options and restricted stock units (“RSUs”), and will expire in 2023. As of June 30, 2018, 1,780,315 shares remained available for grant under the Plan.

Index

During the three months ended June 30, 2018, we granted options for a total of 336,000 shares with a weighted average grant date fair value of $2.31 per options. During the three months ended June 30, 2017, we granted options totaling 331,000 shares with a weighted average grant date fair value of $2.72.

During the six months ended June 30, 2018, we granted options for a total of 1,006,000 shares. The weighted average fair value at the grant dates for options issued during the six months ended June 30, 2018 was $2.52 per option. The fair values of options at the grant date were estimated utilizing the Black-Scholes valuation model with the following weighted average assumptions for the six months ended June 30, 2018 (i) dividend yield on our common stock of 0 percent (ii) expected stock price volatility of 85 percent (iii) a risk-free interest rate of 2.65 percent and (iv) and expected option term of 6 years.

During the six months ended June 30, 2017, we granted options for a total of 356,000 shares with a weighted average grant date fair value of $2.65. The fair values of options at the grant date were estimated utilizing the Black-Scholes valuation model with the following weighted average assumptions for the six months ended June 30, 2017 (i) dividend yield on our common stock of 0 percent (ii) expected stock price volatility of 84 percent (iii) a risk-free interest rate average of 1.94 percent and (iv) an expected option term of 6 years.

During the three months ended June 30, 2018 and 2017, we granted 223,997 and 220,664 RSUs, respectively. The weighted average fair values at the grant dates for RSUs issued during the three months ended June 30, 2018 and 2017 were $3.19 and $3.83 per RSU, respectively. RSUs, which are subject to forfeiture if service terminates prior to the shares vesting, are expensed ratably over the vesting period. During the three months ended June 30, 2018 and 2017, we paid $33 and $29 in withholding taxes on shares issued upon conversion of RSUs. The underlying shares were canceled. These amounts are reflected as financing costs in the accompanying statement of cash flows.

During the six months ended June 30, 2018 and 2017, we granted 243,997 and 220,664 RSUs, respectively. The weighted average fair values at the grant dates for RSUs issued during the six months ended June 30, 2018 and 2017 were $3.28 and $3.83 per RSU, respectively. RSUs, which are subject to forfeiture if service terminates prior to the shares vesting, are expensed ratably over the vesting period. During the six months ended June 30, 2018 and 2017, we paid $33 and $29 in withholding taxes on shares issued upon conversion of RSUs. The underlying shares were canceled. These amounts are reflected as financing costs in the accompanying statement of cash flows.

Stock-based compensation expense included in general and administrative expense was $467 and $855 and in research and development expense was $655 and $1,154 for the three and six months ended June 30, 2018, respectively, and $442 and $834 for general and administrative and $440 and $881 for research and development for the three and six months ended June 30, 2017, respectively.

As of June 30, 2018, the unrecognized stock-based compensation expense related to non-vested stock options and RSUs was $7,160 and $2,001, respectively, which will be amortized over an estimated weighted average period of approximately 3.08 and 2.72 years, respectively.

During the six-month period ended June 30, 2018 we issued 168,219 new shares of common stock as a result of vesting RSUs. No shares of common stock were issued as a result of stock options exercised during the period.

Note 6 — Equity

Common Stock

On August 21, 2015, we filed a universal shelf registration statement with the U.S. Securities and Exchange Commission enabling us to offer and sell from time to time up to $100,000 of equity, debt or other types of securities. We also entered into an at-the-market (“ATM”) equity offering sales agreement with Cowen & Company, LLC (“Cowen”) on August 20, 2015, under which we may offer and sell shares of our common stock having an aggregate value of up to $35,000. On March 8, 2018, we amended our August 20, 2015 equity offering sales agreement (“Amended Agreement”) with Cowen whereby the maximum aggregate value of the Company’s common stock (“Shares”) we may offer and sell, from time to time, was increased from $35,000 to $50,000. We intend to use the proceeds of this offering for GABRIEL product development and marketing, and general corporate purposes, which may include working capital, capital expenditures, other corporate expenses and acquisitions of complementary products, technologies or businesses.

During the six months ended June 30, 2018, we sold 3,072,610 shares under the ATM. The average sales price per common share was $3.91 and the aggregate proceeds from the sales totaled $12,000 during the period. Sales commissions, fees and other costs associated with the ATM totaled $360.

Index

Warrants

In 2015 we issued warrants (“Advisor Warrants”) for the purchase of 25,000 shares of common stock at an exercise price of $7 per share, which expire in April 2020. The Advisor Warrants were issued for advisory services provided by a third party. Our Advisor Warrants were recorded at fair value on the issuance date and included in Additional Paid in Capital on our Condensed Consolidated Balance Sheet. The Advisor Warrants are exercisable by the holder, in whole or in part, until expiration, and may also be net-share-settled. Terms of the warrant agreement include no registration requirements for the underlying common stock and there are no anti-dilution provisions.

Information about warrants outstanding during the three months ended June 30, 2018 follows:

Original Number of Warrants Issued		Exercise Price per Common Share		Exercisable at December 31, 2017		Became Exercisable		Exercised		Terminated / Cancelled / Expired		Exercisable at June 30, 2018		Expiration Date
	25,000	$	7.00		25,000		—		—		—		25,000	April 2020
					25,000		—		—		—		25,000

Index

Note 7 — Litigation

We have multiple intellectual property infringement lawsuits pending in the United States District Court for the Eastern District of Texas, Tyler Division (“USDC”), and United States Court of Appeals for the Federal Circuit (“USCAFC”).

VirnetX Inc. v. Cisco Systems, Inc. et al. (Case 6:10-CV-00417-LED) (“Apple I”)

On August 11, 2010, we filed a complaint against Aastra USA. Inc. (“Aastra”), Apple Inc. (“Apple”), Cisco Systems, Inc. (“Cisco”), and NEC Corporation (“NEC”) in the USDC in which we alleged that these parties infringe on certain of our patents (U.S. Patent Nos. 6,502,135, 7,418,504, 7,921,211 and 7,490,151). We sought damages and injunctive relief. The cases against each defendant were separated by the judge. Aastra and NEC agreed to sign license agreements with us and we dropped all accusations of infringement against them. A jury in USDC decided that our patents were not invalid and rendered a verdict of non-infringement by Cisco on March 4, 2013. Our motion for a new Cisco trial was denied and the case against Cisco was closed.

On November 6, 2012, a jury in the USDC awarded us over $368,000 for Apple’s infringement of four of our patents, plus daily interest up to the final judgment.

Apple filed an appeal of the judgment to the USCAFC. On September 16, 2014, USCAFC affirmed the USDC jury’s finding that all four of our patents at issue are valid and confirmed the USDC jury’s finding of infringement of VPN on Demand under many of the asserted claims of our ‘135 and ‘151 patents, and the USDC’s decision to allow evidence about our license and royalty rates regarding the determination of damages. However, the USCAFC vacated the USDC jury’s damages award and some of the USDC’s claim construction with respect to parts of our ‘504 and ‘211 patents and remanded the damages award and determination of infringement with respect to FaceTime back to the USDC for further proceedings.

On September 30, 2016, pursuant to the 2014 remand from the USCAFC, a jury in the USDC, awarded us $302,400 for Apple’s infringement of four of our patents. On September 29, 2017, the USDC entered its final judgement, denied all of Apple’s post-trial motions, granted all our post-trial motions, including our motion for willful infringement and enhanced the royalty rate during the willfulness period from $1.20 to $1.80 per device, and awarded us costs, certain attorneys’ fees, and prejudgment interest. The total amount in the final judgement was $439,700, including $302,400 (jury verdict), $41,300 (enhanced damages) and $96,000 (costs, fees and interest).

On October 27, 2017 Apple filed its notice of appeal of this final judgement to the USCAFC. Apple filed its opening brief on March 19, 2018. We filed our response on April 4, 2018. On April 11, 2018, USCAFC designated Cases 18-1197-CB, Case 17-1368 and Case 17-1591 as companion cases and assigned to the same merits panel. Events and developments after this order are described below under VirnetX Inc. v. The Mangrove Partners (USCAFC Case 17-1368) (“Consolidated Appeal”).

VirnetX Inc. v. Apple, Inc. (Case 6:12-CV-00855-LED) (“Apple II”)

On April 12, 2018, an USDC jury awarded us $502,600 in this case. The same jury in the second part of the case determined that Apple had willfully infringed all the patents in the case, which per the jury instructions is reserved for only the most egregious behavior, such as where the infringement is malicious, deliberate, consciously wrongful, or done in bad faith. The verdict covers issues of infringement by products that were allegedly changed after the Apple I trial including, Apple’s redesigned VOD (VPN on Demand) in iOS 7 to iOS 11, the redesigned FaceTime in iOS 7 to iOS 11 and OS X 10.9 and later. This case began on November 6, 2012, when we had filed a complaint against Apple in USDC in which we alleged that Apple infringed on certain of our patents, (U.S. Patent Nos. 6,502,135, 7,418,504, 7,921,211 and 7,490,151). We sought damages and injunctive relief. The accused products include the iPhone 5, iPod Touch 5th Generation, iPad 4^th Generation, iPad mini, and the latest Macintosh computers; these products were not included in the Apple I case because they were released after the Apple I case was initiated. Post-Trial Motions hearing was held on July 18, 2018. We are currently awaiting the courts’ ruling on these motions and the final judgment.

VirnetX Inc. v. The Mangrove Partners (USCAFC Case 17-1368) (“Consolidated Appeal”)

On April 11, 2018, the USCAFC in an order designated following appeals as companion cases and assigned to the same merits panel;

·	VirnetX Inc. v. The Mangrove Partners (USCAFC Case 17-1368)

On December 16, 2016, we filed appeals with the USCAFC, appealing the invalidity findings by the Patent Trial and Appeal Board (“PTAB”) in IPR2015-01046, and on December 20, 2016 for IPR2015-1047, involving our U.S. Patent Nos. 6,502,135, and 7,490,151. These appeals also involve Apple, Inc. and one of them involves Black Swamp IP, LLC. These appeals have been consolidated into a single case.

·	VirnetX Inc. v. Cisco Systems, Inc. (USCAFC Case 18-1197-CB) (Appeal of Apple I Case)

On October 27, 2017 Apple filed its notice of appeal of the Final Judgment entered on September 29, 2017 to the United States Court of Appeals for the Federal Circuit.

·	VirnetX Inc. v. Apple Inc., Cisco Systems, Inc. (USCAFC Case 17-1591)

On February 7, 2017, we filed appeals with the USCAFC, appealing the invalidity findings by the PTAB in inter-parties’ reexamination nos. 95/001,788, 95/001,789, and 95/001,856 related to our U.S. Patent Nos. 7,921,211 and 7,418,504. These appeals have been consolidated into a single case

Index

The written briefing in all these USCAFC cases have been concluded; the oral arguments have not yet been scheduled.

VirnetX Inc. v. Apple Inc. (Case 17-2490)

On August 23, 2017, we filed with the USCAFC appeals of the invalidity findings by the PTAB in IPR2016-00331 and IPR2016-00332 involving our U.S. Patent No. 8,504,696. The briefing in these appeals has been concluded; the oral arguments have not yet been scheduled.

VirnetX Inc. (Case 17-2593)

On September 22, 2017, we filed with the USCAFC, appeals of the invalidity findings by the PTAB in IPR2016-00693 and IPR2016-00957 involving our U.S. Patent Nos. 7,418,504 and 7,921,211. The briefing in these appeals has not taken place. The entity that initiated the IPRs, Black Swamp IP, LLC, indicated on October 18, 2017, that it would not participate in the appeals. On November 27, 2017, the USPTO indicated that it would intervene in the appeals. On January 19, 2018, the USCAFC stayed these appeals pending the USCAFC’s decision in Case 17-1591.

One or more potential intellectual property infringement claims may also be available to us against certain other companies who have the resources to defend against any such claims. Although we believe these potential claims are likely valid, commencing a lawsuit can be expensive and time-consuming, and there is no assurance that we could prevail on such potential claims if we made them. In addition, bringing a lawsuit may lead to potential counterclaims which may distract our management and our other resources, including capital resources, from efforts to successfully commercialize our products.

Currently, we are not a party to any other pending legal proceedings and are not aware of any proceeding threatened or contemplated against us.

Index

Note 8 — Effects of Adopting ASU Topic 606

The following tables summarize the effects of adopting this standard on our unaudited condensed consolidated financial statements:

Balance Sheet Highlights	Reported As of December 31, 2017			Effects of Adopting Topic 606			As of January 1, 2018
Current liabilities:
Deferred revenue, current portion	$	1,500		$	(1,500	)	$	—
Total current liabilities	$	4,482		$	(1,500	)	$	2,982

Deferred revenue, non-current portion		1,000			(1,000	)		—
Other liabilities		140			—			140
Total Liabilities	$	5,622		$	(2,500	)	$	3,122
Accumulated deficit	$	(175,516	)	$	2,500		$	(173,016	)
Total Stockholder’s Equity	$	1,553		$	2,500		$	4,053

	As of June 30, 2018 Pre-Topic 606			Effects of Adopting Topic 606			As of June 30, 2018 (as reported)

Deferred revenue, current portion	$	1,500		$	(1,500	)	$	—
Total current liabilities	$	5,084		$	(1,500	)	$	3,584

Deferred revenue, non-current portion		250			(250	)		—
Other liabilities		140			—			140
Total liabilities	$	5,474		$	(1,750	)	$	3,724
Accumulated deficit		(188,820	)		1,750			(187,070	)
Total stockholders’ equity	$	1,897		$	1,750		$	3,647

Income Statement Highlights	Six Months Ended June 30, 2018 Pre-Topic 606			Six Months Ended June 30, 2018 Effects of Adopting Topic 606			Six Months Ended June 30, 2018 (as reported)
Revenue	$	772		$	(750	)	$	22
Loss from operations		(13,320	)		(750	)		(14,070	)
Interest income, net		20			—			20
Loss before taxes		(13,300	)		(750	)		(14,050	)
Provision for income taxes		(5	)		—			(5	)
Net loss	$	(13,305	)	$	(750	)	$	(14,055	)

	Three Months Ended June 30, 2018 Pre-Topic 606			Three Months Ended June 30, 2018 Effects of Adopting Topic 606			Three Months Ended June 30, 2018 (as reported)
Revenue	$	391		$	(375	)	$	16
Loss from operations		(6,087	)		(375	)		(6,462	)
Interest income, net		12			—			12
Loss before taxes		(6,075	)		(375	)		(6,450	)
Net loss	$	(6,075	)	$	(375	)	$	(6,450	)

Index

Cash Flow Statement Highlights	Six Months Ended June 30, 2018 Pre- Topic 606			Six Months Ended June 30, 2018 Effects of Adopting Topic 606			Six Months Ended June 30, 2018 (as reported)
Net loss	$	(13,305	)	$	(750	)	$	(14,055	)
Adjustments to reconcile net loss to net cash used in operating activities:
Deferred revenue		(750	)		750			—
Net cash used in operating activities		(11,484	)		—			(11,484	)

Note 9 — Subsequent Events

Between July 1, 2018 and August 6, 2018, we sold 297,652 shares of common stock under the ATM program. The average sales price per common share sold was $3.48 and the aggregate proceeds from the sales totaled $1,036. Sales commissions, fees and other costs associated with the ATM transactions totaled $31.

On July 8, 2018 we issued 31,865 new shares of common stock as a result of vesting RSUs.

Index

ITEM 2 — MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Company Overview

We are an Internet security software and technology company with patented technology for secure communications including 4G LTE security. Our software and technology solutions, including our Secure Domain Name Registry and GABRIEL Connection Technology™, are designed to facilitate secure communications and provide the security platform required by next-generation Internet-based applications such as instant messaging, or IM, voice over Internet protocol, or VoIP, mobile services, streaming video, file transfer, remote desktop and Machine-to-Machine, or M2M communications. Our technology generates secure connections on a “zero-click” or “single-click” basis, significantly simplifying the deployment of secure real-time communication solutions by eliminating the need for end-users to enter any encryption information. Our portfolio of intellectual property is the foundation of our business model. We currently own approximately 185 total patents and pending applications, including 70 U.S. patents/patent applications and 115 foreign patents/validations/pending applications. Our patent portfolio is primarily focused on securing real-time communications over the Internet, as well as related services such as the establishment and maintenance of a secure domain name registry. Our patented methods also have additional applications in the key areas of device operating systems and network security for Cloud services, M2M communications in the new initiatives like “Smart City”, “Connected Car” and “Connected Home” that would connect everything from social services and citizen engagement to public safety, transportation and economic development to the internet to enable more productivity, features and efficiency in our everyday lives. The subject matter of all our U.S. and foreign patents and pending applications relates generally to securing communication over the internet, and as such covers all our technology and other products. Our issued U.S. and foreign patents expire at various times during the period from 2019 to 2024. Some of our issued patents and pending patent applications were acquired by our principal operating subsidiary; VirnetX, Inc., from Leidos, Inc., or Leidos, (f/k/a Science Applications International Corporation, or SAIC) in 2006 and we are required to make payments to Leidos, based on cash or certain other values generated from those patents. The amount of such payments depends upon the type of value generated, and certain categories are subject to maximums and other limitations.

Our product GABRIEL Secure Communication Platform™, unlike other collaboration and communication products and services on the market today, does not require access to user’s confidential data and reduces the threat of hacking and data mining. It enables individuals and organizations to maintain complete ownership and control over their personal and confidential data, secured within their own private network, while enabling authorized secure encrypted access from anywhere at any time. Our GABRIEL Collaboration Suite™ is a set of applications that run on top of our GABRIEL Secure Communication Platform™. It enables seamless and secure cross-platform communications between user’s devices that have our software installed. Our GABRIEL Collaboration Suite™ is available for download and free trial, for Android, iOS, Windows, Linux and Mac OS X platforms, at http://www.gabrielsecure.com/. We continue to enhance our products and add new functionality to our products. We will provide updates to new and existing customers as they are released to the general public. Over 80 small and medium businesses have installed our GABRIEL Secure Communication Platform™ and GABRIEL Collaboration Suite™ products in their corporate networks. We intend to continue to expand our customer base with targeted promotions and direct sales initiatives.

We are actively recruiting best-of-breed partners in various vertical markets including, healthcare, finance, government, etc., to help us rapidly expand our enterprise customer base. A number of International Association of Certified ISAO (IACI) including, ISAO’s for Maritime & Ports, ISAO Credit Union ISAO, City of Chicago, ISAO Human Trafficking ISAO have chosen to deploy our software as private and secure e-technology to protect their communications. Several other ISAOs are completing their evaluations before deploying our products within their networks.

Index

We have executed a number of patent and technology licenses and intend to seek further licensees for our technology, including our GABRIEL Connection Technology™ to original equipment manufacturers, or OEMs, of chips, servers, smart phones, tablets, e-Readers, laptops, net books and other devices, within the IP-telephony, mobility, fixed-mobile convergence and unified communications markets including 4G/LTE Advanced.

We have submitted a declaration with the 3^rd Generation Partnership Project, or 3GPP, identifying a group of our patents and patent applications that we believe are or may become essential to certain developing specifications in the 3GPP LTE, Systems Architecture Evolution, or SAE project. We have agreed to make available a non-exclusive patent license under fair, reasonable and non-discriminatory terms and conditions, with compensation, or FRAND, to 3GPP members desiring to implement the technical specifications identified by us. We believe that we are positioned to license our essential security patents to 3GPP members as they move into deploying 4G/LTE Advanced devices and solutions.

We have an ongoing GABRIEL Licensing Program under which we offer licenses to a portion of our patent portfolio, technology and software, including our secure domain name registry service, to domain infrastructure providers, communication service providers as well as to system integrators. Our GABRIEL Connection Technology™ License is offered to OEM customers who want to adopt the GABRIEL Connection Technology™ as their solution for establishing secure connections using secure domain names within their products. We have developed GABRIEL Connection Technology™ Software Development Kit (SDK) to assist with rapid integration of these techniques into existing software implementations with minimal code changes and include object libraries, sample code, testing and quality assurance tools and the supporting documentation necessary for a customer to implement our technology. Customers who want to develop their own implementation of our patented techniques for supporting secure domain names, or other techniques that are covered by our patent portfolio for establishing secure communication links, can purchase a patent license. These licenses will typically include an initial license fee, as well as an ongoing royalty.

We have signed Patent License Agreements with Avaya Inc., Aastra USA, Inc., Microsoft Corporation, Mitel Networks Corporation, NEC Corporation and NEC Corporation of America, Siemens Enterprise Communications GmbH & Co. KG, and Siemens Enterprise Communications Inc. to license certain of our patents, for a one-time payment and/or an ongoing royalty for all future sales through the expiration of the licensed patents with respect to certain current and future IP-encrypted products. We have engaged IPVALUE Management Inc. to assist us in commercializing our portfolio of patents on securing real-time communications over the Internet. Under the multi-year agreement, IPVALUE is expected to originate and assist us with negotiating transactions related to patent licensing worldwide with respect to certain third parties.

We believe that the market opportunity for our software and technology solutions is large and expanding as secure domain names are now an integral part of securing the next generation 4G/LTE Advanced wireless networks and M2M communications in areas including Smart City, Connected Car and Connected Home. We also believe that all 4G/LTE Advanced mobile devices will require unique secure domain names and become part of a secure domain name registry.

We intend to continue to license our patent portfolio, technology and software, including our secure domain name registry service, to domain infrastructure providers, communication service providers as well as to system integrators. We intend to seek further license of our technology, including our GABRIEL Connection Technology™ to enterprise customers, developers and original equipment manufacturers, or OEMs, of chips, servers, smart phones, tablets, e-Readers, laptops, net books and other devices, within the IP-telephony, mobility, fixed-mobile convergence and unified communications markets including 4G/LTE.

Our employees include the core development team behind our patent portfolio, technology and software. This team has worked together for over ten years and is the same team that invented and developed this technology while working at Leidos, Inc. (“Leidos”). Leidos is a FORTUNE 500® scientific, engineering and technology applications company that uses its deep domain knowledge to solve problems of vital importance to the nation and the world, in national security, energy and the environment, critical infrastructure and health. The team has continued its research and development work started at Leidos and expanded the set of patents we acquired in 2006 from Leidos, into a larger portfolio of approximately 185 total patents and pending applications, including 70 U.S. patents/patent applications and 115 foreign patents/validations/pending applications This portfolio now serves as the foundation of our licensing business and planned service offerings and is expected to generate the majority of our future revenue in license fees and royalties. We intend to continue our research and development efforts to further strengthen and expand our patent portfolio.

We intend to continue using a primarily outsourced and leveraged model to maintain efficiency and manage costs as we grow our licensing business by, for example, offering incentives to early licensing targets or asserting our rights for use of our patents. We also intend to expand our design pilot in participation with leading 4G/LTE companies (domain infrastructure providers, chipset manufacturers, service providers and others) and build our secure domain name registry.

New Accounting Pronouncements

Index

In May 2014, the FASB issued ASU No. 2014-09 Revenue from Contracts with Customers (“Topic 606”). As amended, Topic 606 supersedes prior revenue recognition requirements in including most industry-specific revenue and recognition guidance. In summary, the core principle of Topic 606 is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. On January 1, 2018 we adopted this standard which resulted in a $2,500 decrease in accumulated deficit and a $2,500 decrease in deferred revenue in our condensed consolidated balance sheet (see Item 1 – Condensed Consolidated Financial Statements).

Index

Results of Operations

Three and Six Months Ended June 30, 2018

Compared with Three and Six Months Ended June 30, 2017

(in thousands, except per share amounts)

Revenue

We had revenues of $16 and $22 for the three and six months ended June 30, 2018, respectively, and revenues of $396 and $771 for the three and six months ended June 30, 2017, respectively.

Revenue for 2018 is from sales of our GABRIEL Connection Technology from non-refundable up-front fees earned during the period. Revenues for the three and six months ended June 30, 2017 included recognized revenue of $375 and $750, respectively, from non-refundable up-front fees earned during the period. In August 2013, we began receiving annual payments on a contract which totaled $10,000 over the 4-year period. Revenues from these fees were deferred and recognized as revenue was earned in accordance with our revenue recognition policy, but not in advance of collection. The decline in revenue was the result of the adoption of new accounting standards in 2018.

Research and Development Expenses

Research and development expenses were $1,186 and $957 for the three months ended June 30, 2018 and 2017, respectively, representing an increase of $229 due primarily to an increase in staff expense. Research and development expenses were $2,191 and $1,873 for the six months ended June 30, 2018 and 2017, respectively, representing an increase of $318 due primarily to an increase in staff expense. Certain prior period amounts of stock based compensation were reclassified out of selling, general and administrative expenses and into research and development to conform with current year presentation. These reclassifications had no impact on operating expenses for any period.

Selling, General and Administrative Expenses

Selling, general and administrative expenses includes wages and benefits of management and administrative personnel, as well as outside legal, accounting, and consulting services.

Our selling, general and administrative expenses for the three months ended June 30, 2018 compared to June 30, 2017 increased by $2,042 to $5,292. The change is primarily due to an increase in legal fees associated with our patent infringement litigation. For the six months ended June 30, 2018 our selling, general and administrative expenses increased by $5,286 to $11,901 compared to the six months ended June 30, 2017. The change was primarily due to a $5,165 increase in legal fees associated with our patent infringement actions. We expect to incur the same levels or increased levels of legal fees over the next two quarters and expect to report losses from operations as a result. (See “Legal Proceedings” for additional information regarding these infringement actions.)

Other Income and Expenses

Interest income decreased by $1 to $12 for the three months ended June 30, 2018, from $13 for the comparable 2017 period, and decreased by $11 to $20 for the six months ended June 30, 2018 from $31 for the six months ended June 30, 2017.

Net loss

Net loss for the three months ended June 30, 2018 and June 30, 2017 was $6,450 and $3,798, respectively. Net loss for the six months ended June 30, 2018 and June 30, 2017 was $14,055 and $7,691, respectively. The changes are primarily due to increases in legal fees associated with our patent infringement actions which are reported in our selling, general and administrative expenses.

Liquidity and Capital Resources

As of June 30, 2018, our cash and cash equivalents totaled approximately $3,968 and our short-term investments totaled approximately $724, compared to cash and cash equivalents of approximately $3,135 and short-term investments of approximately $1,453 at December 31, 2017. Working capital was $1,974 at June 30, 2018, and $697 at December 31, 2017. The increase in cash and investments during the six months ended June 30, 2018 was primarily attributed to proceeds from our universal shelf registration statement and ATM offering during the period.

We expect that our cash and cash equivalents and short-term investments as of June 30, 2018, as well as our ability to obtain cash from sales of common shares under the ATM and the universal shelf registration statement, described below, will be sufficient to fund our current level of selling, general and administration costs, including legal expenses and provide related working capital for the foreseeable future. Over the longer term, we expect to derive the majority of our future revenue from license fees and royalties associated with our patent portfolio, technology, software and secure domain name registry in the United States and other markets around the world.

Index

Universal Shelf Registration Statement and ATM Offering

On August 21, 2015, we filed a universal shelf registration statement with the U.S. Securities and Exchange Commission enabling us to offer and sell from time to time up to $100,000 of equity, debt or other types of securities. We also entered into an at-the-market (“ATM”) equity offering sales agreement with Cowen & Company, LLC (“Cowen”) on August 20, 2015, under which we may offer and sell shares of our common stock having an aggregate value of up to $35,000. On March 8, 2018, we amended our August 20, 2015 equity offering sales agreement (“Amended Agreement”) with Cowen whereby the maximum aggregate value of the Company’s common stock (“Shares”) we may offer and sell, from time to time, was increased from $35,000 to $50,000. We intend to use the proceeds of this offering for Gabriel product development and marketing, and general corporate purposes, which may include working capital, capital expenditures, other corporate expenses and acquisitions of complementary products, technologies or businesses.

On July 30, 2018 we filed a $100,000 replacement registration statement on SEC Form S-3, which will replace our current S-3 registration statement discussed above and expires on September 2, 2018. We have used approximately 40% of our existing and effective S-3 registration. The replacement registration statement will allow us to offer securities after the existing S-3 expires.

We expect to use proceeds from this offering for general corporate purposes, which may include GABRIEL product development and marketing, working capital, capital expenditures, other corporate expenses and acquisitions of complementary products, technologies or businesses.

Income Taxes

At June 30, 2018, we have federal and state net operating loss carryforwards of approximately $103,000 and $117,000, respectively, expiring beginning in 2027 and 2028, respectively.

Contractual Obligations

There have been no material changes to the contractual obligations disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2017.

Off-Balance Sheet Arrangements

None.

Index

ITEM 3 — QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

Interest Rate Risk

We invest our excess cash primarily in highly liquid instruments including money market, mutual funds and U.S. government and U.S. agency securities. We seek to limit the amount of our credit exposure to any one issuer.

Investments in fixed rate instruments carry a degree of interest rate risk. Fixed rate securities may have their fair market value adversely impacted due to a rise in interest rates. Due in part to these factors, our income from investments may decrease in the future.

We considered the historical volatility of short-term interest rates and determined that it was reasonably possible that an adverse change of 100 basis points could be experienced in the near term but would have an immaterial impact in the fair value of our marketable securities, which generally mature within one year of June 30, 2018.

Other Market Risks

We considered the historical volatility of our stock prices and determined that it was reasonably possible that the fair market value of our stock price could increase or decrease substantially in the near term and could have a material impact to our condensed consolidated balance sheets and statement of operations.

ITEM 4 — CONTROLS AND PROCEDURES

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, as of June 30, 2018.

The purpose of this evaluation was to determine whether as of June 30, 2018 our disclosure controls and procedures were effective to provide reasonable assurance that the information we are required to disclose in our filings with the SEC, (i) is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and (ii) accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Based on their evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that as of June 30, 2018, our disclosure controls and procedures were effective.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting during the quarter ended June 30, 2018 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Index

PART II — OTHER INFORMATION

ITEM 1 — LEGAL PROCEEDINGS

VirnetX Inc. v. Cisco Systems, Inc. et al. (Case 6:10-CV-00417-LED) (“Apple I”)

On August 11, 2010, we filed a complaint against Aastra USA. Inc. (“Aastra”), Apple Inc. (“Apple”), Cisco Systems, Inc. (“Cisco”), and NEC Corporation (“NEC”) the USDC in which we alleged that these parties infringe on certain of our patents (U.S. Patent Nos. 6,502,135, 7,418,504, 7,921,211 and 7,490,151). We sought damages and injunctive relief. The cases against each defendant were separated by the judge. Aastra and NEC agreed to sign license agreements with us and we dropped all accusations of infringement against them. A jury in USDC decided that our patents were not invalid and rendered a verdict of non-infringement by Cisco on March 4, 2013. Our motion for a new Cisco trial was denied and the case against Cisco was closed.

On November 6, 2012, a jury the USDC awarded us over $368,000 for Apple’s infringement of four of our patents, plus daily interest up to the final judgment.

VirnetX Inc. v. Apple, Inc. (Case 6:12-CV-00855-LED) (“Apple II”)

VirnetX Inc. v. The Mangrove Partners (USCAFC Case 17-1368) (“Consolidated Appeal”)

On April 11, 2018, the USCAFC in an order designated following appeals as companion cases and assigned to the same merits panel;

·	VirnetX Inc. v. The Mangrove Partners (USCAFC Case 17-1368)

·	VirnetX Inc. v. Cisco Systems, Inc. (USCAFC Case 18-1197-CB) (Appeal of Apple I Case)

On October 27, 2017 Apple filed its notice of appeal of the Final Judgment entered on September 29, 2017 to the United States Court of Appeals for the Federal Circuit.

Index

·	VirnetX Inc. v. Apple Inc., Cisco Systems, Inc. (USCAFC Case 17-1591)

The written briefing in all these USCAFC cases have been concluded; the oral arguments have not yet been scheduled.

VirnetX Inc. v. Apple Inc. (Case 17-2490)

VirnetX Inc. (Case 17-2593)

Currently, we are not a party to any other pending legal proceedings and are not aware of any proceeding threatened or contemplated against us.

Index

ITEM 1A — RISK FACTORS

Our operations and financial results are subject to various risks and uncertainties, including those described below, which could adversely affect our business, financial condition, results of operations, cash flows, and the trading price of our common and capital stock. You should carefully consider the risks and uncertainties described below in addition to the other information set forth in this Quarterly Report on Form 10-Q, including the section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our condensed consolidated financial statements and related notes, before making any investment in our common stock. The risks and uncertainties described below are not the only ones we face. Additional risks and uncertainties not presently known to us or that we currently believe to be immaterial may also adversely affect our business. If any of these risk factors occur, you could lose substantial value or your entire investment in our shares.

Risks Related to Our Business and Our Financial Reporting

We are involved and will continue to be involved in litigation defending our patent portfolio, which can be time-consuming and costly and we cannot anticipate the results.

We spend a significant amount of our financial and management resources to pursue our current litigation. We believe that this litigation and others that we may pursue in the future could continue for years and consume significant financial and management resources. The counterparties to our litigation include large, well-financed companies with substantially greater resources than us. Patent litigation is risky and the outcome is uncertain, and we cannot assure you that any of our current or future litigation matters will result in a favorable outcome for us. In addition, even if we obtain favorable interim rulings or verdicts, they may be inconsistent with the ultimate resolution of the dispute. Also, we cannot assure you that we will not be exposed to claims or sanctions against us which may be costly or impossible for us to defend. Unfavorable or adverse outcomes may result in losses, exhaustion of financial resources or other adverse effects, which could encumber our ability to develop and commercialize our products.

We may need to raise additional capital to support our business growth, and this capital will be dilutive, may cause our stock price to drop or may not be available on acceptable terms, if at all.

We may need to raise additional capital, which may not be available to us when needed or may not be available on terms acceptable to us, to support our business growth or to respond to business opportunities, challenges or unforeseen circumstances, including sales under our ATM or our universal shelf registration statement. Our ability to obtain additional capital, if and when required, will depend on our business plans, investor demand, our operating performance, the condition of the capital markets, the terms of our current contractual obligations and other factors. If we raise additional funds through the issuance of equity, equity-linked or debt securities, including those under our ATM or our Universal Shelf Registration Statement, those securities may have rights, preferences, or privileges senior to the rights of our common stock, and our existing stockholders may experience dilution. Additionally, we are unable to predict the future success of our ATM offering or any other offering. Sales of a substantial number of shares of our common stock in the public market, or the perception that these sales or other financings might occur, could depress the market price of our common stock and could also impair our ability to raise capital through the sale of additional equity securities. If we issue debt securities or incur indebtedness, we could experience increased future payment obligations and a need to comply with restrictive covenants, such as limitations on our ability to incur additional debt, limitations on our ability to acquire, sell or license intellectual property rights and other operating restrictions that could adversely impact our ability to conduct our business. If we are unable to obtain additional capital, or are unable to obtain additional capital on satisfactory terms, our ability to continue to support our business growth or to respond to business opportunities, challenges, or other circumstances could be adversely affected, and our business may be harmed.

We have terminated our revenue sharing and licensing arrangement with PITA and we cannot be sure any of our potential alternative strategies in Japan, or elsewhere, will be successful.

As previously disclosed in our public filings, the PITA Agreements terminated in March 2018. PITA may dispute the effectiveness of that termination and litigation, which may be expensive and distracting to management, may ensue. Although we intend to pursue alternative strategies in our expansion efforts in Japan and other countries, including potential partnerships, joint ventures and other arrangements with third parties, we cannot be sure these efforts will be successful or be favorable to us.

We may not be able to capitalize on market opportunities related to our licensing strategy or our patent portfolio.

Our business strategy includes licensing our patents and technology to other companies in order to reach a larger end-user base than we could reach through direct sales and marketing efforts; as such, our business strategy and revenues will depend on intellectual property licensing fees and royalties for the majority of our revenues. We currently derive minimal revenue from licensing activities and we cannot assure you that we will successfully capitalize on our market opportunities or that our current business strategy will succeed. Factors that may affect our ability to execute our current business strategy include, but are not limited to, the following:

•

Although to date we have entered into a limited number of settlement and license agreements, we may not be successful in entering into further licensing relationships, or if we are successful in entering into such relationships, the acquisition of them may be expensive, and they, as well as our existing settlement and our existing and pending license agreements may not generate the financial results we expect;

Index

•	Third parties may challenge the validity of our patents;

•	The pendency of our various litigations may cause potential licensees not to do business with us;

•	We face, and we expect to continue to face, intense competition from new and established competitors who may have superior products and services or better marketing, financial or other capacities than we do; and

•	It is possible that one or more of our potential customers or licensees develops or otherwise sources products or technologies similar to, competitive with or superior to ours.

If we are not able to adequately protect our patent rights, our business would be negatively impacted.

We believe our patents are valid, enforceable and valuable. Notwithstanding this belief, third parties may make claims of infringement or invalidity claims with respect to our patents and such claims could give rise to material cost for defense or settlement or both, jeopardize or substantially delay a successful outcome of litigation we are or may become involved in, divert resources away from our other activities, limit or cease our revenues related to such patents, or otherwise materially and adversely affect our business. Similar challenges could also prevent us from obtaining additional patents in the future. Additionally, several of our patents are currently, and other patents may in the future be, subject to United States Patent and Trademark Office (“USPTO”) post-grant inter partes review proceedings (“IPR”) which may result in all or part of these patents being invalidated, or the claims of our patents being limited. Unfavorable or adverse outcomes in our litigation or IPRs may result in losses, exhaustion of financial resources, reduction in our ability to enforce our intellectual property rights, or other adverse effects, which could encumber our ability to develop and commercialize our products. Even if we are successful in enforcing our intellectual property rights, our patents may not ultimately provide us with any competitive advantages and may be less valuable than we currently expect. These risks may be heightened in countries other than the United States where laws regarding patent protection are less developed and may be negatively affected by the fact that legal standards in the United States and elsewhere for protection of intellectual property rights in Internet-related businesses are uncertain and still evolving. In addition, there are a significant number of United States and foreign patents and patent applications in our areas of interest, and we expect that significant litigation in these areas will continue and will add uncertainty to the value of certain patents and other intellectual property rights in our areas of interest. If we are unable to protect our intellectual property rights or otherwise realize value from them, our business would be negatively affected.

We can provide no assurances that the licensing of our essential security patents under FRAND will be successful.

At the request of the European Telecommunications Standards Institute (“ETSI”), and the Alliance for Telecommunications Industry Solutions (“ATIS”), we agreed to update our licensing declaration to ETSI and ATIS under their respective Intellectual Property Rights policies. This was in response to our Statement of Patent Holder identifying a group of our patents and patent applications that we believe are or may become essential to certain developing specifications in the 3^rd Generation Partnership Project (3GPP) Long Term Evolution (“LTE”), Systems Architecture Evolution (“SAE”) project. We will make available a non-exclusive patent license under FRAND (fair, reasonable and non-discriminatory terms and conditions, with compensation) for the patents identified by us that are or become essential, to applicants desiring to implement the Technical Specifications identified by us, as set forth in the updated licensing declaration under the ATIS and ETSI Intellectual Property Rights policies. Our licensing declarations under the ATIS and ETSI Intellectual Property Rights policies may limit our flexibility in determining royalties and license terms for certain of our patents. Consequently, we cannot assure you that the licensing of the essential security patents will be successful or that third parties will be willing to enter into licenses with us on reasonable terms or at all, which could have an adverse effect on our business and harm our competitive position.

Because our business is conducted or expected to be conducted in an environment that is subject to rapid change, we may be subject to various developments in regulation, law and consumer preferences to which we may not be able to adapt successfully.

The current regulatory environment for our products and services remains unclear. We can give no assurance that our planned product offerings will be in compliance with laws and regulations of local, state, United States federal or foreign authorities. Further, we can give no assurance that we will not unintentionally violate such laws or regulations or that such laws or regulations will not be modified, or that new laws or regulations will be enacted in the future which would cause us to be in violation of such laws or regulations. For example, Voice-Over-Internet Protocol (VoIP”) services are not currently subject to all the same regulations that apply to traditional telephony, but it is possible that similar regulations may be applied to VoIP in the future and that these could result in substantial costs to us which could adversely affect the marketability of our products and planned products related to VoIP. For further example, the use of the Internet and private Internet Protocol (“IP”) networks for communication is largely unregulated within the United States, but may become regulated in the future; Additionally, several foreign governments have enacted measures that could restrict or prohibit voice communications services over the Internet or private IP networks.

Our business depends on the growth of instant messaging, VoIP, mobile services, streaming video, file transfer and remote desktop and other next-generation Internet-based applications. A decline in the use of these applications due to complexity or cost of these applications relative to alternate traditional or newly developed communications channels, or development of alternative technologies, could cause a material decline in the number of users in these areas.

Index

More aggressive domestic or international regulation of the Internet in general, and Internet telephony providers and services specifically may materially and adversely affect our business, financial condition, operating results and future prospects.

Our exposure to outside influences beyond our control, including new legislation, court rulings or actions by the United States Patent and Trademark Office, could adversely affect our licensing and enforcement activities and results of operations.

Our licensing and enforcement activities are subject to numerous risks from outside influences, including the following:

•

New legislation, regulations or rules related to obtaining patents or enforcing patents could significantly increase our operating costs and decrease our revenue. For instance, the United States Supreme Court has recently modified some tests used by the USPTO in granting patents during the past 20 years which may decrease the likelihood that we will be able to obtain patents and increase the likelihood of challenge of any patents we obtain or license. In addition, the United States recently enacted sweeping changes to the United States patent system under the Leahy-Smith America Invents Act, including changes that transition the United States from a “first-to-invent” system to a “first to file” system and alter the processes for challenging issued patents;

•	More patent applications are filed each year resulting in longer delays in getting patents issued by the USPTO;

•	Federal courts are becoming more crowded, and as a result, patent enforcement litigation is taking longer; and

•	As patent enforcement becomes more prevalent, it may become more difficult for us to voluntarily license our patents.

New legislation, regulations or court rulings related to enforcing patents could harm our business and operating results.

Intellectual property is the subject of intense scrutiny by the courts, legislatures and executive branches of governments around the world. Various patent offices, governments or intergovernmental bodies may implement new legislation, regulations or rulings that impact the patent enforcement process, or the rights of patent holders and such changes could negatively affect licensing efforts and/or litigations. For example, limitations on the ability to bring patent enforcement claims, limitations on potential liability for patent infringement, lower evidentiary standards for invalidating patents, increases in the cost to resolve patent disputes and other similar developments could negatively affect our ability to assert our patent or other intellectual property rights.

It is impossible to determine the extent of the impact of any new laws, regulations or initiatives that may be proposed, or whether any of the proposals will become enacted as laws. Compliance with any new or existing laws or regulations could be difficult and expensive, affect the manner in which we conduct our business and negatively impact our business, prospects, financial condition and results of operations.

If we experience security breaches, we could be exposed to liability and our reputation and business could suffer.

We expect to retain certain confidential and proprietary customer information in our secure data centers and secure domain name registry, as well as personal data and other confidential and proprietary information relating to our business. It will be critical to our business strategy that our facilities and infrastructure remain secure and are perceived by the marketplace to be secure. Our secure domain name registry operations will also depend on our ability to maintain our computer and telecommunications equipment in effective working order and to reasonably protect our systems against interruption, and potentially depend on protection by other registrars in the shared registration system. The secure domain name servers that we will operate will be critical hardware to our registry services operations. Therefore, we expect to have to expend significant time and money to maintain or increase the security of our products, facilities and infrastructure. Security technologies are constantly being tested by computer professionals, academics and “hackers.” Advances in computer capabilities and the techniques for attacking security solutions, new discoveries in the field of cryptography or other events or developments could result in compromises or breaches of our security measures and could make some or all our products obsolete or unmarketable. Likewise, if any of our products are found to have significant security vulnerabilities, then we may need to dedicate engineering and other resources to eliminate the vulnerabilities and to repair or replace products already sold or licensed to our customers. Despite the security measures that we and our service providers utilize, our infrastructure and that of our service providers may be vulnerable to physical break-ins, computer viruses, attacks by hackers, phishing attacks, social engineering, or similar disruptive problems. It is possible that we may have to expend additional financial and other resources to address such problems. As a provider of Internet security software and technology, we may be the target of dedicated efforts by hackers and other third parties to overcome or defeat our security measures. Any physical or electronic break-in or other security breach or compromise of the information stored at our secure data centers and domain name registration systems, including any compromise due to human error or employee or contractor malfeasance, may jeopardize the security of information stored on our premises or in the computer systems and networks of our customers. In such an event, we could face significant liability and current or potential customers could be reluctant to use our services. Additionally, any such data security incident, or the perception that one has occurred could also result in adverse publicity and therefore adversely affect the market’s perception of the security of electronic commerce and communications over IP networks as well as the security or reliability of our services.

A security breach or other security incident could require a substantial level of financial resources to rectify and could result in a claim and investigation that cause us to incur substantial fines, penalties, or other liability and related legal and other costs. Any actual or perceived security breach or other security incident may also harm our reputation and make it more difficult or impossible for us to successfully market to others. Any of the foregoing matters could harm our operating results and financial condition.

Index

Privacy and data security concerns, and data collection and transfer restrictions and related domestic or foreign regulations may limit the use and adoption of our solutions and adversely affect our business.

Personal privacy, information security, and data protection are significant issues in the United States, Europe and many other jurisdictions where we have operations or offer our products. The regulatory framework governing the collection, processing, storage and use of confidential and proprietary business information and personal data is rapidly evolving. The United States. federal and various state and foreign governments have adopted or proposed requirements regarding the collection, distribution, use, security and storage of personally identifiable information and other data relating to individuals, and federal and state consumer protection laws are being applied to enforce regulations related to the online collection, use and dissemination of data.

Further, many foreign countries and governmental bodies, including the European Union (EU”), where we conduct business, have laws and regulations concerning the collection and use of personal data obtained from their residents or by businesses operating within their jurisdiction. These laws and regulations often are more restrictive than those in the United States. Laws and regulations in these jurisdictions apply broadly to the collection, use, storage, disclosure and security of data that identifies or may be used to identify or locate an individual, such as names, email addresses and, in some jurisdictions, IP addresses.

We also expect that there will continue to be new proposed laws, regulations and industry standards concerning privacy, data protection and information security in the United States, the EU, and other jurisdictions. For example, the European Commission adopted a General Data Protection Regulation (the “GDPR”) that became fully effective on May 25, 2018, superseding prior EU data protection legislation, imposing more stringent EU data protection requirements, and providing for greater penalties for noncompliance. We are in the process of reviewing the obligations imposed on us for achieving GDPR compliance and we may be required to incur substantial expense in order to make significant changes to our product and business operations in connection with compliance with the GDPR, all of which may adversely affect our revenue and product sales in the United Kingdom, a Data Protection Bill that substantially implements the GDPR also became law in May 2018. Additionally, California recently enacted legislation, the California Consumer Privacy Act (the “CCPA”) that will, among other things, require covered companies to provide new disclosures to California consumers, and afford such consumers new abilities to opt-out of certain sales of personal information, when it goes into effect on January 1, 2020. Legislators have stated that they intend to propose amendments to the CCPA before it goes into effect, and it remains unclear what, if any, modifications will be made to this legislation or how it will be interpreted. We cannot yet predict the impact of the CCPA on our business or operations, but it may require us to modify our data processing practices and policies and to incur substantial costs and expenses in an effort to comply. We cannot yet fully determine the impact these or future laws, regulations and standards may have on our business. Privacy, data protection and information security laws and regulations are often subject to differing interpretations, may be inconsistent among jurisdictions, and may be alleged to be inconsistent with our current or future practices. Additionally, we may be bound by contractual requirements applicable to our collection, use, processing, and disclosure of various types of data, including personal data, and may be bound by, or voluntarily comply with, self-regulatory or other industry standards relating to these matters. These and other requirements could reduce demand for our products, increase our costs, impair our ability to grow our business, or restrict our ability to store and process data or, in some cases, impact our ability to offer our service in some locations and may subject us to liability. Any failure or perceived failure to comply with applicable laws, regulations, industry standards, and contractual obligations may adversely affect our business. Further, in view of new or modified federal, state or foreign laws and regulations, industry standards, contractual obligations and other legal obligations, or any changes in their interpretation, we may find it necessary or desirable to fundamentally change our business activities and practices or to expend significant resources to modify our product and otherwise adapt to these changes. We may be unable to make such changes and modifications in a commercially reasonable manner or at all, and our ability to develop new products and features could be limited.

The costs of compliance with and other burdens imposed by laws, regulations and standards may limit the use and adoption of our service and reduce overall demand for it, or lead to significant fines, penalties or liabilities for any noncompliance. Privacy, information security, and data protection concerns, whether valid or not valid, may inhibit market adoption of our platform, particularly in certain industries and foreign countries.

We expect that we will experience long and unpredictable sales cycles, which may impact our operating results.

The sales cycle between initial customer contact and execution of a contract or license agreement with a customer or purchaser of our products can vary widely. We expect that our sales cycles will be long and unpredictable due to several factors, including but not limited to:

•	The need to educate potential customers about our patent rights and our product and service capabilities;

•	Our customers’ willingness to invest potentially substantial resources and modify their network infrastructures to take advantage of our products;

•	Our customers’ budgetary constraints;

•	The timing of our customers’ budget cycles;

•	Delays caused by customers’ internal review processes; and

•	Long sales cycles that may increase the risk that our financial resources are exhausted before we are able to generate significant revenue.

In addition, potential customers of our products include local, state, federal and foreign government authorities. Sales to government authorities can be extended and unpredictable. Government authorities generally have complex budgeting, purchasing, and regulatory processes that govern their capital spending, and their spending is likely to be adversely impacted by economic conditions. In addition, in many instances, sales to government authorities may require field trials and may be delayed by the time it takes for government officials to evaluate multiple competing bids, negotiate terms, and award contracts.

Index

For these reasons the sales cycle associated with our products is subject to a number of significant risks that are beyond our control. Consequently, if our forecasted customer orders are not realized or delayed, our revenues and results of operations could be materially and adversely affected.

If we are unable to expand our revenue sources or establish, sustain, grow or replace relationships with a diversified customer base, our revenues may be limited.

We currently generate revenue from a limited number of customers that have entered Settlement and License Agreements. Although our GABRIEL Collaboration Suite™ is currently generating limited revenue, it will take time for us to grow our installed user base and generate new customers. Additionally, there is no guarantee that we will be able to derive revenue from new customers, sustain or increase revenue from existing customers or replace customers from whom we currently generate revenue. As a result, our revenue may be limited or static.

We have limited technical resources and are at an early stage in commercialization of our GABRIEL Collaboration Suite™.

Part of our business includes the internal development of commercial products we seek to monetize. This aspect of our business may require significant capital, time and resources and we cannot guarantee that it will be successful or meet our expectations. We currently have only one commercial product, the GABRIEL Collaboration Suite™. As such, we have a small technical team, which may limit our ability to rapidly adapt our product to customer requirements or add new product features to maintain our competitive edge and drive adoption. Based on the scale of our technical resources, our limited historical financial data upon which to base our projected revenue or planned operating expenses related to our GABRIEL Collaboration Suite™, we may not be able to effectively:

•	Generate revenues or profit from product sales;

•	Drive adoption of our products;

•	Attract and retain customers for our products;

•	Provide appropriate levels of customer training and support for our products;

•	Implement an effective marketing strategy to promote awareness of our products;

•	Focus our research and development efforts in areas that generate returns on our efforts;

•	Anticipate and adapt to changes in our market; or

•	Protect our products from any system failures or other breaches.

In addition, a high percentage of our expenses are and will continue to be fixed. Accordingly, if we do not generate revenue as and when anticipated, our losses may be greater than expected and our operating results will suffer.

Our products are highly technical and may contain undetected errors, which could cause harm to our reputation and adversely affect our business.

Our products are highly technical and complex and, when deployed, may contain errors or defects. Despite testing, some errors in our products may only be discovered after a product has been installed and used by customers. Any errors or defects discovered in our products after commercial release could result in failure to achieve market acceptance, loss of revenue or delay in revenue recognition, loss of customers and increased service and warranty cost, any of which could adversely affect our business, operating results and financial condition. In addition, we could face claims for product liability, tort or breach of warranty, including claims relating to changes to our products made by our channel partners. The performance of our products could have unforeseen or unknown adverse effects on the networks over which they are delivered as well as on third-party applications and services that utilize our services, which could result in legal claims against us, harming our business. Furthermore, we expect to provide implementation, consulting and other technical services in connection with the implementation and ongoing maintenance of our products, which typically involves working with sophisticated software, computing and communications systems. We expect that our contracts with customers will contain provisions relating to warranty disclaimers and liability limitations, which may not be upheld. Defending a lawsuit, regardless of its merit, is costly and may divert management’s attention and adversely affect the market’s perception of us and our products. In addition, if our business liability insurance coverage proves inadequate or future coverage is unavailable on acceptable terms or at all, our business, operating results and financial condition could be adversely impacted.

Malfunctions of third-party communications infrastructure, hardware and software expose us to a variety of risks that we cannot control.

Our business will depend upon, among other things, the capacity, reliability, security and unimpeded access of the infrastructure owned by third parties that we will use to deploy our offerings. We have no control over the operation, quality or maintenance of a significant portion of that infrastructure or whether or not those third parties will upgrade or improve their equipment. We depend on these companies to maintain the operational integrity of our connections. If one or more of these companies is unable or unwilling to supply or expand its levels of service to us in the future, our operations could be severely interrupted. Also, to the extent that the number of users of networks utilizing our current or future products suddenly increases, the technology platform and secure hosting services which will be required to accommodate a higher volume of traffic may result in slower response times or service interruptions. System interruptions or increases in response time could result in a loss of potential or existing users and, if sustained or repeated, could reduce the appeal of the networks to users. In addition, users depend on real-time communications; outages caused by increased traffic could result in delays and system failures. These types of occurrences could cause users to perceive that our solution does not function properly and could therefore adversely affect our ability to attract and retain licensees, strategic partners and customers.

Index

System failure or interruption or our failure to meet increasing demands on our systems could harm our business.

The success of our license and service offerings will depend on the uninterrupted operation of various systems, secure data centers and other computer and communication networks that we establish. To the extent, the number of users of networks utilizing our future products suddenly increases, the technology platform and hosting services which will be required to accommodate a higher volume of traffic may result in slower response times, service interruptions or delays or system failures. Our systems and operations will also be vulnerable to damage or interruption from, among other things:

•	Power loss, transmission cable cuts and other telecommunications failures;

•	Damage or interruption caused by fire, earthquake, and other natural disasters;

•	Computer viruses or software defects; and

•	Physical or electronic break-ins, sabotage, intentional acts of vandalism, terrorist attacks and other events beyond our control.

System interruptions or failures and increases or delays in response time could result in a loss of potential or existing users and, if sustained or repeated, could reduce the appeal of the networks to users. These types of occurrences could cause users to perceive that our solution does not function properly and could therefore adversely affect our ability to attract and retain licensees, strategic partners and customers.

Any significant problem with our systems or operations could result in lost revenue, customer dissatisfaction or lawsuits against us. A failure in the operation of our secure domain name registration system could result in the inability of one or more registrars to register and maintain secure domain names for a period of time. A failure in the operation or update of the master directory that we plan to maintain could result in deletion or discontinuation of assigned secure domain names for a period of time. The inability of the registrar systems we establish, including our back-office billing and collections infrastructure, and telecommunications systems to meet the demands of an increasing number of secure domain name requests could result in substantial degradation in our customer support service and our ability to process registration requests in a timely manner.

Our ability to sell our solutions will be dependent on the quality of our technical support, and our failure to deliver high-quality technical support services could have a material adverse effect on our sales and results of operations.

If we do not effectively assist our customers in deploying our products, succeed in helping our customers quickly resolve post-deployment issues and provide effective ongoing support, or if potential customers perceive that we may not be able achieve to the foregoing, our ability to sell our products would be adversely affected, and our reputation with current and potential customers could be harmed. In addition, as we expand our operations internationally, our technical support team will face additional challenges, including those associated with delivering support, training and documentation in languages other than English. Our failure to deliver and maintain high-quality technical support services to our customers could result in customers choosing to use our competitors’ products and support services instead of ours in the future.

Telephone carriers have petitioned governmental agencies to enforce regulatory tariffs, which, if granted, would increase the cost of online communication, and such increase in cost may impede the growth of online communication and adversely affect our business.

Use of the Internet has over-burdened existing telecommunications infrastructures, and many high traffic areas have begun to experience interruptions in service. As a result, certain local telephone carriers have petitioned governmental agencies to enforce regulatory tariffs on IP telephony traffic that crosses over their traditional telephone networks. If the relief sought in these petitions is granted, the costs of communicating via online could increase substantially, potentially adversely affecting the growth in the use of online secure communications. Any of these developments could have an adverse effect on our business.

Index

The departure of Kendall Larsen, our Chief Executive Officer and President, and/or other key personnel could compromise our ability to execute our strategic plan and may result in additional severance costs to us.

Our success largely depends on the skills, experience and performance of our key personnel. Due to the specialized nature of our business and limited staff, we are particularly dependent on Kendall Larsen, our Chief Executive Officer and President. We have no employment agreements with any of our key executives that prevent them from leaving us at any time. In addition, we do not maintain key person life insurance for any of our officers or key employees. The loss of Mr. Larsen, or our failure to retain other key personnel or failure to adequately plan for the succession of key personnel, would jeopardize our ability to execute our strategic plan and materially harm our business.

We will need to recruit and retain additional qualified personnel to successfully grow our business.

Our future success will depend, in part, on our ability to attract and retain qualified engineering, operations, marketing, sales and executive personnel. Inability to attract and retain such personnel could adversely affect our business. Competition for engineering, operations, marketing, sales and executive personnel is intense, particularly in the technology and Internet sectors and in the regions where we conduct our business. We may need to invest significant amounts of cash and equity to attract and retain employees and expend significant time and resources to identify, recruit, train and integrate such employees, and we may never realize returns on these investments. Additionally, we can provide no assurance that we will attract or retain such personnel.

Our international expansion will subject us to additional costs and risks, and our plans may not be successful.

We expect to expand our presence internationally through, for example, international partnerships with third parties and the possibility of establishing international subsidiaries and offices. Our international expansion may present challenges and risks, including those inherent in international operations, to us and may require significant attention from management. We may not be successful in our international partnerships, expansion efforts, and we may incur significant operating expenses

We may identify future material weakness which may result in late filings, increased costs or declines in our share price.

Although we believe that we currently maintain effective control over our disclosures and procedures and internal control over financial reporting, we may in the future identify deficiencies regarding the design and effectiveness of our system of internal control over financial reporting. If we experience any material weaknesses in our internal control over financial reporting the future or are unable to provide unqualified management or attestation reports about our internal controls, we may be unable to meet financial and other reporting deadlines and may incur costs associated with remediation, and any of which could cause our share price to decline.

Risks Related to Our Common Stock

Trading in our common stock is limited and the price of our common shares may be subject to substantial volatility.

Our common stock is listed on the NYSE American LLC (formerly the NYSE MKT LLC). Over the past years, the market price of our common stock has experienced significant fluctuations. Between July 1, 2017, and June 30, 2018, the reported last adjusted closing price on NYSE American LLC for our common stock ranged between $2.20 and $8.25 per share. The price of our common stock may continue to be volatile as a result of several factors, some of which are beyond our control. These factors include, but not limited to, the following:

•	Developments or lack thereof in any then-outstanding litigation;

•	Quarterly variations in our operating results;

•	Large purchases or sales of common stock or derivative transactions related to our stock;

•	Actual or anticipated announcements of new products or services by us or competitors;

•	General conditions in the markets in which we compete; and

•	General social, political, economic and financial conditions, including the significant volatility in the global financial markets.

In addition, we believe there has been and may continue to be substantial trading in derivatives of our stock, including short selling activity or related similar activities, which are beyond our control and which may be beyond the full control of the SEC and Financial Institutions Regulatory Authority or “FINRA”. While the SEC and FINRA rules prohibit some forms of short selling and other activities that may result in stock price manipulation, such activity may nonetheless occur without detection or enforcement. We have held conversations with regulators concerning trading activity in our stock; however, there can be no assurance that should there be any illegal manipulation in the trading of our stock, it will be detected, prosecuted or successfully eradicated. Significant short selling or other types of market manipulation could cause our stock trading price to decline, to become more volatile, or both.

Index

The market price of our common stock has been and may continue to be volatile, and you could lose all or part of your investment.

The trading price of our common stock has been volatile since our initial public offering and is likely to continue to be volatile. Factors that could cause fluctuations in the market price of our common stock include, but are not limited to the following:

•	Price and volume fluctuations in the overall stock market from time to time;

•	Volatility in the market prices and trading volumes of companies in our industry or companies that investors consider comparable;

•	Changes in operating performance and stock market valuations of other companies generally, or those in our industry;

•	Sales of shares of our common stock by us or our stockholders;

•	Failure of securities analysts to maintain coverage of us, changes in financial estimates by securities analysts who follow us, or our failure to meet these estimates or the expectations of investors;

•	The financial projections we may provide to the public, any changes in those projections or our failure to meet those projections;

•	Announcements by us or our competitors of new products or services;

•	The public’s reaction to our press releases, other public announcements and filings with the SEC;

•	Rumors and market speculation involving us or other companies in our industry;

•	Actual or anticipated changes in our results of operations;

•	Actual or anticipated developments in our business, our competitors’ businesses or the competitive landscape generally;

•	Litigation involving us, our industry or both, or investigations by regulators into our operations or those of our competitors;

•	Announced or completed acquisitions of businesses or technologies by us or our competitors;

•	New laws or regulations or new interpretations of existing laws or regulations applicable to our business;

•	Changes in accounting standards, policies, guidelines, interpretations or principles;

•	Any significant change in our management; and

•	General economic conditions and slow or negative growth of our markets.

Further, in recent years the stock markets have experienced extreme price and volume fluctuations that have affected and continue to affect the market prices of equity securities of many companies. These fluctuations often have been unrelated or disproportionate to the operating performance of those companies. In addition, the stock prices of many technology companies have experienced wide fluctuations that have often been unrelated to the operating performance of those companies. These broad market and industry fluctuations, as well as general economic, political and market conditions such as recessions, government shutdowns, interest rate changes the stability of the EU and the exit of the United Kingdom or international currency fluctuations, may cause the market price of our common stock to decline. In the past, following periods of volatility in the overall market and the market price of a particular company’s securities, securities class action litigation has often been instituted against these companies.

We do not currently pay dividends on our common stock and thus stockholders must look to appreciation of our common stock to realize a gain on their investments.

Our dividend policy is within the discretion of our Board of Directors and will depend upon various factors, including our business, financial condition, results of operations, capital requirements, and investment opportunities. We therefore cannot make assurances that our Board of Directors will determine to pay regular or special dividends in the future. Accordingly, unless our Board of Directors determines to pay dividends, stockholders will be required to look to appreciation of our common stock to realize a gain on their investment. This appreciation may not occur.

Index

The exercise of our outstanding stock options, RSU’s and issuance of new shares would result in a dilution of our current stockholders’ voting power and an increase in the number of shares eligible for future resale in the public market which may negatively impact the market price of our stock.

The exercise of our outstanding vested stock options would dilute the ownership interests of our existing stockholders. As of June 30, 2018, we had outstanding options to purchase an aggregate of 6,042,316 shares of common stock representing approximately 10% of our total shares outstanding of which 3,503,260 were vested and therefore exercisable. To the extent outstanding stock options are exercised, additional shares of common stock will be issued, existing stockholders’ percentage voting interests will decline and the number of shares eligible for resale in the public market will increase. Such increase may have a negative effect on the value or market trading price of our common stock.

The market price of our common stock may decline because our operating results may not be consistent and may be difficult to predict.

Our reported net income has fluctuated in the past due to several factors. We expect that our future operating results may also fluctuate due to the same or similar factors. We had a net loss of $28.6 million for the year ended December 31, 2016, a net loss of $17.3 million for the year ended December 31, 2017, and a net loss of $14 million for the six months ended June 30, 2018, with an accumulated deficit of $187 million. The following include some of the factors that may cause our operating results to fluctuate:

•	The outcome of actions to enforce our intellectual property rights currently in progress or that we may undertake in the future, and the timing thereof;

•	The amount and timing of receipt of license fees from potential infringers, licensees or customers;

•	The rate of adoption of our patented technologies;

•

The number of new license arrangements we may execute, or that may expire, within a particular period and the scope of those licenses, including the number of our patents which are licensed, the extent of prior infringement of our patent rights, royalty rates, timing of payment obligations, expiration date etc.;

•	The success of a licensee in selling products that use our patented technologies; and

•	The amount and timing of expenses related to our patent filings and enforcement proceedings, including litigation, related to our intellectual property rights.

These fluctuations may make our business particularly difficult to manage, adversely affect our business and operating results, make our operating results difficult for investors to predict and, further, cause our results to fall below investor’s expectations and adversely affect the market price of our common stock.

Because ownership of our common stock is concentrated, investors may have limited influence on stockholder decisions.

As of June 30, 2018, our executive officers and directors beneficially owned approximately 14.7% of our outstanding common stock. In addition, a group of stockholders that, as of December 31, 2007, held 4,766,666 shares, or approximately 8% of our outstanding common stock, have entered into a voting agreement with us that requires them to vote all of their shares of our voting stock in favor of the director nominees approved by our Board of Directors at each director election going forward, and in a manner that is proportional to the votes cast by all other voting shares as to any other matters submitted to the stockholders for a vote. However, we cannot be certain how many shares of our common stock this group of stockholders currently owns. Because of their beneficial ownership interest, our officers and directors could significantly influence stockholder actions of which you disapprove or that are contrary to your interests. This ability to exercise significant influence could prevent or significantly delay another company from acquiring or merging with us.

Our protective provisions in our amended and restated certificate of incorporation and bylaws could make it difficult for a third party to successfully acquire us even if you would like to sell your stock to them.

We have a number of protective provisions in our amended and restated certificate of incorporation and bylaws that could delay, discourage or prevent a third party from acquiring control of us without the approval of our Board of Directors. These protective provisions include:

•

A staggered Board of Directors: This means that only one or two directors (since we have a five-person Board of Directors) will be up for election at any given annual meeting. This has the effect of delaying the ability of stockholders to affect a change in control of us because it would take two annual meetings to effectively replace a majority of the Board of Directors.

•

Blank check preferred stock: Our Board of Directors has the authority to establish the rights, preferences and privileges of our 10,000,000 authorized, but unissued, shares of preferred stock. Therefore, this stock may be issued at the discretion of our Board of Directors with preferences over your shares of our common stock in a manner that is materially dilutive to you. In addition, blank check preferred stock can be used to create a “poison pill” which is designed to deter a hostile bidder from buying a controlling interest in our stock without the approval of our Board of Directors. We have not adopted such a “poison pill;” but our Board of Directors has the ability to do so in the future, very rapidly and without stockholder approval.

Index

•

Advance notice requirements for director nominations and for new business to be brought up at stockholder meetings: Stockholders wishing to submit director nominations or raise matters to a vote of the stockholders must provide notice to us within very specific date windows and in very specific form in order to have the matter voted on at a stockholder meeting. This has the effect of giving our Board of Directors and management more time to react to stockholder proposals generally and could also have the effect of disregarding a stockholder proposal or deferring it to a subsequent meeting to the extent such proposal is not raised properly.

•

No stockholder actions by written consent: No stockholder or group of stockholders may take actions rapidly and without prior notice to our Board of Directors and management or to the minority stockholders. Along with the advance notice requirements described above, this provision also gives our Board of Directors and management more time to react to proposed stockholder actions.

•	Super majority requirement for stockholder amendments to the By-laws: Stockholder proposals to alter or amend our By-laws or to adopt new By-laws can only be approved by the affirmative vote of at least 66 2/3% of the outstanding shares of our common stock.

•

No ability of stockholders to call a special meeting of the stockholders: Only the Board of Directors or management can call special meetings of the stockholders. This could mean that stockholders, even those who represent a significant percentage of our shares of common stock, may need to wait for the annual meeting before nominating directors or raising other business proposals to be voted on by the stockholders.

In addition, the provisions of Section 203 of the Delaware General Corporate Law govern us. These provisions may prohibit large stockholders, in particular those owning 15% or more of our outstanding voting stock, from merging or combining with us for a certain period of time.

These and other provisions in our amended and restated certificate of incorporation, our bylaws and under Delaware law could discourage potential takeover attempts, reduce the price that investors might be willing to pay for shares of our common stock in the future and result in the market price being lower than it would be without these provisions

Index

ITEM 6 —EXHIBITS.

The documents listed in the Exhibit Index of the Quarterly Report on Form 10-Q are incorporated by reference or are filed with this Quarterly Report on Form 10-Q, in each case as indicated therein (numbered in accordance with Item 601 of Regulation S-K).

Index

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	VIRNETX HOLDING CORPORATION

	By:	/s/ Kendall Larsen
		Name	Kendall Larsen

		Title	Chief Executive Officer (Principal Executive Officer)

	By:	/s/ Richard H. Nance
		Name	Richard H. Nance

		Title	Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)

Date: August 9, 2018

Index

EXHIBIT INDEX

Exhibit Number	Description
31.1**	Certification of the President and Chief Executive Officer pursuant to Exchange Act Rules 13a – 14(a) and 15d – 14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2**	Certification of the Chief Financial Officer pursuant to Exchange Act Rules 13a – 14(a) and 15d – 14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1***	Certification of the President and Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2***	Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101	Interactive Data Files

*	Portions of this Exhibit have been omitted pursuant to a request for confidential treatment. The omitted portions were filed separately with the Securities and Exchange Commission.

**	Filed herewith.

***

The certifications attached as Exhibit 32.1 and Exhibit 32.2 that accompany this Quarterly Report on Form 10-Q are deemed furnished and not filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of VirnetX Holding Corporation under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Quarterly Report on Form 10-Q, irrespective of any general incorporation language contained in such filing.

EX-31.1 2 ex31_1.htm EXHIBIT 31.1

EXHIBIT 31.1

CERTIFICATIONS

I, Kendall Larsen, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of VirnetX Holding Corporation for the quarter ended June 30, 2018;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15 (e) and 15d-15 (e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15 (f) and 15d-15 (f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

	/s/ Kendall Larsen
	Kendall Larsen
	President and Chief Executive Officer
	(Principal Executive Officer)

Date: August 9, 2018

EX-31.2 3 ex31_2.htm EXHIBIT 31.2

EXHIBIT 31.2

CERTIFICATIONS

I, Richard H. Nance, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of VirnetX Holding Corporation for the quarter ended June 30, 2018;

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

	/s/ Richard H. Nance
	Richard H. Nance
	Chief Financial Officer
	(Principal Financial Officer and Principal Accounting Officer)

Date: August 9, 2018

EX-32.1 4 ex32_1.htm EXHIBIT 32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of VirnetX Holding Corporation (the “Company”) on Form 10-Q for the quarter ended June 30, 2018 as filed with the Securities and Exchange Commission on August 9, 2018 (the “Report”), I, Kendall Larsen, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

	/s/ Kendall Larsen
	Kendall Larsen
	President and Chief Executive Officer
	(Principal Executive Officer)

Date: August 9, 2018

EX-32.2 5 ex32_2.htm EXHIBIT 32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of VirnetX Holding Corporation (the “Company”) on Form 10-Q for the quarter ended June 30, 2018 as filed with the Securities and Exchange Commission on August 9, 2018 (the “Report”), I, Richard H. Nance, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

	/s/ Richard H. Nance
	Richard H. Nance
	Chief Financial Officer
	(Principal Financial Officer and Principal Accounting Officer)

Date: August 9, 2018

EX-101.INS 6 vhc-20180630.xml XBRL INSTANCE DOCUMENT 0001082324 2018-01-01 2018-06-30 0001082324 2018-08-06 0001082324 2017-12-31 0001082324 2018-06-30 0001082324 2017-01-01 2017-06-30 0001082324 2017-04-01 2017-06-30 0001082324 2018-04-01 2018-06-30 0001082324 2016-12-31 0001082324 2017-06-30 0001082324 us-gaap:AccountingStandardsUpdate201409Member 2017-01-01 2017-06-30 0001082324 us-gaap:AccountingStandardsUpdate201409Member 2018-01-01 2018-06-30 0001082324 us-gaap:PatentsMember 2018-06-30 0001082324 us-gaap:PatentsMember us-gaap:NonUsMember 2018-06-30 0001082324 country:US us-gaap:PatentsMember 2018-06-30 0001082324 vhc:ContractSettlement2013To2016Member 2018-06-30 0001082324 vhc:ContractSettlement2013To2016Member 2017-04-01 2017-06-30 0001082324 vhc:ContractSettlement2013To2016Member 2017-01-01 2017-06-30 0001082324 us-gaap:CashMember 2017-12-31 0001082324 us-gaap:CashMember 2018-06-30 0001082324 us-gaap:USTreasurySecuritiesMember 2017-12-31 0001082324 us-gaap:USGovernmentDebtSecuritiesMember 2018-06-30 0001082324 us-gaap:USTreasurySecuritiesMember 2018-06-30 0001082324 us-gaap:MutualFundMember 2018-06-30 0001082324 us-gaap:MutualFundMember 2017-12-31 0001082324 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2018-06-30 0001082324 us-gaap:USTreasurySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2018-06-30 0001082324 us-gaap:FairValueMeasurementsRecurringMember 2018-06-30 0001082324 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2017-12-31 0001082324 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member us-gaap:MutualFundMember 2018-06-30 0001082324 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CashMember 2017-12-31 0001082324 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MutualFundMember 2017-12-31 0001082324 us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0001082324 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member us-gaap:USTreasurySecuritiesMember 2017-12-31 0001082324 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member us-gaap:USGovernmentDebtSecuritiesMember 2018-06-30 0001082324 us-gaap:CashMember us-gaap:FairValueMeasurementsRecurringMember 2018-06-30 0001082324 us-gaap:AccountingStandardsUpdate201409Member us-gaap:RetainedEarningsMember 2017-12-31 0001082324 vhc:ContractWithCustomerMember us-gaap:AccountingStandardsUpdate201409Member 2017-12-31 0001082324 us-gaap:StateAndLocalJurisdictionMember 2018-06-30 0001082324 us-gaap:DomesticCountryMember 2018-06-30 0001082324 us-gaap:StateAndLocalJurisdictionMember us-gaap:EarliestTaxYearMember 2018-01-01 2018-06-30 0001082324 us-gaap:EarliestTaxYearMember us-gaap:DomesticCountryMember 2018-01-01 2018-06-30 0001082324 us-gaap:AccountingStandardsUpdate201409Member 2017-01-01 2017-12-31 0001082324 us-gaap:BuildingMember 2018-01-01 2018-06-30 0001082324 us-gaap:AirTransportationEquipmentMember vhc:K2InvestmentFundLLCMember 2017-01-01 2017-06-30 0001082324 us-gaap:AirTransportationEquipmentMember vhc:K2InvestmentFundLLCMember 2017-04-01 2017-06-30 0001082324 us-gaap:AirTransportationEquipmentMember vhc:K2InvestmentFundLLCMember 2018-01-01 2018-06-30 0001082324 us-gaap:AirTransportationEquipmentMember vhc:K2InvestmentFundLLCMember 2018-04-01 2018-06-30 0001082324 us-gaap:AirTransportationEquipmentMember vhc:K2InvestmentFundLLCMember 2018-06-30 0001082324 vhc:Plan2013Member 2017-05-01 2017-05-31 0001082324 vhc:Plan2013Member 2018-06-30 0001082324 us-gaap:EmployeeStockOptionMember 2018-04-01 2018-06-30 0001082324 us-gaap:EmployeeStockOptionMember 2017-01-01 2017-06-30 0001082324 us-gaap:EmployeeStockOptionMember 2017-04-01 2017-06-30 0001082324 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-06-30 0001082324 us-gaap:RestrictedStockUnitsRSUMember 2017-01-01 2017-06-30 0001082324 us-gaap:RestrictedStockUnitsRSUMember 2017-04-01 2017-06-30 0001082324 us-gaap:RestrictedStockUnitsRSUMember 2018-04-01 2018-06-30 0001082324 us-gaap:RestrictedStockUnitsRSUMember 2018-01-01 2018-06-30 0001082324 us-gaap:ResearchAndDevelopmentExpenseMember 2018-04-01 2018-06-30 0001082324 us-gaap:ResearchAndDevelopmentExpenseMember 2017-01-01 2017-06-30 0001082324 us-gaap:GeneralAndAdministrativeExpenseMember 2018-04-01 2018-06-30 0001082324 us-gaap:ResearchAndDevelopmentExpenseMember 2018-01-01 2018-06-30 0001082324 us-gaap:ResearchAndDevelopmentExpenseMember 2017-04-01 2017-06-30 0001082324 us-gaap:GeneralAndAdministrativeExpenseMember 2017-04-01 2017-06-30 0001082324 us-gaap:GeneralAndAdministrativeExpenseMember 2018-01-01 2018-06-30 0001082324 us-gaap:GeneralAndAdministrativeExpenseMember 2017-01-01 2017-06-30 0001082324 us-gaap:EmployeeStockOptionMember 2018-06-30 0001082324 us-gaap:RestrictedStockUnitsRSUMember 2018-06-30 0001082324 us-gaap:CommonStockMember vhc:UniversalShelfRegistrationStatementMember 2015-08-21 0001082324 us-gaap:CommonStockMember vhc:ATMAgreementMember 2015-08-20 0001082324 us-gaap:CommonStockMember vhc:ATMAgreementMember 2018-03-08 0001082324 us-gaap:CommonStockMember vhc:ATMAgreementMember 2018-01-01 2018-06-30 0001082324 vhc:AdvisorWarrantsMember us-gaap:WarrantMember 2018-06-30 0001082324 us-gaap:WarrantMember 2017-12-31 0001082324 vhc:AdvisorWarrantsMember us-gaap:WarrantMember 2017-12-31 0001082324 us-gaap:WarrantMember vhc:AdvisorWarrantsMember 2018-01-01 2018-06-30 0001082324 us-gaap:WarrantMember 2018-01-01 2018-06-30 0001082324 us-gaap:WarrantMember 2018-06-30 0001082324 us-gaap:PositiveOutcomeOfLitigationMember vhc:VirnetXIncVCiscoSystemsIncEtAlCase610CV00417LEDAppleIMember 2017-09-29 2017-09-29 0001082324 us-gaap:PositiveOutcomeOfLitigationMember vhc:VirnetXIncVCiscoSystemsIncEtAlCase610CV00417LEDAppleIMember 2016-09-30 2016-09-30 0001082324 us-gaap:PositiveOutcomeOfLitigationMember vhc:VirnetXIncVAppleIncCase612CV00855LEDAppleIIMember 2018-04-12 2018-04-12 0001082324 us-gaap:PositiveOutcomeOfLitigationMember vhc:VirnetXIncVCiscoSystemsIncEtAlCase610CV00417LEDAppleIMember srt:MinimumMember 2012-11-06 2012-11-06 0001082324 us-gaap:PositiveOutcomeOfLitigationMember vhc:VirnetXIncVCiscoSystemsIncEtAlCase610CV00417LEDAppleIMember 2012-11-06 2012-11-06 0001082324 us-gaap:PositiveOutcomeOfLitigationMember srt:MaximumMember vhc:VirnetXIncVCiscoSystemsIncEtAlCase610CV00417LEDAppleIMember 2017-09-29 2017-09-29 0001082324 us-gaap:PositiveOutcomeOfLitigationMember vhc:VirnetXIncVCiscoSystemsIncEtAlCase610CV00417LEDAppleIMember srt:MinimumMember 2017-09-29 2017-09-29 0001082324 us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member us-gaap:AccountingStandardsUpdate201409Member 2017-12-31 0001082324 us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2018-06-30 0001082324 vhc:CalculatedUnderRevenueGuidanceInEffectAfterTopic606Member 2017-12-31 0001082324 us-gaap:AccountingStandardsUpdate201409Member us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-06-30 0001082324 us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2018-04-01 2018-06-30 0001082324 us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2018-01-01 2018-06-30 0001082324 us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member us-gaap:AccountingStandardsUpdate201409Member 2018-04-01 2018-06-30 0001082324 us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member us-gaap:AccountingStandardsUpdate201409Member 2018-01-01 2018-06-30 0001082324 us-gaap:CommonStockMember vhc:ATMAgreementMember us-gaap:SubsequentEventMember 2018-07-01 2018-08-06 0001082324 us-gaap:SubsequentEventMember us-gaap:RestrictedStockUnitsRSUMember 2018-07-08 2018-07-08 xbrli:shares iso4217:USD iso4217:USD xbrli:shares vhc:Patent vhc:Institution xbrli:pure false --12-31 2018-06-30 No No Yes Accelerated Filer VirnetX Holding Corp 0001082324 62622325 2018 Q2 10-Q

2966000

414000

2000

393000

399000

-13000

177076000

190724000

472000

213000

683000

75000

2008000

1715000

655000

881000

467000

1154000

440000

442000

855000

834000

7371000

7175000

5179000

5558000

1000

616000

2616000

2636000

1469000

80000

1087000

2000000

644000

724000

1453000

80000

724000

1453000

2635000

2617000

2001000

80000

1468000

1087000

616000

1000

724000

1453000

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;">Note 2 —  Basis of Presentation and Summary of Significant Accounting Policies</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; text-align: justify;">Unaudited Interim Financial Information</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The accompanying Condensed Consolidated Balance Sheet as of June 30, 2018, the Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2018 and 2017, the Condensed Consolidated Statements of Comprehensive Loss for the three and six months ended June 30, 2018 and 2017, and the Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2018 and 2017 are unaudited. These unaudited interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”). In our opinion, the unaudited interim condensed consolidated financial statements include all adjustments of a normal recurring nature necessary for the fair presentation of our financial position as of June 30, 2018, our results of operations for the three and six months ended June 30, 2018 and 2017, and our cash flows for the six months ended June 30, 2018 and 2017. The results of operations for the three and six months ended June 30, 2018 are not necessarily indicative of the results to be expected for the year ending December 31, 2018.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">These unaudited interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2017, filed with the SEC on March 16, 2018.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; text-align: justify;">Use of Estimates</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">We prepare our condensed consolidated financial statements in accordance with U.S. GAAP. In doing so, we have to make estimates and assumptions that affect our reported amounts of assets, liabilities, revenues, and expenses, as well as related disclosure of contingent assets and liabilities. In some cases, we could reasonably have used different accounting policies and estimates. In some cases, changes in our accounting estimates are reasonably likely to occur. Accordingly, actual results could differ materially from our estimates. To the extent that there are material differences between these estimates and actual results, our financial condition or results of operations will be affected. We base our estimates on past experience and other assumptions that we believe are reasonable under the circumstances, at the time they are made, and we evaluate these estimates on an ongoing basis. We refer to accounting estimates of this type as critical accounting policies and estimates, which we discuss further below.</div><div style="text-align: left;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; text-align: justify;">Basis of Consolidation</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The condensed consolidated financial statements include the accounts of VirnetX Holding Corporation and our wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated.</div><div> </div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; text-align: justify;">Reclassifications</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Certain prior period amounts were reclassified to conform to the current year’s presentation. None of these reclassifications had an impact on reported operating expenses, operating income or net income for any of the periods presented.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; text-align: left;">Revenue Recognition</div><div style="text-align: justify;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;">Most of our revenue historically has been derived from licensing and royalty fees from contracts with customers which often spanned several years. We account for revenue in accordance with Accounting Standards Update (“ASU”) No.2014-09, Revenue from Contracts with Customers “Topic 606”, which we adopted on January 1, 2018 using the modified-retrospective method (see Note 8 – Effects of Adopting ASU Topic 606).  Prior to January 1, 2018 we recognized revenue in accordance with previous guidance as described in our Annual Report on Form 10-K for the year ended December 31, 2017.</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;"> </div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;">A performance obligation is a promise in a contract to transfer a distinct good or service to the customer in accordance with Topic 606. A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. Our revenue arrangements may consist of multiple-element arrangements, with revenue for each unit of accounting recognized as the product or service is delivered to the customer.</div></div><div style="text-align: justify;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">With the <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal;">licensing of our patents, </font>performance obligations are generally satisfied at a point in time as work is complete and our patent rights are transferred to our customers. We generally have no further obligation to our customers regarding our technology.</div><div style="text-align: justify;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Certain contracts may require our customers to enter into a hosting arrangement with us and for these arrangements revenue is recognized over time, generally over the life of the servicing contract.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; text-align: justify;">Deferred revenue</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">From 2013 to 2016, we received contractual payments totaling $10,000. In accordance with our revenue recognition policy, we deferred and then recognized revenue over the life of the contract, but not ahead of collection. We recognized $375 and $750 of revenue, related to this contract during the three and six months ended June 30, 2017. On January 1, 2018, we adopted Topic 606 and applied the modification retrospective approach as discussed above.</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;"> </div></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; text-align: justify;">Earnings Per Share</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Basic earnings per share are computed by dividing earnings available to common stockholders by the weighted average number of outstanding common shares during the period.  Diluted earnings per share are computed by dividing net income by the weighted average number of shares outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; text-align: justify;">Concentration of Credit Risk and Other Risks and Uncertainties</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Our cash and cash equivalents are primarily maintained at two major financial institutions in the United States. A portion of those balances are insured by the Federal Deposit Insurance Corporation.  During the six months ended June 30, 2018 we had funds which were uninsured.   We do not believe that we are subject to any unusual financial risk beyond the normal risk associated with commercial banking relationships with major financial institutions. We have not experienced any losses on our deposits of cash and cash equivalents.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; text-align: left;">Prepaid Expenses</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Prepaid expenses at June 30, 2018 include the current portion of prepaid rent for a facility lease for corporate promotional and marketing purposes. From inception, the prepayment totaling $4,000 is being amortized over the 10-year term of the lease. The unamortized non-current portion of the prepayment is included in Prepaid expenses, non-current on the condensed consolidated balance sheet.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; text-align: left;">Impairment of Long-Lived Assets</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">On an annual basis, we identify and record impairment losses on long-lived assets when events and changes in circumstances indicate that the carrying amount of an asset might not be recoverable.  Recoverability is measured by comparison of the anticipated future net undiscounted cash flows to the related assets’ carrying value.  If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the projected discounted future net cash flows arising from the asset.</div><div> </div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; text-align: justify;">Fair Value of Financial Instruments</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Fair value is the price that would result from an orderly transaction between market participants at the measurement date. A fair value hierarchy prioritizes the inputs used to measure fair value.  The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement).  Level 2 measurements utilize either directly or indirectly observable inputs in markets other than quoted prices in active markets.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Our financial instruments are stated at amounts that equal, or approximate, fair value.  When we estimate fair value, we utilize market data or assumptions that we believe market participants would use in pricing the financial instrument, including assumptions about risk and inputs to the valuation technique.  We use valuation techniques, primarily the income and market approach, which maximizes the use of observable inputs and minimize the use of unobservable inputs for recurring fair value measurements.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Mutual Funds:</font> Valued at the quoted net asset value of shares held.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">U.S. Government and U.S. Agency Securities</font>:  Fair value measured at the closing price reported on the active market on which the individual securities are traded.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The following tables show the adjusted cost, gross unrealized gains, gross unrealized losses and fair value of our securities by significant investment category as of June 30, 2018, and December 31, 2017.</div><div><br /></div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; margin-left: 9pt; text-indent: -9pt;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="22" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30, 2018</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; margin-left: 9pt; text-indent: -9pt;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Adjusted</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Cost</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Unrealized</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Gains</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Unrealized</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Losses</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Fair</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Value</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Cash</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">and Cash</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Equivalents</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Investments</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Available</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">for Sale</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Cash</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,056</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,056</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,056</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; margin-left: 9pt; background-color: #ffffff; text-indent: -9pt;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Level 1:</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Mutual funds</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,087</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,087</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,087</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">U.S. government securities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">80</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">80</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">80</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">U.S. agency securities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,468</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,469</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">825</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">644</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; padding-bottom: 2px; margin-left: 9pt; background-color: #cceeff; text-indent: -9pt;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,635</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,636</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,912</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">724</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Total</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4,691</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4,692</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,968</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">724</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td></tr></table><div style="text-align: left;"> </div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; margin-left: 9pt; text-indent: -9pt;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="22" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">December 31, 2017</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: center; margin-left: 9pt; text-indent: -9pt;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Adjusted</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Cost</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Unrealized</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Gains</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Unrealized</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Losses</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Fair</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Value</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Cash and</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Cash</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Equivalents</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Investments</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Available</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">for Sale</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;"> </td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Cash</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,972</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,972</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,972</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; margin-left: 9pt; background-color: #ffffff; text-indent: -9pt;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Level 1:</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Mutual funds</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">616</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">616</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">616</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">U.S. agency securities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,001</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">547</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,453</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; padding-bottom: 2px; margin-left: 9pt; background-color: #ffffff; text-indent: -9pt;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,617</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,616</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,163</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,453</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Total</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4,589</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4,588</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,135</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,453</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"> </td></tr></table><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; text-align: left;">New Accounting Pronouncements</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In June 2018, the Financial Accounting Standards Board (“FASB”)  issued ASU No. 2018-07, Compensation—Stock Compensation (“Topic 718”)—Improvements to Nonemployee Share-Based Payment Accounting.  The amendments in this update expand the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees.  The amendments specify that Topic 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor’s own operations by issuing share-based payment awards.  The amendments in this update are effective for public business entities for fiscal years beginning after December 15, 2018, including interim periods within that fiscal year and early adoption is permitted.  We adopted the ASU effective June 30, 2018, which had no material impact on our financial position or statement of operations.</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;">In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments-Credit Losses (“Topic 326”). The purpose of this ASU is to require a financial asset measured at amortized cost basis to be presented at the net amount expected to be collected. Credit losses relating to available-for-sale debt securities should be recorded through an allowance for credit losses. This ASU is effective for interim and annual reporting periods beginning after December 15, 2019. We are evaluating the impact this guidance will have on our financial position and statement of operations.</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;"> </div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;">In February 2016, FASB issued ASU No. 2016-02, Leases (“Topic 842”). Topic 842 requires an entity to recognize right-of-use assets and lease liabilities on its balance sheet and disclose key information about leasing arrangements. For public companies, Topic 842 is effective for annual reporting periods beginning after December 15, 2018, including interim periods within that reporting period, with early adoption permitted. We are evaluating the impact this guidance will have on our financial position and statement of operations.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;">In May 2014, the FASB issued ASU No. 2014-09 Revenue from Contracts with Customers (“Topic 606”). As amended, Topic 606 supersedes prior revenue recognition requirements including most industry-specific revenue recognition guidance. In summary, the core principle of Topic 606 is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. On January 1, 2018 we adopted this standard which resulted in a $2,500 decrease in accumulated deficit and a $2,500 decrease in deferred revenue in our consolidated balance sheet (see Note 8 — Effects of Adopting ASU Topic 606).</div></div></div>

833000

-4415000

2056000

1972000

1912000

825000

3968000

1163000

1087000

1972000

616000

3135000

547000

2056000

3135000

3968000

6627000

2212000

1972000

2056000

25000

7.00

100000000

0.0001

62292808

59051978

62292808

6000

-3798000

-7696000

-14055000

-6451000

375000

750000

2500000

1000000

250000

-1000000

-250000

1500000

-1500000

1500000

-1500000

2500000

34000000

41000000

15000

10000

-0.10

-0.23

-0.13

-0.07

2175000

219000

P3Y0M29D

P2Y8M19D

7160000

2001000

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; text-align: justify;">Fair Value of Financial Instruments</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Fair value is the price that would result from an orderly transaction between market participants at the measurement date. A fair value hierarchy prioritizes the inputs used to measure fair value.  The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement).  Level 2 measurements utilize either directly or indirectly observable inputs in markets other than quoted prices in active markets.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Our financial instruments are stated at amounts that equal, or approximate, fair value.  When we estimate fair value, we utilize market data or assumptions that we believe market participants would use in pricing the financial instrument, including assumptions about risk and inputs to the valuation technique.  We use valuation techniques, primarily the income and market approach, which maximizes the use of observable inputs and minimize the use of unobservable inputs for recurring fair value measurements.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Mutual Funds:</font> Valued at the quoted net asset value of shares held.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">U.S. Government and U.S. Agency Securities</font>:  Fair value measured at the closing price reported on the active market on which the individual securities are traded.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The following tables show the adjusted cost, gross unrealized gains, gross unrealized losses and fair value of our securities by significant investment category as of June 30, 2018, and December 31, 2017.</div><div><br /></div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; margin-left: 9pt; text-indent: -9pt;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="22" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30, 2018</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; margin-left: 9pt; text-indent: -9pt;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Adjusted</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Cost</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Unrealized</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Gains</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Unrealized</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Losses</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Fair</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Value</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Cash</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">and Cash</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Equivalents</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Investments</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Available</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">for Sale</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Cash</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,056</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,056</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,056</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; margin-left: 9pt; background-color: #ffffff; text-indent: -9pt;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Level 1:</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Mutual funds</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,087</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,087</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,087</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">U.S. government securities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">80</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">80</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">80</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">U.S. agency securities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,468</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,469</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">825</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">644</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; padding-bottom: 2px; margin-left: 9pt; background-color: #cceeff; text-indent: -9pt;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,635</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,636</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,912</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">724</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Total</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4,691</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4,692</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,968</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">724</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td></tr></table><div style="text-align: left;"> </div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; margin-left: 9pt; text-indent: -9pt;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="22" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">December 31, 2017</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: center; margin-left: 9pt; text-indent: -9pt;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Adjusted</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Cost</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Unrealized</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Gains</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Unrealized</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Losses</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Fair</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Value</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Cash and</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Cash</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Equivalents</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Investments</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Available</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">for Sale</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;"> </td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Cash</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,972</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,972</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,972</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; margin-left: 9pt; background-color: #ffffff; text-indent: -9pt;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Level 1:</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Mutual funds</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">616</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">616</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">616</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">U.S. agency securities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,001</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">547</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,453</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; padding-bottom: 2px; margin-left: 9pt; background-color: #ffffff; text-indent: -9pt;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,617</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,616</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,163</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,453</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Total</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4,589</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4,588</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,135</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,453</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"> </td></tr></table></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The following tables show the adjusted cost, gross unrealized gains, gross unrealized losses and fair value of our securities by significant investment category as of June 30, 2018, and December 31, 2017.</div><div><br /></div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; margin-left: 9pt; text-indent: -9pt;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="22" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30, 2018</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; margin-left: 9pt; text-indent: -9pt;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Adjusted</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Cost</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Unrealized</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Gains</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Unrealized</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Losses</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Fair</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Value</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Cash</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">and Cash</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Equivalents</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Investments</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Available</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">for Sale</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Cash</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,056</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,056</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,056</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; margin-left: 9pt; background-color: #ffffff; text-indent: -9pt;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Level 1:</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Mutual funds</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,087</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,087</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,087</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">U.S. government securities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">80</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">80</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">80</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">U.S. agency securities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,468</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,469</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">825</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">644</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; padding-bottom: 2px; margin-left: 9pt; background-color: #cceeff; text-indent: -9pt;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,635</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,636</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,912</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">724</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Total</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4,691</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4,692</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,968</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">724</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td></tr></table><div style="text-align: left;"> </div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; margin-left: 9pt; text-indent: -9pt;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="22" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">December 31, 2017</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: center; margin-left: 9pt; text-indent: -9pt;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Adjusted</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Cost</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Unrealized</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Gains</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Unrealized</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Losses</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Fair</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Value</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Cash and</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Cash</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Equivalents</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Investments</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Available</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">for Sale</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;"> </td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Cash</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,972</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,972</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,972</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; margin-left: 9pt; background-color: #ffffff; text-indent: -9pt;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Level 1:</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Mutual funds</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">616</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">616</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">616</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">U.S. agency securities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,001</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">547</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,453</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; padding-bottom: 2px; margin-left: 9pt; background-color: #ffffff; text-indent: -9pt;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,617</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,616</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,163</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,453</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 28%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Total</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4,589</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4,588</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,135</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,453</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"> </td></tr></table></div>

-7686000

-6450000

-3798000

-14050000

-375000

-6075000

-750000

-13300000

5000

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;">Note 3 - Income Taxes</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">We had income tax expense of $0 and $5 for the three and six-months ended June 30, 2018 and 2017, respectively, as a result of minimum tax payments. During the three and six-month period ended June 30, 2018 and 2017, we had net operating losses (“NOLs”) which generated deferred tax assets for NOL carryforwards. We provided valuation allowances against the net deferred tax assets including the deferred tax assets for NOL carryforwards. Valuation allowances provided for our net deferred tax assets increased by approximately $7,400 and $3,747 for the six months ended June 30, 2018 and 2017, respectively.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of the deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Based on the available objective evidence, management believes it is more likely than not that the net deferred tax assets at June 30, 2018 will not be fully realizable. Accordingly, management has maintained a full valuation allowance against its net deferred tax assets at June 30, 2018. The valuation allowance carried against our net deferred tax assets was approximately $41,000 and $34,000 at June 30, 2018 and December 31, 2017, respectively.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">At June 30, 2018, we have federal and state net operating loss carryforwards of approximately $103,000 and $117,000, respectively, expiring beginning in 2027 and 2028, respectively.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers, (“Topic 606”) which amends revenue recognition principles and provides a single set of criteria for revenue recognition among all industries. We adopted the new standard effective January 1, 2018 under the modified retrospective method.  Under the modified retrospective method, we recognized deferred revenue of $2,500 through retained earnings.  The tax provision is prepared based on the assumption that the Company will file accounting method change form 3115 with 2018 tax return to reflect the adoption of Topic 606.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Our tax years for 2005 and forward are subject to examination by the U.S. tax authority and various state tax authorities. These years are open due to net operating losses and tax credits remaining unutilized from such years.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Our policy is to recognize interest and penalties accrued on uncertain tax positions as a component of income tax expense. As of June 30, 2018, we had accrued immaterial amounts of interest and penalties related to the uncertain tax positions.</div></div>

-750000

750000

2552000

-1362000

2000

-1000

6000

-1923000

-1303000

13000

80000

31000

13000

20000

12000

20000

12000

P10Y

P12M

2019-10-31

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;">Note 7 — Litigation</div><div style="text-align: left;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">We have multiple intellectual property infringement lawsuits pending in the United States District Court for the Eastern District of Texas, Tyler Division (“USDC”), and United States Court of Appeals for the Federal Circuit (“USCAFC”).</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"> </div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; text-align: justify;">VirnetX Inc. v. Cisco Systems, Inc. et al. (Case 6:10-CV-00417-LED) (“Apple I”)</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;">On August 11, 2010, we filed a complaint against Aastra USA. Inc. (“Aastra”), Apple Inc. (“Apple”), Cisco Systems, Inc. (“Cisco”), and NEC Corporation (“NEC”) in the USDC in which we alleged that these parties infringe on certain of our patents (U.S. Patent Nos. 6,502,135, 7,418,504, 7,921,211 and 7,490,151). We sought damages and injunctive relief. The cases against each defendant were separated by the judge. Aastra and NEC agreed to sign license agreements with us and we dropped all accusations of infringement against them. A jury in USDC decided that our patents were not invalid and rendered a verdict of non-infringement by Cisco on March 4, 2013. Our motion for a new Cisco trial was denied and the case against Cisco was closed.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;">On November 6, 2012, a jury in the USDC awarded us over $368,000 for Apple’s infringement of four of our patents, plus daily interest up to the final judgment.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;">Apple filed an appeal of the judgment to the USCAFC. On September 16, 2014, USCAFC affirmed the USDC jury’s finding that all four of our patents at issue are valid and confirmed the USDC jury’s finding of infringement of VPN on Demand under many of the asserted claims of our ‘135 and ‘151 patents, and the USDC’s decision to allow evidence about our license and royalty rates regarding the determination of damages. However, the USCAFC vacated the USDC jury’s damages award and some of the USDC’s claim construction with respect to parts of our ‘504 and ‘211 patents and remanded the damages award and determination of infringement with respect to FaceTime back to the USDC for further proceedings.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;">On September 30, 2016, pursuant to the 2014 remand from the USCAFC, a jury in the USDC, awarded us $302,400 for Apple’s infringement of four of our patents. On September 29, 2017, the USDC entered its final judgement, denied all of Apple’s post-trial motions, granted all our post-trial motions, including our motion for willful infringement and enhanced the royalty rate during the willfulness period from $1.20 to $1.80 per device, and awarded us costs, certain attorneys’ fees, and prejudgment interest. The total amount in the final judgement was $439,700, including $302,400 (jury verdict), $41,300 (enhanced damages) and $96,000 (costs, fees and interest).</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;">On October 27, 2017 Apple filed its notice of appeal of this final judgement to the USCAFC. Apple filed its opening brief on March 19, 2018. We filed our response on April 4, 2018. On April 11, 2018, USCAFC designated <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Cases 18-1197-CB, Case 17-1368 and Case 17-1591 </font>as companion cases and assigned to the same merits panel. Events and developments after this order are described below under<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;"> VirnetX Inc. v. The Mangrove Partners (USCAFC Case 17-1368) (“Consolidated Appeal”)</font>.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; text-align: justify;">VirnetX Inc. v. Apple, Inc. (Case 6:12-CV-00855-LED) (“Apple II”)</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;">On April 12, 2018, an USDC jury awarded us $502,600 in this case. The same jury in the second part of the case determined that Apple had willfully infringed all the patents in the case, which per the jury instructions is reserved for only the most egregious behavior, such as where the infringement is malicious, deliberate, consciously wrongful, or done in bad faith. The verdict covers issues of infringement by products that were allegedly changed after the Apple I trial including, Apple’s redesigned VOD (VPN on Demand) in iOS 7 to iOS 11, the redesigned FaceTime in iOS 7 to iOS 11 and OS X 10.9 and later. This case began on November 6, 2012, when we had filed a complaint against Apple in USDC in which we alleged that Apple infringed on certain of our patents, (U.S. Patent Nos. 6,502,135, 7,418,504, 7,921,211 and 7,490,151). We sought damages and injunctive relief. The accused products include the iPhone 5, iPod Touch 5th Generation, iPad 4<sup style="font-size: smaller; vertical-align: text-top; line-height: 1;">th</sup> Generation, iPad mini, and the latest Macintosh computers; these products were not included in the Apple I case because they were released after the Apple I case was initiated. Post-Trial Motions hearing was held on July 18, 2018. We are currently awaiting the courts’ ruling on these motions and the final judgment.</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;"> </div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; text-align: justify;">VirnetX Inc. v. The Mangrove Partners (USCAFC Case 17-1368) (“Consolidated Appeal”)</div></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">On April 11, 2018, the USCAFC in an order designated following appeals<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;"> </font>as companion cases and assigned to the same merits panel;</div><div><br /></div><div><div><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td style="width: 36pt; vertical-align: top; align: right;"><div style="font-size: 10pt; font-family: Symbol, serif; font-weight: bold; text-align: left; margin-left: 18pt;">·</div></td><td style="width: auto; vertical-align: top;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; text-align: left;">VirnetX Inc. v. The Mangrove Partners (USCAFC Case 17-1368)</div></td></tr></table></div></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;"> </div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; margin-left: 36pt;">On December 16, 2016, we filed appeals with the USCAFC, appealing the invalidity findings by the Patent Trial and Appeal Board (“PTAB”) in IPR2015-01046, and on December 20, 2016 for IPR2015-1047, involving our U.S. Patent Nos. 6,502,135, and 7,490,151. These appeals also involve Apple, Inc. and one of them involves Black Swamp IP, LLC. These appeals have been consolidated into a single case.</div><div><br /></div><div><div><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td style="width: 36pt; vertical-align: top; align: right;"><div style="font-size: 10pt; font-family: Symbol, serif; font-weight: bold; text-align: left; margin-left: 18pt;">·</div></td><td style="width: auto; vertical-align: top;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; text-align: left;">VirnetX Inc. v. Cisco Systems, Inc. (USCAFC Case 18-1197-CB) (Appeal of Apple I Case)</div></td></tr></table></div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; margin-left: 36pt;">On October 27, 2017 Apple filed its notice of appeal of the Final Judgment entered on September 29, 2017 to the United States Court of Appeals for the Federal Circuit.</div><div><br /></div><div><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td style="width: 36pt; vertical-align: top; align: right;"><div style="font-size: 10pt; font-family: Symbol, serif; font-weight: bold; text-align: left; margin-left: 18pt;">·</div></td><td style="width: auto; vertical-align: top;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; text-align: left;">VirnetX Inc. v. Apple Inc., Cisco Systems, Inc. (USCAFC Case 17-1591)</div></td></tr></table></div></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"> </div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify; margin-left: 36pt;">On February 7, 2017, we filed appeals with the USCAFC, appealing the invalidity findings by the PTAB in inter-parties’ reexamination nos. 95/001,788, 95/001,789, and 95/001,856 related to our U.S. Patent Nos. 7,921,211 and 7,418,504<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">.</font> These appeals have been consolidated into a single case.</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"> </div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify; margin-left: 36pt;">The written briefing in all these USCAFC cases have been concluded; the oral arguments have not yet been scheduled.</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"> </div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: justify;">VirnetX Inc. v. Apple Inc. (Case 17-2490)</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"> </div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">On August 23, 2017, we filed with the USCAFC appeals of the invalidity findings by the PTAB in IPR2016-00331 and IPR2016-00332 involving our U.S. Patent No. 8,504,696. The briefing in these appeals has been concluded; the oral arguments have not yet been scheduled.</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"> </div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: justify;">VirnetX Inc. (Case 17-2593)</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"> </div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">On September 22, 2017, we filed with the USCAFC, appeals of the invalidity findings by the PTAB in IPR2016-00693 and IPR2016-00957 involving our U.S. Patent Nos. 7,418,504 and 7,921,211. The briefing in these appeals has not taken place. The entity that initiated the IPRs, Black Swamp IP, LLC, indicated on October 18, 2017, that it would not participate in the appeals. On November 27, 2017, the USPTO indicated that it would intervene in the appeals. On January 19, 2018, the USCAFC stayed these appeals pending the USCAFC’s decision in Case 17-1591.</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"> </div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">One or more potential intellectual property infringement claims may also be available to us against certain other companies who have the resources to defend against any such claims. Although we believe these potential claims are likely valid, commencing a lawsuit can be expensive and time-consuming, and there is no assurance that we could prevail on such potential claims if we made them. In addition, bringing a lawsuit may lead to potential counterclaims which may distract our management and our other resources, including capital resources, from efforts to successfully commercialize our products.</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"> </div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Currently, we are not a party to any other pending legal proceedings and are not aware of any proceeding threatened or contemplated against us.</div></div>

3724000

5622000

-2500000

3122000

-1750000

5474000

7175000

7371000

4482000

3584000

-1500000

5084000

-1500000

2982000

439700000

302400000

502600000

368000000

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;">Note 1 — Business Description</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">VirnetX Holding Corporation, which we refer to as “we”, “us”, “our”, “the Company” or “VirnetX”, is engaged in the business of commercializing a portfolio of patents. We seek to license our technology, including GABRIEL Connection Technology™, to various original equipment manufacturers, or OEMs, that use our technologies in the development and manufacturing of their own products within the IP-telephony, mobility, fixed-mobile convergence and unified communications markets. Since 2012 we had revenues from settlements of patent infringement disputes whereby we received consideration for past sales of licensees that utilized our technology, where there was no prior patent license agreement, as well as license agreement revenues from settlements providing licensing for the continued use of our technology (see “Revenue Recognition”).</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Our portfolio of intellectual property is the foundation of our business model. We currently own approximately 185 total patents and pending applications, including 70 U.S. patents/patent applications and 115 foreign patents/validations/pending applications. Our patent portfolio is primarily focused on securing real-time communications over the Internet, as well as related services such as the establishment and maintenance of a secure domain name registry. Our patented methods also have additional applications in the key areas of device operating systems and network security for Cloud services, Machine-to-Machine (“M2M”), communications in areas including “Smart City,” “Connected Car” and “Connected Home.” All our U.S. and foreign patents and pending patent applications relate generally to securing communications over the internet and as such, cover all our technology and other products. Our issued U.S. and foreign patents expire at various times during the period from 2019 to 2024. Some of our issued patents and pending patent applications were acquired by our principal operating subsidiary, VirnetX, Inc., from Leidos, Inc. (“Leidos”) (f/k/a Science Applications International Corporation, or SAIC) in 2006 and we are required to make payments to Leidos based on cash or certain other values generated from those patents in certain circumstances. The amount of such payments depends upon the type of value generated and certain categories are subject to maximums and other limitations.</div></div>

11606000

-29000

5004000

711000

-9390000

-11484000

-6450000

-14055000

-7691000

-3798000

-6075000

-13305000

-750000

-375000

-7717000

-6462000

-14070000

-3811000

-750000

-6087000

-375000

-13320000

4207000

6478000

8488000

14092000

2028-12-31

2027-12-31

117000000

103000000

-1000

-4000

140000

-1000

-5000

33000

29000

33000

29000

33000

29000

756000

924000

0.0001

10000000

4000000

1989000

1796000

591000

864000

11639000

5760000

1635000

7000

17000

1186000

2191000

957000

1873000

-175516000

-187070000

-173016000

2500000

1750000

-188820000

771000

396000

16000

22000

391000

772000

-375000

-750000

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: justify;">Note 8 — Effects of Adopting ASU Topic 606</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The following tables summarize the effects of adopting this standard on our unaudited condensed consolidated financial statements:</div><div><br /></div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left; margin-left: 9pt; text-indent: -9pt;">Balance Sheet Highlights</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 3pt;">Reported As of</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 3pt;">December 31, 2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 4pt;">Effects of Adopting</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 4pt;">Topic 606</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 3pt;">As of</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 3pt;">January 1, 2018</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left; margin-left: 9pt; text-indent: -9pt;">Current liabilities:</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Deferred revenue, current portion</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,500</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,500</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left; margin-left: 9pt; text-indent: -9pt;">Total current liabilities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4,482</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,500</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,982</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; margin-left: 9pt; background-color: #cceeff; text-indent: -9pt;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Deferred revenue, non-current portion</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Other liabilities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">140</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">140</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Total Liabilities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5,622</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(2,500</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,122</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left; margin-left: 9pt; text-indent: -9pt;">Accumulated deficit</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(175,516</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,500</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(173,016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left; margin-left: 9pt; text-indent: -9pt;">Total Stockholder’s Equity</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,553</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,500</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4,053</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td></tr></table><div><br /></div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="width: 52%; vertical-align: bottom; padding-bottom: 2px; text-align: center; margin-left: 9pt; text-indent: -9pt;">  <div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left; margin-left: 9pt; text-indent: -9pt;"> </div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">As of</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30,</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2018</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Pre-Topic 606</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Effects of Adopting</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Topic 606</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">As of</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30,</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2018</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">(as reported)</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; margin-left: 9pt; text-indent: -9pt;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Deferred revenue, current portion</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,500</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,500</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left; margin-left: 9pt; text-indent: -9pt;">Total current liabilities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5,084</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,500</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,584</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; margin-left: 9pt; background-color: #cceeff; text-indent: -9pt;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Deferred revenue, non-current portion</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">250</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(250</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Other liabilities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">140</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">140</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left; margin-left: 9pt; text-indent: -9pt;">Total liabilities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5,474</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,750</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,724</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Accumulated deficit</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(188,820</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,750</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(187,070</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left; margin-left: 9pt; text-indent: -9pt;">Total stockholders’ equity</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,897</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,750</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,647</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td></tr></table><div><br /></div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="width: 52%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; margin-left: 9pt; text-indent: -9pt;">Income Statement Highlights</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Six Months Ended</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30, 2018</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Pre-Topic 606</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Six Months Ended</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30, 2018</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Effects of Adopting</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Topic 606</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Six Months Ended</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30, 2018</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">(as reported)</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Revenue</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">772</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(750</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">22</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Loss from operations</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(13,320</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(750</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(14,070</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Interest income, net</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">20</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">20</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Loss before taxes</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(13,300</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(750</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(14,050</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Provision for income taxes</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(5</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(5</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left; margin-left: 9pt; text-indent: -9pt;">Net loss</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">(13,305</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">(750</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">(14,055</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">)</div></td></tr></table><div><br /></div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="width: 52%; vertical-align: top; padding-bottom: 2px; margin-left: 9pt; text-indent: -9pt;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Three Months Ended</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30, 2018</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Pre-Topic 606</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Three Months Ended</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30, 2018</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Effects of Adopting</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Topic 606</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Three Months Ended</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30, 2018</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">(as reported)</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Revenue</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">391</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(375</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">16</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Loss from operations</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(6,087</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(375</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(6,462</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Interest income, net</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">12</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">12</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Loss before taxes</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(6,075</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(375</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(6,450</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left; margin-left: 9pt; text-indent: -9pt;">Net loss</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">(6,075</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">(375</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">(6,450</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">)</div></td></tr></table><div> </div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; margin-left: 9pt; text-indent: -9pt;">Cash Flow Statement Highlights</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Six</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Months</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Ended</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30,</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2018</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Pre-Topic 606</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Six</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Months</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Ended</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30, </div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2018</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Effects of</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Adopting Topic</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">606</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Six</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Months</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Ended</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30,</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2018</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">(as reported)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td></tr><tr><td valign="bottom" style="width: 64%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Net loss</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(13,305</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(750</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(14,055</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 64%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Adjustments to reconcile net loss to net cash used in operating activities:</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 64%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Deferred revenue</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(750</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">)</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">750</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 64%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left; margin-left: 9pt; text-indent: -9pt;">Net cash used in operating activities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">(11,484</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">(11,484</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr></table></div>

P6Y

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The following tables summarize the effects of adopting this standard on our unaudited condensed consolidated financial statements:</div><div><br /></div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left; margin-left: 9pt; text-indent: -9pt;">Balance Sheet Highlights</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 3pt;">Reported As of</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 3pt;">December 31, 2017</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 4pt;">Effects of Adopting</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 4pt;">Topic 606</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 3pt;">As of</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center; text-indent: 3pt;">January 1, 2018</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left; margin-left: 9pt; text-indent: -9pt;">Current liabilities:</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Deferred revenue, current portion</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,500</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,500</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left; margin-left: 9pt; text-indent: -9pt;">Total current liabilities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4,482</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,500</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,982</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; margin-left: 9pt; background-color: #cceeff; text-indent: -9pt;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Deferred revenue, non-current portion</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Other liabilities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">140</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">140</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Total Liabilities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5,622</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(2,500</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,122</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left; margin-left: 9pt; text-indent: -9pt;">Accumulated deficit</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(175,516</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,500</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(173,016</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left; margin-left: 9pt; text-indent: -9pt;">Total Stockholder’s Equity</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,553</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,500</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4,053</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td></tr></table><div><br /></div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="width: 52%; vertical-align: bottom; padding-bottom: 2px; text-align: center; margin-left: 9pt; text-indent: -9pt;">  <div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left; margin-left: 9pt; text-indent: -9pt;"> </div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">As of</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30,</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2018</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Pre-Topic 606</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Effects of Adopting</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Topic 606</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">As of</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30,</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2018</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">(as reported)</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; margin-left: 9pt; text-indent: -9pt;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Deferred revenue, current portion</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,500</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,500</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left; margin-left: 9pt; text-indent: -9pt;">Total current liabilities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5,084</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,500</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,584</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; margin-left: 9pt; background-color: #cceeff; text-indent: -9pt;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Deferred revenue, non-current portion</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">250</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(250</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Other liabilities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">140</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">140</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left; margin-left: 9pt; text-indent: -9pt;">Total liabilities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5,474</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,750</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,724</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Accumulated deficit</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(188,820</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,750</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(187,070</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left; margin-left: 9pt; text-indent: -9pt;">Total stockholders’ equity</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,897</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,750</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,647</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td></tr></table><div><br /></div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="width: 52%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; margin-left: 9pt; text-indent: -9pt;">Income Statement Highlights</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Six Months Ended</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30, 2018</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Pre-Topic 606</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Six Months Ended</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30, 2018</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Effects of Adopting</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Topic 606</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Six Months Ended</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30, 2018</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">(as reported)</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Revenue</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">772</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(750</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">22</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Loss from operations</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(13,320</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(750</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(14,070</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Interest income, net</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">20</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">20</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Loss before taxes</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(13,300</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(750</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(14,050</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Provision for income taxes</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(5</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(5</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left; margin-left: 9pt; text-indent: -9pt;">Net loss</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">(13,305</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">(750</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">(14,055</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">)</div></td></tr></table><div><br /></div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="width: 52%; vertical-align: top; padding-bottom: 2px; margin-left: 9pt; text-indent: -9pt;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Three Months Ended</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30, 2018</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Pre-Topic 606</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Three Months Ended</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30, 2018</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Effects of Adopting</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Topic 606</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Three Months Ended</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30, 2018</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">(as reported)</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Revenue</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">391</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(375</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">16</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Loss from operations</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(6,087</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(375</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(6,462</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Interest income, net</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">12</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">12</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Loss before taxes</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(6,075</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(375</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(6,450</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 52%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left; margin-left: 9pt; text-indent: -9pt;">Net loss</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">(6,075</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">(375</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">$</div></td><td valign="bottom" style="width: 13%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">(6,450</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">)</div></td></tr></table><div> </div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; margin-left: 9pt; text-indent: -9pt;">Cash Flow Statement Highlights</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Six</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Months</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Ended</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30,</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2018</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Pre-Topic 606</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Six</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Months</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Ended</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30, </div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2018</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Effects of</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Adopting Topic</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">606</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Six</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Months</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Ended</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30,</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2018</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">(as reported)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td></tr><tr><td valign="bottom" style="width: 64%; vertical-align: bottom; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Net loss</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(13,305</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(750</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(14,055</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="width: 64%; vertical-align: bottom; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Adjustments to reconcile net loss to net cash used in operating activities:</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"> </td></tr><tr><td valign="bottom" style="width: 64%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Deferred revenue</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(750</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">)</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">750</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td></tr><tr><td valign="bottom" style="width: 64%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left; margin-left: 9pt; text-indent: -9pt;">Net cash used in operating activities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">(11,484</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">(11,484</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr></table></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Information about warrants outstanding during the three months ended June 30, 2018 follows:</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"> </div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Original</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Number</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">of</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Warrants</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Issued</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Exercise</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Price per</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Common</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Share</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Exercisable at</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">December 31,</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Became</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Exercisable</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Exercised</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Terminated /</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Cancelled /</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Expired</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Exercisable</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">at June 30,</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2018</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Expiration</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Date</div></td></tr><tr><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">25,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">7.00</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">25,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">25,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 17%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">April 2020</div></td></tr><tr><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">25,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">25,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 17%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td></tr></table></div>

11901000

6615000

3250000

5292000

2500000

25000

336000

356000

331000

1006000

0.0194

0.0265

0.84

0.85

220664

223997

243997

3.83

3.28

3.83

3.19

1780315

2.65

2.31

2.52

2.72

16624469

168219

31865

3072610

297652

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: left;">Note 6 — Equity</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; text-align: justify;">Common Stock</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;">On August 21, 2015, we filed a universal shelf registration statement with the U.S. Securities and Exchange Commission enabling us to offer and sell from time to time up to $100,000 of equity, debt or other types of securities. We also entered into an at-the-market (“ATM”) equity offering sales agreement with Cowen & Company, LLC (“Cowen”) on August 20, 2015, under which we may offer and sell shares of our common stock having an aggregate value of up to $35,000. On March 8, 2018, we amended our August 20, 2015 equity offering sales agreement (“Amended Agreement”) with Cowen whereby the maximum aggregate value of the Company’s common stock (“Shares”) we may offer and sell, from time to time, was increased from $35,000 to $50,000. We intend to use the proceeds of this offering for GABRIEL product development and marketing, and general corporate purposes, which may include working capital, capital expenditures, other corporate expenses and acquisitions of complementary products, technologies or businesses.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">During the six months ended June 30, 2018, we sold 3,072,610 shares under the ATM. The average sales price per common share was $3.91 and the aggregate proceeds from the sales totaled $12,000 during the period. Sales commissions, fees and other costs associated with the ATM totaled $360.</div><div style="text-align: justify; margin-left: 0.1pt; margin-right: 0.1pt;"> </div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; text-align: justify;">Warrants</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">In 2015 we issued warrants (“Advisor Warrants”) for the purchase of 25,000 shares of common stock at an exercise price of $7 per share, which expire in April 2020. The Advisor Warrants were issued for advisory services provided by a third party. Our Advisor Warrants were recorded at fair value on the issuance date and included in Additional Paid in Capital on our Condensed Consolidated Balance Sheet. The Advisor Warrants are exercisable by the holder, in whole or in part, until expiration, and may also be net-share-settled. Terms of the warrant agreement include no registration requirements for the underlying common stock and there are no anti-dilution provisions.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Information about warrants outstanding during the three months ended June 30, 2018 follows:</div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"> </div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Original</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Number</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">of</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Warrants</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Issued</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Exercise</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Price per</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Common</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Share</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Exercisable at</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">December 31,</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2017</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Became</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Exercisable</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Exercised</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Terminated /</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Cancelled /</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Expired</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"> </td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Exercisable</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">at June 30,</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">2018</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"> </td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Expiration</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Date</div></td></tr><tr><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">25,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">7.00</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">25,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">25,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"> </td><td valign="bottom" style="width: 17%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">April 2020</div></td></tr><tr><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #ffffff;"> </td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">25,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">—</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">25,000</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;"> </td><td valign="bottom" style="width: 17%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"> </td></tr></table></div>

1553000

3647000

4053000

1750000

2500000

1897000

3747000

7400000

61532000

58170000

58195000

60835000

P30D 8000 360000 31000 100000000 35000000 50000000 3.91 3.48 12000000 1036000 1.80 1.20 96000000 41300000 185 115 70 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; text-align: justify;">Deferred revenue</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">From 2013 to 2016, we received contractual payments totaling $10,000. In accordance with our revenue recognition policy, we deferred and then recognized revenue over the life of the contract, but not ahead of collection. We recognized $375 and $750 of revenue, related to this contract during the three and six months ended June 30, 2017. On January 1, 2018, we adopted Topic 606 and applied the modification retrospective approach as discussed above.</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;"> </div></div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; text-align: justify;">Unaudited Interim Financial Information</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">The accompanying Condensed Consolidated Balance Sheet as of June 30, 2018, the Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2018 and 2017, the Condensed Consolidated Statements of Comprehensive Loss for the three and six months ended June 30, 2018 and 2017, and the Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2018 and 2017 are unaudited. These unaudited interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”). In our opinion, the unaudited interim condensed consolidated financial statements include all adjustments of a normal recurring nature necessary for the fair presentation of our financial position as of June 30, 2018, our results of operations for the three and six months ended June 30, 2018 and 2017, and our cash flows for the six months ended June 30, 2018 and 2017. The results of operations for the three and six months ended June 30, 2018 are not necessarily indicative of the results to be expected for the year ending December 31, 2018.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">These unaudited interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2017, filed with the SEC on March 16, 2018.</div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic; text-align: left;">Prepaid Expenses</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;">Prepaid expenses at June 30, 2018 include the current portion of prepaid rent for a facility lease for corporate promotional and marketing purposes. From inception, the prepayment totaling $4,000 is being amortized over the 10-year term of the lease. The unamortized non-current portion of the prepayment is included in Prepaid expenses, non-current on the condensed consolidated balance sheet.</div></div> 10000000 4588000 4692000 4589000 4691000 2 2020-04-30 0 2500000

EX-101.SCH 7 vhc-20180630.xsd XBRL TAXONOMY EXTENSION SCHEMA 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 010000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 010100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 020000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 030000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 040000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 060100 - Disclosure - Business Description link:presentationLink link:calculationLink link:definitionLink 060200 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 060300 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 060400 - Disclosure - Commitments and Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 060500 - Disclosure - Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 060600 - Disclosure - Equity link:presentationLink link:calculationLink link:definitionLink 060700 - Disclosure - Litigation link:presentationLink link:calculationLink link:definitionLink 060800 - Disclosure - Effects of Adopting ASU Topic 606 link:presentationLink link:calculationLink link:definitionLink 060900 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 070200 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 080200 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 080600 - Disclosure - Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 080800 - Disclosure - Effects of Adopting ASU Topic 606 (Tables) link:presentationLink link:calculationLink link:definitionLink 090100 - Disclosure - Business Description (Details) link:presentationLink link:calculationLink link:definitionLink 090200 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 090200 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details)Default link:presentationLink link:calculationLink link:definitionLink 090300 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 090400 - Disclosure - Commitments and Related Party Transactions (Details) link:presentationLink link:calculationLink link:definitionLink 090500 - Disclosure - Stock-Based Compensation (Details) link:presentationLink link:calculationLink link:definitionLink 090600 - Disclosure - Equity, Common Stock (Details) link:presentationLink link:calculationLink link:definitionLink 090602 - Disclosure - Equity, Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 090700 - Disclosure - Litigation (Details) link:presentationLink link:calculationLink link:definitionLink 090800 - Disclosure - Effects of Adopting ASU Topic 606, Balance Sheet Highlights (Details) link:presentationLink link:calculationLink link:definitionLink 090802 - Disclosure - Effects of Adopting ASU Topic 606, Income Statement Highlights (Details) link:presentationLink link:calculationLink link:definitionLink 090806 - Disclosure - Effects of Adopting ASU Topic 606, Cash Flow Statement Highlights (Details) link:presentationLink link:calculationLink link:definitionLink 090900 - Disclosure - Subsequent Events (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 vhc-20180630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 vhc-20180630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 vhc-20180630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Amendment Flag Current Fiscal Year End Date Document Period End Date Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Filer Category Entity Public Float Entity Registrant Name Entity Central Index Key Entity Common Stock, Shares Outstanding Document Fiscal Year Focus Document Fiscal Period Focus Document Type Award Type [Axis] ASU 2016-09 [Member] Accounting Standards Update 2016-09 [Member] Basis of Presentation and Summary of Significant Accounting Policies [Abstract] ASU 2014-09 [Member] ASU Topic 606 [Member] Accounting Standards Update 2014-09 [Member] Accounts payable and accrued liabilities Accounts Payable and Accrued Liabilities, Current Accounts receivables Income tax liability Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Additional paid-in capital Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to reconcile net loss to net cash used in operating activities [Abstract] Adjustments for New Accounting Pronouncements [Axis] Aircraft [Member] Air Transportation Equipment [Member] Rental fees incurred for use of aircraft Stock-based compensation Stock-based compensation expense Cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category [Abstract] Assets, Fair Value Disclosure [Abstract] ASSETS Assets [Abstract] Total assets Assets Total current assets Assets, Current Current assets: Unrealized Losses Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax Fair Value Investments Available for Sale Available-for-sale Securities Adjusted Cost Available-for-sale Securities, Amortized Cost Basis Unrealized Gains Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax Investments available for sale Debt Securities, Available-for-sale, Current Balance Sheet Location [Domain] Balance Sheet Location [Axis] Basis of Presentation and Summary of Significant Accounting Policies Offices [Member] Building [Member] Pre-Topic 606 [Member] Net change in cash and cash equivalents Cash and Cash Equivalents, Period Increase (Decrease) Cash and Cash Equivalents Fair Value Cash and Cash Equivalents, Fair Value Disclosure Cash [Member] Cash and cash equivalents Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Adjusted Cost Non-cash transactions Original number of warrants issued (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Class of Warrant or Right [Line Items] Class of Warrant or Right [Domain] Class of Warrant or Right [Axis] Class of Warrant or Right [Table] Exercise price per common share (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Commitments and Related Party Transactions [Abstract] Commitments and contingencies (Note 4) Commitments and Related Party Transactions Commitments Disclosure [Text Block] Common Stock [Member] Common stock, shares authorized (in shares) Common stock, par value (in dollars per share) Common stock, shares issued (in shares) Common stock, shares outstanding (in shares) Common stock, par value $0.0001 per share: Authorized: 100,000,000 shares at June 30, 2018 and December 31, 2017, Issued and outstanding: 62,292,808 shares and 59,051,978 shares, at June 30, 2018 and December 31, 2017, respectively Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Concentration of Credit Risk and Other Risks and Uncertainties Basis of Consolidation Revenue recognized Deferred revenue recognized Deferred revenue, non-current portion Contract with Customer, Liability, Noncurrent Deferred Revenue [Abstract] Deferred revenue, current portion Deferred revenue, current portion Cumulative effect adjustments Cumulative Effect of New Accounting Principle in Period of Adoption Income Taxes [Abstract] Deferred Tax Assets, Operating Loss Carryforwards, Components [Abstract] Valuation allowance carried against net deferred tax assets Deferred Tax Assets, Valuation Allowance Depreciation Effects of Adopting Topic 606 [Member] Stock-Based Compensation [Abstract] Stock-Based Compensation Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Federal [Member] Earliest Tax Year [Member] Earnings Per Share Basic and diluted loss per share (in dollars per share) Earnings Per Share, Basic and Diluted Accrued payroll and related expenses Weighted average amortization period Stock Options [Member] Unrecognized stock-based compensation expense expected to be recognized related to non-vested stock options Unrecognized stock-based compensation expense expected to be recognized related to non-vested RSUs Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options Equity Component [Domain] Equity [Abstract] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value Measurements, Recurring and Nonrecurring [Table] Measurement Frequency [Axis] Fair Value Hierarchy and NAV [Axis] Asset Class [Axis] Asset Class [Domain] Recurring [Member] Fair Value, Measurement Frequency [Domain] Fair Value Hierarchy and NAV [Domain] Fair Value of Financial Instruments Cash and Available-for-Sale Securities Adjusted Cost, Gross Unrealized Gains, Gross Unrealized Losses and Fair Value by Significant Investment Category Level 1 [Member] Fair Value, Inputs, Level 1 [Member] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets [Line Items] Number of patents allegedly infringed upon by Apple, Inc. Gain Contingency, Patents Found Infringed upon, Number Litigation [Abstract] Gain Contingency, Quantities, Patents [Abstract] Gain Contingencies, Nature [Axis] Gain Contingency, Nature [Domain] Gain Contingencies [Table] Gain Contingencies [Line Items] General and Administrative Expense [Member] Geographic Distribution [Domain] Geographic Distribution [Axis] Intellectual Property [Member] Impairment of Long-Lived Assets Income Statement Location [Domain] Income Statement Location [Axis] Income Taxes [Abstract] Income Tax Authority [Axis] Income Tax Authority [Domain] Loss before taxes Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) [Abstract] Income Statement Highlights [Abstract] Provision for income tax Income tax expense Provision for income taxes Income Tax Expense (Benefit) Income Taxes Income Tax Disclosure [Text Block] Deferred revenue Increase (Decrease) in Contract with Customer, Liability Accounts payable and accrued liabilities Accounts receivables Increase (Decrease) in Accounts Receivable Income tax liability Increase (Decrease) in Income Taxes Payable Accrued payroll and related expenses Increase (Decrease) in Employee Related Liabilities Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Changes in assets and liabilities: Initial Application Period Cumulative Effect Transition [Axis] Initial Application Period Cumulative Effect Transition [Domain] Business Description [Abstract] Intangible Assets, Gross (Excluding Goodwill) [Abstract] Interest income, net Interest income, net Lease term Term of lease Lessee, Operating Lease, Term of Contract Office and Aircraft Leases [Abstract] Lessee, Operating Lease, Description [Abstract] Operating lease expiration date Litigation Legal Matters and Contingencies [Text Block] LIABILITIES AND STOCKHOLDERS' EQUITY Total liabilities Liabilities Total liabilities and stockholders' equity Liabilities and Equity Current liabilities: Current liabilities [Abstract] Total current liabilities Total current liabilities Amount of damages awarded in patent infringement case Loss Contingency, Damages Awarded, Value Mutual Funds [Member] Mutual Fund [Member] Business Description Cash flows from financing activities: Net cash provided by (used in) financing activities Net Cash Provided by (Used in) Financing Activities Net cash provided by investing activities Net Cash Provided by (Used in) Investing Activities Cash flows from investing activities: Cash flows from operating activities: Net cash used in operating activities Net cash used in operating activities Net loss Net loss Net loss New Accounting Pronouncements New Accounting Pronouncements or Change in Accounting Principle [Line Items] New Accounting Pronouncements [Abstract] Adjustments for New Accounting Pronouncement [Member] EX-101.PRE 11 vhc-20180630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 12 image0.jpg begin 644 image0.jpg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htm IDEA: XBRL DOCUMENT v3.10.0.1

Document and Entity Information - shares
6 Months Ended

Jun. 30, 2018

Aug. 06, 2018

Document and Entity Information [Abstract]

Entity Registrant Name VirnetX Holding Corp

Entity Central Index Key 0001082324

Current Fiscal Year End Date --12-31

Entity Well-known Seasoned Issuer No

Entity Voluntary Filers No

Entity Current Reporting Status Yes

Entity Filer Category Accelerated Filer

Entity Common Stock, Shares Outstanding 62,622,325

Document Fiscal Year Focus 2018

Document Fiscal Period Focus Q2

Document Type 10-Q

Amendment Flag false

Document Period End Date Jun. 30, 2018

X

- Definition
If the value is true, then the document is an amendment to previously-filed/accepted document.
+ References
No definition available.
+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
End date of current fiscal year in the format --MM-DD.
+ References
No definition available.
+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition
The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.
+ References
No definition available.
+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
+ References
No definition available.
+ Details

Name: dei_EntityCommonStockSharesOutstanding

Namespace Prefix: dei_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
No definition available.
+ Details

Name: dei_EntityCurrentReportingStatus

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated), (5) Smaller Reporting Accelerated Filer or (6) Smaller Reporting Company and Large Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityFilerCategory

Namespace Prefix: dei_

Data Type: dei:filerCategoryItemType

Balance Type: na

Period Type: duration

X

- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.
+ References
No definition available.
+ Details

Name: dei_EntityVoluntaryFilers

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.
+ References
No definition available.
+ Details

Name: dei_EntityWellKnownSeasonedIssuer

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: vhc_DocumentAndEntityInformationAbstract

Namespace Prefix: vhc_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 14 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
$ in Thousands

Jun. 30, 2018

Dec. 31, 2017

Current assets:

Cash and cash equivalents $ 3,968 $ 3,135

Accounts receivables 2 0

Investments available for sale 724 1,453

Prepaid expenses and other current assets 864 591

Total current assets 5,558 5,179

Prepaid expenses, non-current 1,796 1,989

Property and equipment, net 17 7

Total assets 7,371 7,175

Current liabilities:

Accounts payable and accrued liabilities 2,966 414

Accrued payroll and related expenses 219 2,175

Income tax liability 399 393

Deferred revenue, current portion 0 1,500

Total current liabilities 3,584 4,482

Deferred revenue, non-current portion 0 1,000

Other liabilities 140 140

Total liabilities 3,724 5,622

Commitments and contingencies (Note 4)

Stockholders' equity:

Preferred stock, par value $0.0001 per share Authorized: 10,000,000 shares at June 30, 2018 and December 31, 2017, Issued and outstanding: 0 shares at June 30, 2018 and December 31, 2017 0 0

Common stock, par value $0.0001 per share: Authorized: 100,000,000 shares at June 30, 2018 and December 31, 2017, Issued and outstanding: 62,292,808 shares and 59,051,978 shares, at June 30, 2018 and December 31, 2017, respectively 6 6

Additional paid-in capital 190,724 177,076

Accumulated deficit (187,070) (175,516)

Accumulated other comprehensive loss (13) (13)

Total stockholders' equity 3,647 1,553

Total liabilities and stockholders' equity $ 7,371 $ 7,175

X

- Definition
Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19,20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 8
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130549-203045

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccountsReceivableNetCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(15)(b)(1))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(15)(1))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(20))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccruedIncomeTaxesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=114867106&loc=d3e637-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14A
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669686-108580

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14
-URI http://asc.fasb.org/extlink&oid=114867106&loc=d3e681-108580
+ Details

Name: us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30)(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AdditionalPaidInCapital

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(11))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(12))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910
+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6801-107765

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.9)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765
+ Details

Name: us-gaap_AssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_AssetsCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109979856&loc=d3e26626-111562
+ Details

Name: us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3044-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.25)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.(a),19)
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.17)
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=82911808&loc=d3e14326-108349
+ Details

Name: us-gaap_CommitmentsAndContingencies

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=82913815&loc=SL49130532-203044

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=82913815&loc=SL49130531-203044

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 8
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130549-203045
+ Details

Name: us-gaap_ContractWithCustomerLiabilityCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 8
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130549-203045

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=82913815&loc=SL49130532-203044

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=82913815&loc=SL49130531-203044
+ Details

Name: us-gaap_ContractWithCustomerLiabilityNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_EmployeeRelatedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19-26)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_Liabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(23))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(25))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(32))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LiabilitiesAndStockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.21)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_LiabilitiesCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.24)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_OtherLiabilitiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(7))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(8))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PrepaidExpenseAndOtherAssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of amounts paid in advance for expenses which will be charged against earnings in periods after one year or beyond the operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.17)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PrepaidExpenseNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(14))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(8))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(13))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The cumulative amount of the reporting entity's undistributed earnings or deficit.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30)(a)(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(23)(a)(4))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_StockholdersEquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 15 R3.htm IDEA: XBRL DOCUMENT v3.10.0.1

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares

Jun. 30, 2018

Dec. 31, 2017

Stockholders' equity:

Preferred stock, par value (in dollars per share) $ 0.0001 $ 0.0001

Preferred stock, shares authorized (in shares) 10,000,000 10,000,000

Preferred stock, shares issued (in shares) 0 0

Preferred stock, shares outstanding (in shares) 0 0

Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001

Common stock, shares authorized (in shares) 100,000,000 100,000,000

Common stock, shares issued (in shares) 62,292,808 59,051,978

Common stock, shares outstanding (in shares) 62,292,808 59,051,978

X

- Definition
Face amount or stated value per share of common stock.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_StockholdersEquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 16 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended

Jun. 30, 2018

Jun. 30, 2017

Jun. 30, 2018

Jun. 30, 2017

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) [Abstract]

Revenue $ 16 $ 396 $ 22 $ 771

Operating expense:

Research and development 1,186 957 2,191 1,873

Selling, general and administrative 5,292 3,250 11,901 6,615

Total operating expense 6,478 4,207 14,092 8,488

Loss from operations (6,462) (3,811) (14,070) (7,717)

Interest income, net 12 13 20 31

Loss before taxes (6,450) (3,798) (14,050) (7,686)

Provision for income tax 0 0 (5) (5)

Net loss $ (6,450) $ (3,798) $ (14,055) $ (7,691)

Basic and diluted loss per share (in dollars per share) $ (0.10) $ (0.07) $ (0.23) $ (0.13)

Weighted average shares outstanding basic and diluted (in shares) 61,532 58,195 60,835 58,170

X

- Definition
The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1337-109256
+ Details

Name: us-gaap_EarningsPerShareBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h)(1)(i))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeStatementAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (h)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 20
-Section 45
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324
+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The net amount of operating interest income (expense).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04.10)
-URI http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260
+ Details

Name: us-gaap_InterestIncomeExpenseNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669619-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669625-108580

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=114873790&loc=SL114874131-224263

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OperatingExpensesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The net result for the period of deducting operating expenses from operating revenues.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 985
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 730
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373
+ Details

Name: us-gaap_ResearchAndDevelopmentExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130543-203045

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130539-203045

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130545-203045
+ Details

Name: us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section 30
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=68048583&loc=d3e3636-108311

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.4)
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227
+ Details

Name: us-gaap_SellingGeneralAndAdministrativeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).
+ References
No definition available.
+ Details

Name: us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 17 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended

Jun. 30, 2018

Jun. 30, 2017

Jun. 30, 2018

Jun. 30, 2017

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited) [Abstract]

Net loss $ (6,450) $ (3,798) $ (14,055) $ (7,691)

Other comprehensive income (loss):

Change in equity adjustment from foreign currency translation, net of tax 0 0 0 (1)

Change in unrealized gain on investments, net of tax (1) 0 0 (4)

Total other comprehensive income gain (loss) (1) 0 0 (5)

Comprehensive loss $ (6,451) $ (3,798) $ (14,055) $ (7,696)

X

- Definition
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=114867106&loc=d3e557-108580

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669625-108580

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669619-108580
+ Details

Name: us-gaap_ComprehensiveIncomeNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669619-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669625-108580

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=114873790&loc=SL114874131-224263

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 45
-Paragraph 18
-URI http://asc.fasb.org/extlink&oid=109240241&loc=d3e32157-110900

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 45
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=109240241&loc=d3e32211-110900

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=109240241&loc=d3e32022-110900

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 10A
-Subparagraph (a-c)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669646-108580

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=114867106&loc=d3e637-108580
+ Details

Name: us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax of other comprehensive income (loss) attributable to parent entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669625-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(3)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669619-108580

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount after tax, before reclassification adjustments, of unrealized holding gain (loss) on available-for-sale securities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 10A
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669646-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=114867106&loc=d3e637-108580
+ Details

Name: us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 18 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
6 Months Ended

Jun. 30, 2018

Jun. 30, 2017

Cash flows from operating activities:

Net loss $ (14,055) $ (7,691)

Adjustments to reconcile net loss to net cash used in operating activities:

Depreciation 10 15

Stock-based compensation 2,008 1,715

Changes in assets and liabilities:

Prepaid expenses and other assets (80) (13)

Accounts payable and accrued liabilities 2,552 (1,362)

Accrued payroll and related expenses (1,923) (1,303)

Accounts receivables (2) 0

Income tax liability 6 (1)

Deferred revenue 0 (750)

Net cash used in operating activities (11,484) (9,390)

Cash flows from investing activities:

Purchase of investments (924) (756)

Proceeds from sale or maturity of investments 1,635 5,760

Net cash provided by investing activities 711 5,004

Cash flows from financing activities:

Proceeds from sale of common stock 11,639 0

Payments of taxes on restricted stock units (33) (29)

Net cash provided by (used in) financing activities 11,606 (29)

Net change in cash and cash equivalents 833 (4,415)

Cash and cash equivalents, beginning of period 3,135 6,627

Cash and cash equivalents, end of period 3,968 2,212

ASU Topic 606 [Member]

Non-cash transactions

Deferred revenue reclassified to retained earnings - ASC 606 adoption $ 2,500 $ 0

X

- References
No definition available.
+ Details

Name: us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5047-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 14.F)
-URI http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)(i)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_AllocatedShareBasedCompensationExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3044-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.
+ References
No definition available.
+ Details

Name: us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585
+ Details

Name: us-gaap_Depreciation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInAccountsReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInContractWithCustomerLiability

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInOperatingCapitalAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of increase (decrease) in prepaid expenses, and assets classified as other.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3521-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3521-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3536-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3521-108585

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669619-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669625-108580

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=114873790&loc=SL114874131-224263

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash outflow to satisfy an employee's income tax withholding obligation as part of a net-share settlement of a share-based award.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3291-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 25
-Paragraph 19A
-URI http://asc.fasb.org/extlink&oid=107668666&loc=SL79513924-113897
+ Details

Name: us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow to acquire debt and equity securities not classified as either held-to-maturity securities or trading securities which would be classified as available-for-sale securities and reported at fair value, with unrealized gains and losses excluded from earnings and reported in a separate component of shareholders' equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=109979856&loc=d3e26853-111562

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (a),(b)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3213-108585
+ Details

Name: us-gaap_PaymentsToAcquireAvailableForSaleSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash inflow from the additional capital contribution to the entity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromIssuanceOfCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.
+ References
No definition available.
+ Details

Name: us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Value of deferred revenue reclassified to retained earnings in noncash transactions.
+ References
No definition available.
+ Details

Name: vhc_DeferredRevenueReclassifiedToRetainedEarnings

Namespace Prefix: vhc_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 19 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1

Business Description
6 Months Ended

Jun. 30, 2018

Business Description [Abstract]

Business Description
Note 1 — Business Description

VirnetX Holding Corporation, which we refer to as “we”, “us”, “our”, “the Company” or “VirnetX”, is engaged in the business of commercializing a portfolio of patents. We seek to license our technology, including GABRIEL Connection Technology™, to various original equipment manufacturers, or OEMs, that use our technologies in the development and manufacturing of their own products within the IP-telephony, mobility, fixed-mobile convergence and unified communications markets. Since 2012 we had revenues from settlements of patent infringement disputes whereby we received consideration for past sales of licensees that utilized our technology, where there was no prior patent license agreement, as well as license agreement revenues from settlements providing licensing for the continued use of our technology (see “Revenue Recognition”).

Our portfolio of intellectual property is the foundation of our business model. We currently own approximately 185 total patents and pending applications, including 70 U.S. patents/patent applications and 115 foreign patents/validations/pending applications. Our patent portfolio is primarily focused on securing real-time communications over the Internet, as well as related services such as the establishment and maintenance of a secure domain name registry. Our patented methods also have additional applications in the key areas of device operating systems and network security for Cloud services, Machine-to-Machine (“M2M”), communications in areas including “Smart City,” “Connected Car” and “Connected Home.” All our U.S. and foreign patents and pending patent applications relate generally to securing communications over the internet and as such, cover all our technology and other products. Our issued U.S. and foreign patents expire at various times during the period from 2019 to 2024. Some of our issued patents and pending patent applications were acquired by our principal operating subsidiary, VirnetX, Inc., from Leidos, Inc. (“Leidos”) (f/k/a Science Applications International Corporation, or SAIC) in 2006 and we are required to make payments to Leidos based on cash or certain other values generated from those patents in certain circumstances. The amount of such payments depends upon the type of value generated and certain categories are subject to maximums and other limitations.

X

- Definition
The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-URI http://asc.fasb.org/topic&trid=2134479
+ Details

Name: us-gaap_NatureOfOperations

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 20 R8.htm IDEA: XBRL DOCUMENT v3.10.0.1

Basis of Presentation and Summary of Significant Accounting Policies
6 Months Ended

Jun. 30, 2018

Basis of Presentation and Summary of Significant Accounting Policies [Abstract]

Basis of Presentation and Summary of Significant Accounting Policies
Note 2 — Basis of Presentation and Summary of Significant Accounting Policies

Unaudited Interim Financial Information

The accompanying Condensed Consolidated Balance Sheet as of June 30, 2018, the Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2018 and 2017, the Condensed Consolidated Statements of Comprehensive Loss for the three and six months ended June 30, 2018 and 2017, and the Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2018 and 2017 are unaudited. These unaudited interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”). In our opinion, the unaudited interim condensed consolidated financial statements include all adjustments of a normal recurring nature necessary for the fair presentation of our financial position as of June 30, 2018, our results of operations for the three and six months ended June 30, 2018 and 2017, and our cash flows for the six months ended June 30, 2018 and 2017. The results of operations for the three and six months ended June 30, 2018 are not necessarily indicative of the results to be expected for the year ending December 31, 2018.

These unaudited interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2017, filed with the SEC on March 16, 2018.

Use of Estimates

We prepare our condensed consolidated financial statements in accordance with U.S. GAAP. In doing so, we have to make estimates and assumptions that affect our reported amounts of assets, liabilities, revenues, and expenses, as well as related disclosure of contingent assets and liabilities. In some cases, we could reasonably have used different accounting policies and estimates. In some cases, changes in our accounting estimates are reasonably likely to occur. Accordingly, actual results could differ materially from our estimates. To the extent that there are material differences between these estimates and actual results, our financial condition or results of operations will be affected. We base our estimates on past experience and other assumptions that we believe are reasonable under the circumstances, at the time they are made, and we evaluate these estimates on an ongoing basis. We refer to accounting estimates of this type as critical accounting policies and estimates, which we discuss further below.

Basis of Consolidation

The condensed consolidated financial statements include the accounts of VirnetX Holding Corporation and our wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated.

Reclassifications

Certain prior period amounts were reclassified to conform to the current year’s presentation. None of these reclassifications had an impact on reported operating expenses, operating income or net income for any of the periods presented.

Revenue Recognition

Most of our revenue historically has been derived from licensing and royalty fees from contracts with customers which often spanned several years. We account for revenue in accordance with Accounting Standards Update (“ASU”) No.2014-09, Revenue from Contracts with Customers “Topic 606”, which we adopted on January 1, 2018 using the modified-retrospective method (see Note 8 – Effects of Adopting ASU Topic 606). Prior to January 1, 2018 we recognized revenue in accordance with previous guidance as described in our Annual Report on Form 10-K for the year ended December 31, 2017.

A performance obligation is a promise in a contract to transfer a distinct good or service to the customer in accordance with Topic 606. A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. Our revenue arrangements may consist of multiple-element arrangements, with revenue for each unit of accounting recognized as the product or service is delivered to the customer.

With the licensing of our patents, performance obligations are generally satisfied at a point in time as work is complete and our patent rights are transferred to our customers. We generally have no further obligation to our customers regarding our technology.

Certain contracts may require our customers to enter into a hosting arrangement with us and for these arrangements revenue is recognized over time, generally over the life of the servicing contract.

Deferred revenue

From 2013 to 2016, we received contractual payments totaling $10,000. In accordance with our revenue recognition policy, we deferred and then recognized revenue over the life of the contract, but not ahead of collection. We recognized $375 and $750 of revenue, related to this contract during the three and six months ended June 30, 2017. On January 1, 2018, we adopted Topic 606 and applied the modification retrospective approach as discussed above.

Earnings Per Share

Basic earnings per share are computed by dividing earnings available to common stockholders by the weighted average number of outstanding common shares during the period. Diluted earnings per share are computed by dividing net income by the weighted average number of shares outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued.

Concentration of Credit Risk and Other Risks and Uncertainties

Our cash and cash equivalents are primarily maintained at two major financial institutions in the United States. A portion of those balances are insured by the Federal Deposit Insurance Corporation. During the six months ended June 30, 2018 we had funds which were uninsured. We do not believe that we are subject to any unusual financial risk beyond the normal risk associated with commercial banking relationships with major financial institutions. We have not experienced any losses on our deposits of cash and cash equivalents.

Prepaid Expenses

Prepaid expenses at June 30, 2018 include the current portion of prepaid rent for a facility lease for corporate promotional and marketing purposes. From inception, the prepayment totaling $4,000 is being amortized over the 10-year term of the lease. The unamortized non-current portion of the prepayment is included in Prepaid expenses, non-current on the condensed consolidated balance sheet.

Impairment of Long-Lived Assets

On an annual basis, we identify and record impairment losses on long-lived assets when events and changes in circumstances indicate that the carrying amount of an asset might not be recoverable. Recoverability is measured by comparison of the anticipated future net undiscounted cash flows to the related assets’ carrying value. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the projected discounted future net cash flows arising from the asset.

Fair Value of Financial Instruments

Fair value is the price that would result from an orderly transaction between market participants at the measurement date. A fair value hierarchy prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). Level 2 measurements utilize either directly or indirectly observable inputs in markets other than quoted prices in active markets.

Our financial instruments are stated at amounts that equal, or approximate, fair value. When we estimate fair value, we utilize market data or assumptions that we believe market participants would use in pricing the financial instrument, including assumptions about risk and inputs to the valuation technique. We use valuation techniques, primarily the income and market approach, which maximizes the use of observable inputs and minimize the use of unobservable inputs for recurring fair value measurements.

Mutual Funds: Valued at the quoted net asset value of shares held.

U.S. Government and U.S. Agency Securities: Fair value measured at the closing price reported on the active market on which the individual securities are traded.

The following tables show the adjusted cost, gross unrealized gains, gross unrealized losses and fair value of our securities by significant investment category as of June 30, 2018, and December 31, 2017.

June 30, 2018

Adjusted
Cost

Unrealized
Gains

Unrealized
Losses

Fair
Value

Cash
and Cash
Equivalents

Investments
Available
for Sale

Cash

$
2,056

$
-

$
-

$
2,056

$
2,056

$
-

Level 1:

Mutual funds

1,087

-

-

1,087

1,087

-

U.S. government securities

80

-

-

80

-

80

U.S. agency securities

1,468

1

-

1,469

825

644

2,635

1

-

2,636

1,912

724

Total

$
4,691

$
1

$
-

$
4,692

$
3,968

$
724

December 31, 2017

Adjusted
Cost

Unrealized
Gains

Unrealized
Losses

Fair
Value

Cash and
Cash
Equivalents

Investments
Available
for Sale

Cash

$
1,972

$
—

$
—

$
1,972

$
1,972

$
—

Level 1:

Mutual funds

616

—

—

616

616

U.S. agency securities

2,001

—

(1
)

2,000

547

1,453

2,617

—

(1
)

2,616

1,163

1,453

Total

$
4,589

$
—

$
(1
)

$
4,588

$
3,135

$
1,453

New Accounting Pronouncements

In June 2018, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2018-07, Compensation—Stock Compensation (“Topic 718”)—Improvements to Nonemployee Share-Based Payment Accounting. The amendments in this update expand the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. The amendments specify that Topic 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor’s own operations by issuing share-based payment awards. The amendments in this update are effective for public business entities for fiscal years beginning after December 15, 2018, including interim periods within that fiscal year and early adoption is permitted. We adopted the ASU effective June 30, 2018, which had no material impact on our financial position or statement of operations.

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments-Credit Losses (“Topic 326”). The purpose of this ASU is to require a financial asset measured at amortized cost basis to be presented at the net amount expected to be collected. Credit losses relating to available-for-sale debt securities should be recorded through an allowance for credit losses. This ASU is effective for interim and annual reporting periods beginning after December 15, 2019. We are evaluating the impact this guidance will have on our financial position and statement of operations.

In February 2016, FASB issued ASU No. 2016-02, Leases (“Topic 842”). Topic 842 requires an entity to recognize right-of-use assets and lease liabilities on its balance sheet and disclose key information about leasing arrangements. For public companies, Topic 842 is effective for annual reporting periods beginning after December 15, 2018, including interim periods within that reporting period, with early adoption permitted. We are evaluating the impact this guidance will have on our financial position and statement of operations.

In May 2014, the FASB issued ASU No. 2014-09 Revenue from Contracts with Customers (“Topic 606”). As amended, Topic 606 supersedes prior revenue recognition requirements including most industry-specific revenue recognition guidance. In summary, the core principle of Topic 606 is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. On January 1, 2018 we adopted this standard which resulted in a $2,500 decrease in accumulated deficit and a $2,500 decrease in deferred revenue in our consolidated balance sheet (see Note 8 — Effects of Adopting ASU Topic 606).

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-URI http://asc.fasb.org/topic&trid=2122369
+ Details

Name: us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 21 R9.htm IDEA: XBRL DOCUMENT v3.10.0.1

Income Taxes
6 Months Ended

Jun. 30, 2018

Income Taxes [Abstract]

Income Taxes
Note 3 - Income Taxes

We had income tax expense of $0 and $5 for the three and six-months ended June 30, 2018 and 2017, respectively, as a result of minimum tax payments. During the three and six-month period ended June 30, 2018 and 2017, we had net operating losses (“NOLs”) which generated deferred tax assets for NOL carryforwards. We provided valuation allowances against the net deferred tax assets including the deferred tax assets for NOL carryforwards. Valuation allowances provided for our net deferred tax assets increased by approximately $7,400 and $3,747 for the six months ended June 30, 2018 and 2017, respectively.

In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of the deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Based on the available objective evidence, management believes it is more likely than not that the net deferred tax assets at June 30, 2018 will not be fully realizable. Accordingly, management has maintained a full valuation allowance against its net deferred tax assets at June 30, 2018. The valuation allowance carried against our net deferred tax assets was approximately $41,000 and $34,000 at June 30, 2018 and December 31, 2017, respectively.

At June 30, 2018, we have federal and state net operating loss carryforwards of approximately $103,000 and $117,000, respectively, expiring beginning in 2027 and 2028, respectively.

In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers, (“Topic 606”) which amends revenue recognition principles and provides a single set of criteria for revenue recognition among all industries. We adopted the new standard effective January 1, 2018 under the modified retrospective method. Under the modified retrospective method, we recognized deferred revenue of $2,500 through retained earnings. The tax provision is prepared based on the assumption that the Company will file accounting method change form 3115 with 2018 tax return to reflect the adoption of Topic 606.

Our tax years for 2005 and forward are subject to examination by the U.S. tax authority and various state tax authorities. These years are open due to net operating losses and tax credits remaining unutilized from such years.

Our policy is to recognize interest and penalties accrued on uncertain tax positions as a component of income tax expense. As of June 30, 2018, we had accrued immaterial amounts of interest and penalties related to the uncertain tax positions.

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeTaxDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-URI http://asc.fasb.org/topic&trid=2144680
+ Details

Name: us-gaap_IncomeTaxDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 22 R10.htm IDEA: XBRL DOCUMENT v3.10.0.1

Commitments and Related Party Transactions
6 Months Ended

Jun. 30, 2018

Commitments and Related Party Transactions [Abstract]

Commitments and Related Party Transactions
Note 4 — Commitments and Related Party Transactions

We lease our offices under an operating lease with a third party expiring in October 2019. We recognize rent expense on a straight-line basis over the term of the lease.

We lease the use of an aircraft from K2 Investment Fund LLC (“LLC”) for business travel for employees of the Company. We incurred approximately $75 and $683 compared to $213 and $472 in rental fees and reimbursements to the LLC during the three and six months ended June 30, 2018 and 2017, respectively. Our Chief Executive Officer and Chief Administrative Officer are the managing partners and control the equity interests of the LLC. We entered into a 12-month non-exclusive lease with LLC for use of the plane at a rate of $8 per flight hour, with no minimum usage requirement. The agreement contains other terms and conditions normal in such transactions and can be cancelled by either us or LLC with 30 days’ notice. The lease renews on an annual basis unless terminated by the lessor or lessee. Neither party has exercised their termination rights.

X

- References
No definition available.
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 440
-URI http://asc.fasb.org/topic&trid=2144648
+ Details

Name: us-gaap_CommitmentsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 23 R11.htm IDEA: XBRL DOCUMENT v3.10.0.1

Stock-Based Compensation
6 Months Ended

Jun. 30, 2018

Stock-Based Compensation [Abstract]

Stock-Based Compensation
Note 5 — Stock-Based Compensation

We have a stock incentive plan for employees and others called the VirnetX Holding Corporation 2013 Equity Incentive Plan (the “Plan”), which has been approved by our stockholders. In May 2017, the Board approved an amendment and restatement of the Plan to, among other things, increase the shares reserved under the Plan by 2,500,000 shares (the “Plan Amendment”). Our stockholders approved of the Plan Amendment at the 2017 Annual Meeting of Stockholders held on June 1, 2017. The Plan provides for grants of 16,624,469 shares of our common stock, including stock options and restricted stock units (“RSUs”), and will expire in 2023. As of June 30, 2018, 1,780,315 shares remained available for grant under the Plan.

During the three months ended June 30, 2018, we granted options for a total of 336,000 shares with a weighted average grant date fair value of $2.31 per options. During the three months ended June 30, 2017, we granted options totaling 331,000 shares with a weighted average grant date fair value of $2.72.

During the six months ended June 30, 2018, we granted options for a total of 1,006,000 shares. The weighted average fair value at the grant dates for options issued during the six months ended June 30, 2018 was $2.52 per option. The fair values of options at the grant date were estimated utilizing the Black-Scholes valuation model with the following weighted average assumptions for the six months ended June 30, 2018 (i) dividend yield on our common stock of 0 percent (ii) expected stock price volatility of 85 percent (iii) a risk-free interest rate of 2.65 percent and (iv) and expected option term of 6 years.

During the six months ended June 30, 2017, we granted options for a total of 356,000 shares with a weighted average grant date fair value of $2.65. The fair values of options at the grant date were estimated utilizing the Black-Scholes valuation model with the following weighted average assumptions for the six months ended June 30, 2017 (i) dividend yield on our common stock of 0 percent (ii) expected stock price volatility of 84 percent (iii) a risk-free interest rate average of 1.94 percent and (iv) an expected option term of 6 years.

During the three months ended June 30, 2018 and 2017, we granted 223,997 and 220,664 RSUs, respectively. The weighted average fair values at the grant dates for RSUs issued during the three months ended June 30, 2018 and 2017 were $3.19 and $3.83 per RSU, respectively. RSUs, which are subject to forfeiture if service terminates prior to the shares vesting, are expensed ratably over the vesting period. During the three months ended June 30, 2018 and 2017, we paid $33 and $29 in withholding taxes on shares issued upon conversion of RSUs. The underlying shares were canceled. These amounts are reflected as financing costs in the accompanying statement of cash flows.

During the six months ended June 30, 2018 and 2017, we granted 243,997 and 220,664 RSUs, respectively. The weighted average fair values at the grant dates for RSUs issued during the six months ended June 30, 2018 and 2017 were $3.28 and $3.83 per RSU, respectively. RSUs, which are subject to forfeiture if service terminates prior to the shares vesting, are expensed ratably over the vesting period. During the six months ended June 30, 2018 and 2017, we paid $33 and $29 in withholding taxes on shares issued upon conversion of RSUs. The underlying shares were canceled. These amounts are reflected as financing costs in the accompanying statement of cash flows.

Stock-based compensation expense included in general and administrative expense was $467 and $855 and in research and development expense was $655 and $1,154 for the three and six months ended June 30, 2018, respectively, and $442 and $834 for general and administrative and $440 and $881 for research and development for the three and six months ended June 30, 2017, respectively.

As of June 30, 2018, the unrecognized stock-based compensation expense related to non-vested stock options and RSUs was $7,160 and $2,001, respectively, which will be amortized over an estimated weighted average period of approximately 3.08 and 2.72 years, respectively.

During the six-month period ended June 30, 2018 we issued 168,219 new shares of common stock as a result of vesting RSUs. No shares of common stock were issued as a result of stock options exercised during the period.

X

- Definition
The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-URI http://asc.fasb.org/topic&trid=2228938

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-URI http://asc.fasb.org/subtopic&trid=2208855
+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 24 R12.htm IDEA: XBRL DOCUMENT v3.10.0.1

Equity
6 Months Ended

Jun. 30, 2018

Equity [Abstract]

Equity
Note 6 — Equity

Common Stock

On August 21, 2015, we filed a universal shelf registration statement with the U.S. Securities and Exchange Commission enabling us to offer and sell from time to time up to $100,000 of equity, debt or other types of securities. We also entered into an at-the-market (“ATM”) equity offering sales agreement with Cowen & Company, LLC (“Cowen”) on August 20, 2015, under which we may offer and sell shares of our common stock having an aggregate value of up to $35,000. On March 8, 2018, we amended our August 20, 2015 equity offering sales agreement (“Amended Agreement”) with Cowen whereby the maximum aggregate value of the Company’s common stock (“Shares”) we may offer and sell, from time to time, was increased from $35,000 to $50,000. We intend to use the proceeds of this offering for GABRIEL product development and marketing, and general corporate purposes, which may include working capital, capital expenditures, other corporate expenses and acquisitions of complementary products, technologies or businesses.

During the six months ended June 30, 2018, we sold 3,072,610 shares under the ATM. The average sales price per common share was $3.91 and the aggregate proceeds from the sales totaled $12,000 during the period. Sales commissions, fees and other costs associated with the ATM totaled $360.

Warrants

In 2015 we issued warrants (“Advisor Warrants”) for the purchase of 25,000 shares of common stock at an exercise price of $7 per share, which expire in April 2020. The Advisor Warrants were issued for advisory services provided by a third party. Our Advisor Warrants were recorded at fair value on the issuance date and included in Additional Paid in Capital on our Condensed Consolidated Balance Sheet. The Advisor Warrants are exercisable by the holder, in whole or in part, until expiration, and may also be net-share-settled. Terms of the warrant agreement include no registration requirements for the underlying common stock and there are no anti-dilution provisions.

Information about warrants outstanding during the three months ended June 30, 2018 follows:

Original
Number
of
Warrants
Issued

Exercise
Price per
Common
Share

Exercisable at
December 31,
2017

Became
Exercisable

Exercised

Terminated /
Cancelled /
Expired

Exercisable
at June 30,
2018

Expiration
Date

25,000

$
7.00

25,000

—

—

—

25,000

April 2020

25,000

—

—

—

25,000

X

- References
No definition available.
+ Details

Name: us-gaap_EquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-URI http://asc.fasb.org/topic&trid=2208762
+ Details

Name: us-gaap_StockholdersEquityNoteDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 25 R13.htm IDEA: XBRL DOCUMENT v3.10.0.1

Litigation
6 Months Ended

Jun. 30, 2018

Litigation [Abstract]

Litigation
Note 7 — Litigation

We have multiple intellectual property infringement lawsuits pending in the United States District Court for the Eastern District of Texas, Tyler Division (“USDC”), and United States Court of Appeals for the Federal Circuit (“USCAFC”).

VirnetX Inc. v. Cisco Systems, Inc. et al. (Case 6:10-CV-00417-LED) (“Apple I”)

On August 11, 2010, we filed a complaint against Aastra USA. Inc. (“Aastra”), Apple Inc. (“Apple”), Cisco Systems, Inc. (“Cisco”), and NEC Corporation (“NEC”) in the USDC in which we alleged that these parties infringe on certain of our patents (U.S. Patent Nos. 6,502,135, 7,418,504, 7,921,211 and 7,490,151). We sought damages and injunctive relief. The cases against each defendant were separated by the judge. Aastra and NEC agreed to sign license agreements with us and we dropped all accusations of infringement against them. A jury in USDC decided that our patents were not invalid and rendered a verdict of non-infringement by Cisco on March 4, 2013. Our motion for a new Cisco trial was denied and the case against Cisco was closed.

On November 6, 2012, a jury in the USDC awarded us over $368,000 for Apple’s infringement of four of our patents, plus daily interest up to the final judgment.

Apple filed an appeal of the judgment to the USCAFC. On September 16, 2014, USCAFC affirmed the USDC jury’s finding that all four of our patents at issue are valid and confirmed the USDC jury’s finding of infringement of VPN on Demand under many of the asserted claims of our ‘135 and ‘151 patents, and the USDC’s decision to allow evidence about our license and royalty rates regarding the determination of damages. However, the USCAFC vacated the USDC jury’s damages award and some of the USDC’s claim construction with respect to parts of our ‘504 and ‘211 patents and remanded the damages award and determination of infringement with respect to FaceTime back to the USDC for further proceedings.

On September 30, 2016, pursuant to the 2014 remand from the USCAFC, a jury in the USDC, awarded us $302,400 for Apple’s infringement of four of our patents. On September 29, 2017, the USDC entered its final judgement, denied all of Apple’s post-trial motions, granted all our post-trial motions, including our motion for willful infringement and enhanced the royalty rate during the willfulness period from $1.20 to $1.80 per device, and awarded us costs, certain attorneys’ fees, and prejudgment interest. The total amount in the final judgement was $439,700, including $302,400 (jury verdict), $41,300 (enhanced damages) and $96,000 (costs, fees and interest).

On October 27, 2017 Apple filed its notice of appeal of this final judgement to the USCAFC. Apple filed its opening brief on March 19, 2018. We filed our response on April 4, 2018. On April 11, 2018, USCAFC designated Cases 18-1197-CB, Case 17-1368 and Case 17-1591 as companion cases and assigned to the same merits panel. Events and developments after this order are described below under VirnetX Inc. v. The Mangrove Partners (USCAFC Case 17-1368) (“Consolidated Appeal”).

VirnetX Inc. v. Apple, Inc. (Case 6:12-CV-00855-LED) (“Apple II”)

On April 12, 2018, an USDC jury awarded us $502,600 in this case. The same jury in the second part of the case determined that Apple had willfully infringed all the patents in the case, which per the jury instructions is reserved for only the most egregious behavior, such as where the infringement is malicious, deliberate, consciously wrongful, or done in bad faith. The verdict covers issues of infringement by products that were allegedly changed after the Apple I trial including, Apple’s redesigned VOD (VPN on Demand) in iOS 7 to iOS 11, the redesigned FaceTime in iOS 7 to iOS 11 and OS X 10.9 and later. This case began on November 6, 2012, when we had filed a complaint against Apple in USDC in which we alleged that Apple infringed on certain of our patents, (U.S. Patent Nos. 6,502,135, 7,418,504, 7,921,211 and 7,490,151). We sought damages and injunctive relief. The accused products include the iPhone 5, iPod Touch 5th Generation, iPad 4^th Generation, iPad mini, and the latest Macintosh computers; these products were not included in the Apple I case because they were released after the Apple I case was initiated. Post-Trial Motions hearing was held on July 18, 2018. We are currently awaiting the courts’ ruling on these motions and the final judgment.

VirnetX Inc. v. The Mangrove Partners (USCAFC Case 17-1368) (“Consolidated Appeal”)

On April 11, 2018, the USCAFC in an order designated following appeals as companion cases and assigned to the same merits panel;

·
VirnetX Inc. v. The Mangrove Partners (USCAFC Case 17-1368)

On December 16, 2016, we filed appeals with the USCAFC, appealing the invalidity findings by the Patent Trial and Appeal Board (“PTAB”) in IPR2015-01046, and on December 20, 2016 for IPR2015-1047, involving our U.S. Patent Nos. 6,502,135, and 7,490,151. These appeals also involve Apple, Inc. and one of them involves Black Swamp IP, LLC. These appeals have been consolidated into a single case.

·
VirnetX Inc. v. Cisco Systems, Inc. (USCAFC Case 18-1197-CB) (Appeal of Apple I Case)

On October 27, 2017 Apple filed its notice of appeal of the Final Judgment entered on September 29, 2017 to the United States Court of Appeals for the Federal Circuit.

·
VirnetX Inc. v. Apple Inc., Cisco Systems, Inc. (USCAFC Case 17-1591)

On February 7, 2017, we filed appeals with the USCAFC, appealing the invalidity findings by the PTAB in inter-parties’ reexamination nos. 95/001,788, 95/001,789, and 95/001,856 related to our U.S. Patent Nos. 7,921,211 and 7,418,504. These appeals have been consolidated into a single case.

The written briefing in all these USCAFC cases have been concluded; the oral arguments have not yet been scheduled.

VirnetX Inc. v. Apple Inc. (Case 17-2490)

On August 23, 2017, we filed with the USCAFC appeals of the invalidity findings by the PTAB in IPR2016-00331 and IPR2016-00332 involving our U.S. Patent No. 8,504,696. The briefing in these appeals has been concluded; the oral arguments have not yet been scheduled.

VirnetX Inc. (Case 17-2593)

On September 22, 2017, we filed with the USCAFC, appeals of the invalidity findings by the PTAB in IPR2016-00693 and IPR2016-00957 involving our U.S. Patent Nos. 7,418,504 and 7,921,211. The briefing in these appeals has not taken place. The entity that initiated the IPRs, Black Swamp IP, LLC, indicated on October 18, 2017, that it would not participate in the appeals. On November 27, 2017, the USPTO indicated that it would intervene in the appeals. On January 19, 2018, the USCAFC stayed these appeals pending the USCAFC’s decision in Case 17-1591.

One or more potential intellectual property infringement claims may also be available to us against certain other companies who have the resources to defend against any such claims. Although we believe these potential claims are likely valid, commencing a lawsuit can be expensive and time-consuming, and there is no assurance that we could prevail on such potential claims if we made them. In addition, bringing a lawsuit may lead to potential counterclaims which may distract our management and our other resources, including capital resources, from efforts to successfully commercialize our products.

Currently, we are not a party to any other pending legal proceedings and are not aware of any proceeding threatened or contemplated against us.

X

- Definition
The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-URI http://asc.fasb.org/topic&trid=2127136
+ Details

Name: us-gaap_LegalMattersAndContingenciesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: vhc_LitigationAbstract

Namespace Prefix: vhc_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 26 R14.htm IDEA: XBRL DOCUMENT v3.10.0.1

Effects of Adopting ASU Topic 606
6 Months Ended

Jun. 30, 2018

Effects of Adopting ASU Topic 606 [Abstract]

Effects of Adopting ASU Topic 606
Note 8 — Effects of Adopting ASU Topic 606

The following tables summarize the effects of adopting this standard on our unaudited condensed consolidated financial statements:

Balance Sheet Highlights

Reported As of
December 31, 2017

Effects of Adopting
Topic 606

As of
January 1, 2018

Current liabilities:

Deferred revenue, current portion

$
1,500

$
(1,500
)

$
—

Total current liabilities

$
4,482

$
(1,500
)

$
2,982

Deferred revenue, non-current portion

1,000

(1,000
)

—

Other liabilities

140

—

140

Total Liabilities

$
5,622

$
(2,500
)

$
3,122

Accumulated deficit

$
(175,516
)

$
2,500

$
(173,016
)
Total Stockholder’s Equity

$
1,553

$
2,500

$
4,053

As of
June 30,
2018
Pre-Topic 606

Effects of Adopting
Topic 606

As of
June 30,
2018
(as reported)

Deferred revenue, current portion

$
1,500

$
(1,500
)

$
—

Total current liabilities

$
5,084

$
(1,500
)

$
3,584

Deferred revenue, non-current portion

250

(250
)

—

Other liabilities

140

—

140

Total liabilities

$
5,474

$
(1,750
)

$
3,724

Accumulated deficit

(188,820
)

1,750

(187,070
)
Total stockholders’ equity

$
1,897

$
1,750

$
3,647

Income Statement Highlights

Six Months Ended
June 30, 2018
Pre-Topic 606

Six Months Ended
June 30, 2018
Effects of Adopting
Topic 606

Six Months Ended
June 30, 2018
(as reported)

Revenue

$
772

$
(750
)

$
22

Loss from operations

(13,320
)

(750
)

(14,070
)
Interest income, net

20

—

20

Loss before taxes

(13,300
)

(750
)

(14,050
)
Provision for income taxes

(5
)

—

(5
)
Net loss

$
(13,305
)

$
(750
)

$
(14,055
)

Three Months Ended
June 30, 2018
Pre-Topic 606

Three Months Ended
June 30, 2018
Effects of Adopting
Topic 606

Three Months Ended
June 30, 2018
(as reported)

Revenue

$
391

$
(375
)

$
16

Loss from operations

(6,087
)

(375
)

(6,462
)
Interest income, net

12

—

12

Loss before taxes

(6,075
)

(375
)

(6,450
)
Net loss

$
(6,075
)

$
(375
)

$
(6,450
)

Cash Flow Statement Highlights

Six
Months
Ended
June 30,
2018
Pre-Topic 606

Six
Months
Ended
June 30,
2018
Effects of
Adopting Topic
606

Six
Months
Ended
June 30,
2018
(as reported)

Net loss

$
(13,305
)

$
(750
)

$
(14,055
)
Adjustments to reconcile net loss to net cash used in operating activities:

Deferred revenue

(750
)
750

—

Net cash used in operating activities

(11,484
)

—

(11,484
)

X

- References
No definition available.
+ Details

Name: us-gaap_RevenueFromContractWithCustomerAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-URI http://asc.fasb.org/topic&trid=49130388

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-URI http://asc.fasb.org/topic&trid=2122369
+ Details

Name: us-gaap_RevenueFromContractWithCustomerTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 27 R15.htm IDEA: XBRL DOCUMENT v3.10.0.1

Subsequent Events
6 Months Ended

Jun. 30, 2018

Subsequent Events [Abstract]

Subsequent Events
Note 9 — Subsequent Events

Between July 1, 2018 and August 6, 2018, we sold 297,652 shares of common stock under the ATM program. The average sales price per common share sold was $3.48 and the aggregate proceeds from the sales totaled $1,036. Sales commissions, fees and other costs associated with the ATM transactions totaled $31.

On July 8, 2018 we issued 31,865 new shares of common stock as a result of vesting RSUs.

X

- References
No definition available.
+ Details

Name: us-gaap_SubsequentEventsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 855
-URI http://asc.fasb.org/topic&trid=2122774
+ Details

Name: us-gaap_SubsequentEventsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 28 R16.htm IDEA: XBRL DOCUMENT v3.10.0.1

Basis of Presentation and Summary of Significant Accounting Policies (Policies)
6 Months Ended

Jun. 30, 2018

Basis of Presentation and Summary of Significant Accounting Policies [Abstract]

Unaudited Interim Financial Information
Unaudited Interim Financial Information

The accompanying Condensed Consolidated Balance Sheet as of June 30, 2018, the Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2018 and 2017, the Condensed Consolidated Statements of Comprehensive Loss for the three and six months ended June 30, 2018 and 2017, and the Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2018 and 2017 are unaudited. These unaudited interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”). In our opinion, the unaudited interim condensed consolidated financial statements include all adjustments of a normal recurring nature necessary for the fair presentation of our financial position as of June 30, 2018, our results of operations for the three and six months ended June 30, 2018 and 2017, and our cash flows for the six months ended June 30, 2018 and 2017. The results of operations for the three and six months ended June 30, 2018 are not necessarily indicative of the results to be expected for the year ending December 31, 2018.

These unaudited interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2017, filed with the SEC on March 16, 2018.

Use of Estimates
Use of Estimates

We prepare our condensed consolidated financial statements in accordance with U.S. GAAP. In doing so, we have to make estimates and assumptions that affect our reported amounts of assets, liabilities, revenues, and expenses, as well as related disclosure of contingent assets and liabilities. In some cases, we could reasonably have used different accounting policies and estimates. In some cases, changes in our accounting estimates are reasonably likely to occur. Accordingly, actual results could differ materially from our estimates. To the extent that there are material differences between these estimates and actual results, our financial condition or results of operations will be affected. We base our estimates on past experience and other assumptions that we believe are reasonable under the circumstances, at the time they are made, and we evaluate these estimates on an ongoing basis. We refer to accounting estimates of this type as critical accounting policies and estimates, which we discuss further below.

Basis of Consolidation
Basis of Consolidation

The condensed consolidated financial statements include the accounts of VirnetX Holding Corporation and our wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated.

Reclassifications
Reclassifications

Certain prior period amounts were reclassified to conform to the current year’s presentation. None of these reclassifications had an impact on reported operating expenses, operating income or net income for any of the periods presented.

Revenue Recognition
Revenue Recognition

Most of our revenue historically has been derived from licensing and royalty fees from contracts with customers which often spanned several years. We account for revenue in accordance with Accounting Standards Update (“ASU”) No.2014-09, Revenue from Contracts with Customers “Topic 606”, which we adopted on January 1, 2018 using the modified-retrospective method (see Note 8 – Effects of Adopting ASU Topic 606). Prior to January 1, 2018 we recognized revenue in accordance with previous guidance as described in our Annual Report on Form 10-K for the year ended December 31, 2017.

A performance obligation is a promise in a contract to transfer a distinct good or service to the customer in accordance with Topic 606. A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. Our revenue arrangements may consist of multiple-element arrangements, with revenue for each unit of accounting recognized as the product or service is delivered to the customer.

With the licensing of our patents, performance obligations are generally satisfied at a point in time as work is complete and our patent rights are transferred to our customers. We generally have no further obligation to our customers regarding our technology.

Certain contracts may require our customers to enter into a hosting arrangement with us and for these arrangements revenue is recognized over time, generally over the life of the servicing contract.

Deferred Revenue
Deferred revenue

From 2013 to 2016, we received contractual payments totaling $10,000. In accordance with our revenue recognition policy, we deferred and then recognized revenue over the life of the contract, but not ahead of collection. We recognized $375 and $750 of revenue, related to this contract during the three and six months ended June 30, 2017. On January 1, 2018, we adopted Topic 606 and applied the modification retrospective approach as discussed above.

Earnings Per Share
Earnings Per Share

Basic earnings per share are computed by dividing earnings available to common stockholders by the weighted average number of outstanding common shares during the period. Diluted earnings per share are computed by dividing net income by the weighted average number of shares outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued.

Concentration of Credit Risk and Other Risks and Uncertainties
Concentration of Credit Risk and Other Risks and Uncertainties

Our cash and cash equivalents are primarily maintained at two major financial institutions in the United States. A portion of those balances are insured by the Federal Deposit Insurance Corporation. During the six months ended June 30, 2018 we had funds which were uninsured. We do not believe that we are subject to any unusual financial risk beyond the normal risk associated with commercial banking relationships with major financial institutions. We have not experienced any losses on our deposits of cash and cash equivalents.

Prepaid Expenses
Prepaid Expenses

Prepaid expenses at June 30, 2018 include the current portion of prepaid rent for a facility lease for corporate promotional and marketing purposes. From inception, the prepayment totaling $4,000 is being amortized over the 10-year term of the lease. The unamortized non-current portion of the prepayment is included in Prepaid expenses, non-current on the condensed consolidated balance sheet.

Impairment of Long-Lived Assets
Impairment of Long-Lived Assets

On an annual basis, we identify and record impairment losses on long-lived assets when events and changes in circumstances indicate that the carrying amount of an asset might not be recoverable. Recoverability is measured by comparison of the anticipated future net undiscounted cash flows to the related assets’ carrying value. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the projected discounted future net cash flows arising from the asset.

Fair Value of Financial Instruments
Fair Value of Financial Instruments

Fair value is the price that would result from an orderly transaction between market participants at the measurement date. A fair value hierarchy prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). Level 2 measurements utilize either directly or indirectly observable inputs in markets other than quoted prices in active markets.

Our financial instruments are stated at amounts that equal, or approximate, fair value. When we estimate fair value, we utilize market data or assumptions that we believe market participants would use in pricing the financial instrument, including assumptions about risk and inputs to the valuation technique. We use valuation techniques, primarily the income and market approach, which maximizes the use of observable inputs and minimize the use of unobservable inputs for recurring fair value measurements.

Mutual Funds: Valued at the quoted net asset value of shares held.

U.S. Government and U.S. Agency Securities: Fair value measured at the closing price reported on the active market on which the individual securities are traded.

The following tables show the adjusted cost, gross unrealized gains, gross unrealized losses and fair value of our securities by significant investment category as of June 30, 2018, and December 31, 2017.

June 30, 2018

Adjusted
Cost

Unrealized
Gains

Unrealized
Losses

Fair
Value

Cash
and Cash
Equivalents

Investments
Available
for Sale

Cash

$
2,056

$
-

$
-

$
2,056

$
2,056

$
-

Level 1:

Mutual funds

1,087

-

-

1,087

1,087

-

U.S. government securities

80

-

-

80

-

80

U.S. agency securities

1,468

1

-

1,469

825

644

2,635

1

-

2,636

1,912

724

Total

$
4,691

$
1

$
-

$
4,692

$
3,968

$
724

December 31, 2017

Adjusted
Cost

Unrealized
Gains

Unrealized
Losses

Fair
Value

Cash and
Cash
Equivalents

Investments
Available
for Sale

Cash

$
1,972

$
—

$
—

$
1,972

$
1,972

$
—

Level 1:

Mutual funds

616

—

—

616

616

U.S. agency securities

2,001

—

(1
)

2,000

547

1,453

2,617

—

(1
)

2,616

1,163

1,453

Total

$
4,589

$
—

$
(1
)

$
4,588

$
3,135

$
1,453

New Accounting Pronouncements
New Accounting Pronouncements

In June 2018, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2018-07, Compensation—Stock Compensation (“Topic 718”)—Improvements to Nonemployee Share-Based Payment Accounting. The amendments in this update expand the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. The amendments specify that Topic 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor’s own operations by issuing share-based payment awards. The amendments in this update are effective for public business entities for fiscal years beginning after December 15, 2018, including interim periods within that fiscal year and early adoption is permitted. We adopted the ASU effective June 30, 2018, which had no material impact on our financial position or statement of operations.

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments-Credit Losses (“Topic 326”). The purpose of this ASU is to require a financial asset measured at amortized cost basis to be presented at the net amount expected to be collected. Credit losses relating to available-for-sale debt securities should be recorded through an allowance for credit losses. This ASU is effective for interim and annual reporting periods beginning after December 15, 2019. We are evaluating the impact this guidance will have on our financial position and statement of operations.

In February 2016, FASB issued ASU No. 2016-02, Leases (“Topic 842”). Topic 842 requires an entity to recognize right-of-use assets and lease liabilities on its balance sheet and disclose key information about leasing arrangements. For public companies, Topic 842 is effective for annual reporting periods beginning after December 15, 2018, including interim periods within that reporting period, with early adoption permitted. We are evaluating the impact this guidance will have on our financial position and statement of operations.

In May 2014, the FASB issued ASU No. 2014-09 Revenue from Contracts with Customers (“Topic 606”). As amended, Topic 606 supersedes prior revenue recognition requirements including most industry-specific revenue recognition guidance. In summary, the core principle of Topic 606 is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. On January 1, 2018 we adopted this standard which resulted in a $2,500 decrease in accumulated deficit and a $2,500 decrease in deferred revenue in our consolidated balance sheet (see Note 8 — Effects of Adopting ASU Topic 606).

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for credit risk.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 825
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=108315417&loc=d3e61044-112788
+ Details

Name: us-gaap_ConcentrationRiskCreditRisk

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.3A-02)
-URI http://asc.fasb.org/extlink&oid=27015204&loc=d3e355033-122828

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section S99
-Paragraph 3
-Subparagraph (SX 210.3A-03)
-URI http://asc.fasb.org/extlink&oid=27015204&loc=d3e355100-122828

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684
+ Details

Name: us-gaap_ConsolidationPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257
+ Details

Name: us-gaap_EarningsPerSharePolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for determining the fair value of financial instruments.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 60
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=109250915&loc=d3e13279-108611

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790
+ Details

Name: us-gaap_FairValueOfFinancialInstrumentsPolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 05
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 5.CC)
-URI http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742
+ Details

Name: us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.
+ References
No definition available.
+ Details

Name: us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for reclassifications that affects the comparability of the financial statements.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755
+ Details

Name: us-gaap_PriorPeriodReclassificationAdjustmentDescription

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for revenue from contract with customer.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-URI http://asc.fasb.org/topic&trid=49130388
+ Details

Name: us-gaap_RevenueFromContractWithCustomerPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592
+ Details

Name: us-gaap_UseOfEstimates

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for deferred revenue from contract with customer.
+ References
No definition available.
+ Details

Name: vhc_DeferredRevenueFromContractWithCustomerPolicyTextBlock

Namespace Prefix: vhc_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for prepaid expenses.
+ References
No definition available.
+ Details

Name: vhc_PrepaidExpensesPolicyTextBlock

Namespace Prefix: vhc_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for unaudited interim financial information.
+ References
No definition available.
+ Details

Name: vhc_UnauditedInterimFinancialInformationTextBlock

Namespace Prefix: vhc_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 29 R17.htm IDEA: XBRL DOCUMENT v3.10.0.1

Basis of Presentation and Summary of Significant Accounting Policies (Tables)
6 Months Ended

Jun. 30, 2018

Basis of Presentation and Summary of Significant Accounting Policies [Abstract]

Cash and Available-for-Sale Securities Adjusted Cost, Gross Unrealized Gains, Gross Unrealized Losses and Fair Value by Significant Investment Category
The following tables show the adjusted cost, gross unrealized gains, gross unrealized losses and fair value of our securities by significant investment category as of June 30, 2018, and December 31, 2017.

June 30, 2018

Adjusted
Cost

Unrealized
Gains

Unrealized
Losses

Fair
Value

Cash
and Cash
Equivalents

Investments
Available
for Sale

Cash

$
2,056

$
-

$
-

$
2,056

$
2,056

$
-

Level 1:

Mutual funds

1,087

-

-

1,087

1,087

-

U.S. government securities

80

-

-

80

-

80

U.S. agency securities

1,468

1

-

1,469

825

644

2,635

1

-

2,636

1,912

724

Total

$
4,691

$
1

$
-

$
4,692

$
3,968

$
724

December 31, 2017

Adjusted
Cost

Unrealized
Gains

Unrealized
Losses

Fair
Value

Cash and
Cash
Equivalents

Investments
Available
for Sale

Cash

$
1,972

$
—

$
—

$
1,972

$
1,972

$
—

Level 1:

Mutual funds

616

—

—

616

616

U.S. agency securities

2,001

—

(1
)

2,000

547

1,453

2,617

—

(1
)

2,616

1,163

1,453

Total

$
4,589

$
—

$
(1
)

$
4,588

$
3,135

$
1,453

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=99377789&loc=d3e19207-110258

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=99377789&loc=d3e19190-110258

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=99377789&loc=d3e19207-110258
+ Details

Name: us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 30 R18.htm IDEA: XBRL DOCUMENT v3.10.0.1

Equity (Tables)
6 Months Ended

Jun. 30, 2018

Equity [Abstract]

Information about Warrants Outstanding
Information about warrants outstanding during the three months ended June 30, 2018 follows:

Original
Number
of
Warrants
Issued

Exercise
Price per
Common
Share

Exercisable at
December 31,
2017

Became
Exercisable

Exercised

Terminated /
Cancelled /
Expired

Exercisable
at June 30,
2018

Expiration
Date

25,000

$
7.00

25,000

—

—

—

25,000

April 2020

25,000

—

—

—

25,000

X

- References
No definition available.
+ Details

Name: us-gaap_EquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5047-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(i))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-Section S99
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=68057994&loc=d3e25284-112666
+ Details

Name: us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 31 R19.htm IDEA: XBRL DOCUMENT v3.10.0.1

Effects of Adopting ASU Topic 606 (Tables)
6 Months Ended

Jun. 30, 2018

Effects of Adopting ASU Topic 606 [Abstract]

Effects of Adopting New Accounting Standard on Financial Statements
The following tables summarize the effects of adopting this standard on our unaudited condensed consolidated financial statements:

Balance Sheet Highlights

Reported As of
December 31, 2017

Effects of Adopting
Topic 606

As of
January 1, 2018

Current liabilities:

Deferred revenue, current portion

$
1,500

$
(1,500
)

$
—

Total current liabilities

$
4,482

$
(1,500
)

$
2,982

Deferred revenue, non-current portion

1,000

(1,000
)

—

Other liabilities

140

—

140

Total Liabilities

$
5,622

$
(2,500
)

$
3,122

Accumulated deficit

$
(175,516
)

$
2,500

$
(173,016
)
Total Stockholder’s Equity

$
1,553

$
2,500

$
4,053

As of
June 30,
2018
Pre-Topic 606

Effects of Adopting
Topic 606

As of
June 30,
2018
(as reported)

Deferred revenue, current portion

$
1,500

$
(1,500
)

$
—

Total current liabilities

$
5,084

$
(1,500
)

$
3,584

Deferred revenue, non-current portion

250

(250
)

—

Other liabilities

140

—

140

Total liabilities

$
5,474

$
(1,750
)

$
3,724

Accumulated deficit

(188,820
)

1,750

(187,070
)
Total stockholders’ equity

$
1,897

$
1,750

$
3,647

Income Statement Highlights

Six Months Ended
June 30, 2018
Pre-Topic 606

Six Months Ended
June 30, 2018
Effects of Adopting
Topic 606

Six Months Ended
June 30, 2018
(as reported)

Revenue

$
772

$
(750
)

$
22

Loss from operations

(13,320
)

(750
)

(14,070
)
Interest income, net

20

—

20

Loss before taxes

(13,300
)

(750
)

(14,050
)
Provision for income taxes

(5
)

—

(5
)
Net loss

$
(13,305
)

$
(750
)

$
(14,055
)

Three Months Ended
June 30, 2018
Pre-Topic 606

Three Months Ended
June 30, 2018
Effects of Adopting
Topic 606

Three Months Ended
June 30, 2018
(as reported)

Revenue

$
391

$
(375
)

$
16

Loss from operations

(6,087
)

(375
)

(6,462
)
Interest income, net

12

—

12

Loss before taxes

(6,075
)

(375
)

(6,450
)
Net loss

$
(6,075
)

$
(375
)

$
(6,450
)

Cash Flow Statement Highlights

Six
Months
Ended
June 30,
2018
Pre-Topic 606

Six
Months
Ended
June 30,
2018
Effects of
Adopting Topic
606

Six
Months
Ended
June 30,
2018
(as reported)

Net loss

$
(13,305
)

$
(750
)

$
(14,055
)
Adjustments to reconcile net loss to net cash used in operating activities:

Deferred revenue

(750
)
750

—

Net cash used in operating activities

(11,484
)

—

(11,484
)

X

- References
No definition available.
+ Details

Name: us-gaap_RevenueFromContractWithCustomerAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 45
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=109236672&loc=d3e765-108305

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.10-01.(b)(6))
-URI http://asc.fasb.org/extlink&oid=27015980&loc=d3e46468-122699

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22580-107794

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=109236672&loc=d3e725-108305

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794
+ Details

Name: us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 32 R20.htm IDEA: XBRL DOCUMENT v3.10.0.1

Business Description (Details) - Patents [Member]

Jun. 30, 2018

Patent

Business Description [Abstract]

Number of patents and pending applications 185

U.S. [Member]

Business Description [Abstract]

Number of patents and pending applications 70

Foreign [Member]

Business Description [Abstract]

Number of patents and pending applications 115

X

- References
No definition available.
+ Details

Name: us-gaap_IntangibleAssetsGrossExcludingGoodwillAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Represents number of patents and pending applications owned by the entity.
+ References
No definition available.
+ Details

Name: vhc_NumberOfPatentsAndPendingApplicationsOwned

Namespace Prefix: vhc_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_GeographicDistributionAxis=country_US

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_GeographicDistributionAxis=us-gaap_NonUsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 33 R21.htm IDEA: XBRL DOCUMENT v3.10.0.1

Basis of Presentation and Summary of Significant Accounting Policies (Details)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended

Jun. 30, 2017

USD ($)

Jun. 30, 2018

USD ($)

Institution

Jun. 30, 2017

USD ($)

Dec. 31, 2017

USD ($)

Dec. 31, 2016

USD ($)

Concentration of Credit Risk and Others Risks and Uncertainties [Abstract]

Number of financial institutions holding company's cash | Institution 2

Prepaid Expenses [Abstract]

Prepayment of facility lease for corporate promotional and marketing purposes $ 4,000

Lease term 10 years

Cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category [Abstract]

Adjusted Cost $ 2,212 $ 3,968 $ 2,212 $ 3,135 $ 6,627

Adjusted Cost 2,635 2,617

Unrealized Gains 1 0

Unrealized Losses 0 (1)

Fair Value 2,636 2,616

Adjusted Cost 4,691 4,589

Fair Value 4,692 4,588

Investments Available for Sale 2,636 2,616

Cash [Member]

Cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category [Abstract]

Adjusted Cost 2,056 1,972

Fair Value 2,056 1,972

Cash and Cash Equivalents 2,056 1,972

Mutual Funds [Member]

Cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category [Abstract]

Adjusted Cost 1,087 616

Unrealized Gains 0 0

Unrealized Losses 0 0

Fair Value 1,087 616

Investments Available for Sale 1,087 616

U.S. Government Securities [Member]

Cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category [Abstract]

Adjusted Cost 80

Unrealized Gains 0

Unrealized Losses 0

Fair Value 80

Investments Available for Sale 80

U.S. Agency Securities [Member]

Cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category [Abstract]

Adjusted Cost 1,468 2,001

Unrealized Gains 1 0

Unrealized Losses 0 (1)

Fair Value 1,469 2,000

Investments Available for Sale 1,469 2,000

Recurring [Member]

Cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category [Abstract]

Fair Value 3,968 3,135

Fair Value 724 1,453

Cash and Cash Equivalents 3,968 3,135

Investments Available for Sale 724 1,453

Recurring [Member] | Cash [Member]

Cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category [Abstract]

Fair Value 2,056 1,972

Cash and Cash Equivalents 2,056 1,972

Recurring [Member] | Level 1 [Member]

Cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category [Abstract]

Fair Value 1,912 1,163

Fair Value 724 1,453

Cash and Cash Equivalents 1,912 1,163

Investments Available for Sale 724 1,453

Recurring [Member] | Level 1 [Member] | Mutual Funds [Member]

Cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category [Abstract]

Fair Value 1,087 616

Fair Value 0

Cash and Cash Equivalents 1,087 616

Investments Available for Sale 0

Recurring [Member] | Level 1 [Member] | U.S. Government Securities [Member]

Cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category [Abstract]

Fair Value 0

Fair Value 80

Cash and Cash Equivalents 0

Investments Available for Sale 80

Recurring [Member] | Level 1 [Member] | U.S. Agency Securities [Member]

Cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category [Abstract]

Fair Value 825 547

Fair Value 644 1,453

Cash and Cash Equivalents 825 547

Investments Available for Sale 644 1,453

2013 to 2016 Contract [Member]

Deferred Revenue [Abstract]

Total contractual payments received $ 10,000

Revenue recognized $ 375 $ 750

ASU 2014-09 [Member]

Deferred Revenue [Abstract]

Revenue recognized 2,500

ASU 2014-09 [Member] | Retained Earnings [Member]

New Accounting Pronouncements [Abstract]

Cumulative effect adjustments (2,500)

ASU 2014-09 [Member] | Deferred Revenue [Member]

New Accounting Pronouncements [Abstract]

Cumulative effect adjustments $ (2,500)

X

- References
No definition available.
+ Details

Name: us-gaap_AssetsFairValueDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of investment in debt and equity securities categorized neither as held-to-maturity nor trading.
+ References
No definition available.
+ Details

Name: us-gaap_AvailableForSaleSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before tax of unrealized gain in accumulated other comprehensive income (AOCI) on investments in debt and equity securities classified as available-for-sale.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=82897076&loc=d3e27161-111563
+ Details

Name: us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount before tax of unrealized loss in accumulated other comprehensive income (AOCI) on investments in debt and equity securities classified as available-for-sale.
+ References
No definition available.
+ Details

Name: us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
This item represents the cost of debt and equity securities, which are categorized neither as held-to-maturity nor trading, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any.
+ References
No definition available.
+ Details

Name: us-gaap_AvailableForSaleSecuritiesAmortizedCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3044-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
+ References
No definition available.
+ Details

Name: us-gaap_CashAndCashEquivalentsFairValueDisclosure

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_ContractWithCustomerAssetAndLiabilityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 8
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130549-203045
+ Details

Name: us-gaap_ContractWithCustomerLiabilityRevenueRecognized

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax of increase (decrease) to equity or (increase) decrease to net assets, resulting from the cumulative effect adjustment of a new accounting principle applied in the period of adoption.
+ References
No definition available.
+ Details

Name: us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 3
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918673-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseTermOfContract

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_PrepaidExpenseCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of asset related to consideration paid in advance for rent that provides economic benefits within a future period of one year or the normal operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 340
-SubTopic 10
-Section 05
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6787-107765

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 340
-SubTopic 10
-Section 05
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=68074540&loc=d3e5865-108316

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (g)(3)
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765
+ Details

Name: us-gaap_PrepaidRent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_RisksAndUncertaintiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
This item represents the cost of cash and debt and equity securities, which are categorized neither as held-to-maturity nor trading, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any.
+ References
No definition available.
+ Details

Name: vhc_CashAndAvailableForSaleSecuritiesAmortizedCostBasis

Namespace Prefix: vhc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Fair value portion of cash and investment in debt and equity securities categorized neither as held-to-maturity nor trading.
+ References
No definition available.
+ Details

Name: vhc_CashAndAvailableForSaleSecuritiesFairValueDisclosure

Namespace Prefix: vhc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Number of financial institutions holding the company's cash and cash equivalents.
+ References
No definition available.
+ Details

Name: vhc_ConcentrationRiskNumberOfFinancialInstitutions

Namespace Prefix: vhc_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of contract payments received to date.
+ References
No definition available.
+ Details

Name: vhc_ContractPaymentsReceivedToDate

Namespace Prefix: vhc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_FairValueByAssetClassAxis=us-gaap_CashMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByAssetClassAxis=us-gaap_MutualFundMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByAssetClassAxis=us-gaap_USGovernmentDebtSecuritiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByAssetClassAxis=us-gaap_USTreasurySecuritiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_MajorCustomersAxis=vhc_ContractSettlement2013To2016Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BalanceSheetLocationAxis=vhc_ContractWithCustomerMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 34 R22.htm IDEA: XBRL DOCUMENT v3.10.0.1

Income Taxes (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended

Jun. 30, 2018

Jun. 30, 2017

Jun. 30, 2018

Jun. 30, 2017

Dec. 31, 2017

Income Taxes [Abstract]

Income tax expense $ 0 $ 0 $ 5 $ 5

Net change in valuation allowance 7,400 $ 3,747

Valuation allowance carried against net deferred tax assets 41,000 41,000 $ 34,000

ASU 2014-09 [Member]

Income Taxes [Abstract]

Deferred revenue recognized $ 2,500

Federal [Member]

Income Taxes [Abstract]

Net operating loss carryforwards 103,000 $ 103,000

Federal [Member] | Earliest Tax Year [Member]

Income Taxes [Abstract]

Operating loss carryforwards, expiration dates Dec. 31, 2027

State [Member]

Income Taxes [Abstract]

Net operating loss carryforwards $ 117,000 $ 117,000

State [Member] | Earliest Tax Year [Member]

Income Taxes [Abstract]

Operating loss carryforwards, expiration dates Dec. 31, 2028

X

- Definition
Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 8
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130549-203045
+ Details

Name: us-gaap_ContractWithCustomerLiabilityRevenueRecognized

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsComponentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319
+ Details

Name: us-gaap_DeferredTaxAssetsValuationAllowance

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeTaxDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (h)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 20
-Section 45
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324
+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319
+ Details

Name: us-gaap_OperatingLossCarryforwards

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Expiration date of each operating loss carryforward included in operating loss carryforward, in CCYY-MM-DD format.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319
+ Details

Name: us-gaap_OperatingLossCarryforwardsExpirationDate

Namespace Prefix: us-gaap_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=84176650&loc=d3e32123-109318
+ Details

Name: us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_TaxPeriodAxis=us-gaap_EarliestTaxYearMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 35 R23.htm IDEA: XBRL DOCUMENT v3.10.0.1

Commitments and Related Party Transactions (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended

Jun. 30, 2018

Jun. 30, 2017

Jun. 30, 2018

Jun. 30, 2017

Office and Aircraft Leases [Abstract]

Term of lease 10 years 10 years

Offices [Member]

Office and Aircraft Leases [Abstract]

Operating lease expiration date Oct. 31, 2019

K2 Investment Fund LLC [Member] | Aircraft [Member]

Office and Aircraft Leases [Abstract]

Rental fees incurred for use of aircraft $ 75 $ 213 $ 683 $ 472

Term of lease 12 months 12 months

Rate of aircraft lease (in dollars per flight hour) $ 8

Term of notice for cancellation of lease 30 days

X

- Definition
Expenses incurred related to the lease of aircraft from outside third parties that are used in the entity's business operations and direct costs incurred at airports primarily consisting of fees paid to the airport authority for takeoff and landing, gate and facility fees, and other related fees.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.2(e))
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227
+ Details

Name: us-gaap_AircraftRentalAndLandingFees

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Date which lease or group of leases is set to expire, in CCYY-MM-DD format.
+ References
No definition available.
+ Details

Name: us-gaap_LeaseExpirationDate1

Namespace Prefix: us-gaap_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_LesseeOperatingLeaseDescriptionAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 3
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918673-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseTermOfContract

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: instant

X

- Definition
Refers to the rate of aircraft lease in dollars per flight hour.
+ References
No definition available.
+ Details

Name: vhc_RateOfAircraftLease

Namespace Prefix: vhc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Refers to the term of notice for cancellation of lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
No definition available.
+ Details

Name: vhc_TermOfNoticeForCancellationOfLease

Namespace Prefix: vhc_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_CounterpartyNameAxis=vhc_K2InvestmentFundLLCMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AirTransportationEquipmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 36 R24.htm IDEA: XBRL DOCUMENT v3.10.0.1

Stock-Based Compensation (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended

May 31, 2017

Jun. 30, 2018

Jun. 30, 2017

Jun. 30, 2018

Jun. 30, 2017

Share-based Compensation [Abstract]

Withholding taxes paid on shares issued upon conversion of RSUs $ 33 $ 29

Stock-based compensation expense 2,008 1,715

General and Administrative Expense [Member]

Share-based Compensation [Abstract]

Stock-based compensation expense $ 467 $ 442 855 834

Research and Development Expense [Member]

Share-based Compensation [Abstract]

Stock-based compensation expense $ 655 $ 440 $ 1,154 $ 881

Stock Options [Member]

Share-based Compensation [Abstract]

Options granted (in shares) 336,000 331,000 1,006,000 356,000

Options granted, weighted average grant date fair value (in dollars per share) $ 2.31 $ 2.72 $ 2.52 $ 2.65

Dividend yield 0.00% 0.00%

Expected stock price volatility 85.00% 84.00%

Risk-free interest rate 2.65% 1.94%

Expected option term 6 years 6 years

Unrecognized stock-based compensation expense expected to be recognized related to non-vested stock options $ 7,160 $ 7,160

Weighted average amortization period 3 years 29 days

Options exercised (in shares) 0

Restricted Stock Units (RSUs) [Member]

Share-based Compensation [Abstract]

RSUs granted (in shares) 223,997 220,664 243,997 220,664

Weighted average grant date fair value of RSU's granted (in dollars per share) $ 3.19 $ 3.83 $ 3.28 $ 3.83

Withholding taxes paid on shares issued upon conversion of RSUs $ 33 $ 29 $ 33 $ 29

Unrecognized stock-based compensation expense expected to be recognized related to non-vested RSUs $ 2,001 $ 2,001

Weighted average amortization period 2 years 8 months 19 days

New shares of common stock issued as a result of vesting RSUs (in shares) 168,219

2013 Plan [Member]

Share-based Compensation [Abstract]

Additional shares authorized for issuance (in shares) 2,500,000

Shares authorized for issuance (in shares) 16,624,469 16,624,469

Shares available for grant (in shares) 1,780,315 1,780,315

X

- Definition
Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5047-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 14.F)
-URI http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)(i)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_AllocatedShareBasedCompensationExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Unrecognized cost of unvested share-based awards, other than options, awarded to employees as compensation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Unrecognized cost of unvested options awarded to employees as compensation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of cash outflow to satisfy an employee's income tax withholding obligation as part of a net-share settlement of a share-based award.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3291-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 25
-Paragraph 19A
-URI http://asc.fasb.org/extlink&oid=107668666&loc=SL79513924-113897
+ Details

Name: us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(1)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(1)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iii)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(ii)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The risk-free interest rate assumption that is used in valuing an option on its own shares.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iv)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of additional shares authorized for issuance under an established share-based compensation plan.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Gross number of share options (or share units) granted during the period.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)(1)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of share instruments newly issued under a share-based compensation plan.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(i)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 14.D.2)
-URI http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of share options (or share units) exercised during the current period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(2)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PlanNameAxis=vhc_Plan2013Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 37 R25.htm IDEA: XBRL DOCUMENT v3.10.0.1

Equity, Common Stock (Details) - Common Stock [Member] - USD ($)
$ / shares in Units, $ in Thousands
6 Months Ended

Jun. 30, 2018

Mar. 08, 2018

Aug. 21, 2015

Aug. 20, 2015

Universal Shelf Registration Statement [Member]

Common Stock [Abstract]

Securities offered for sale, aggregate value $ 100,000

ATM Agreement [Member]

Common Stock [Abstract]

Securities offered for sale, aggregate value $ 50,000 $ 35,000

Number of shares of common stock sold (in shares) 3,072,610

Average sales price per common share (in dollars per share) $ 3.91

Aggregate proceeds from sales of common stock $ 12,000

Sales commissions, fees and other costs associated with issuance of common stock $ 360

X

- Definition
Number of new stock issued during the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_StockholdersEquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Represents aggregate proceeds from sale agreement of shares of common stock.
+ References
No definition available.
+ Details

Name: vhc_AggregateProceedsFromSaleAgreementOfSharesOfCommonStock

Namespace Prefix: vhc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Average price of a single share of common stock issued during the period.
+ References
No definition available.
+ Details

Name: vhc_CommonStockIssuedDuringPeriodAveragePricePerShare

Namespace Prefix: vhc_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Aggregate value of securities offered for sale.
+ References
No definition available.
+ Details

Name: vhc_EquityDebtAndOtherSecuritiesOfferedForSale

Namespace Prefix: vhc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Cost associated with sale of common stock.
+ References
No definition available.
+ Details

Name: vhc_StockIssuanceCost

Namespace Prefix: vhc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_SubsidiarySaleOfStockAxis=vhc_UniversalShelfRegistrationStatementMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_SubsidiarySaleOfStockAxis=vhc_ATMAgreementMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 38 R26.htm IDEA: XBRL DOCUMENT v3.10.0.1

Equity, Warrants (Details) - Warrants [Member]
6 Months Ended

Jun. 30, 2018

$ / shares

shares

Information about warrants outstanding [Abstract]

Exercisable, beginning of period (in shares) 25,000

Became exercisable (in shares) 0

Exercised (in shares) 0

Terminated/cancelled/expired (in shares) 0

Exercisable, end of period (in shares) 25,000

Advisor Warrants [Member]

Information about warrants outstanding [Abstract]

Original number of warrants issued (in shares) 25,000

Exercise price per common share (in dollars per share) | $ / shares $ 7.00

Exercisable, beginning of period (in shares) 25,000

Became exercisable (in shares) 0

Exercised (in shares) 0

Terminated/cancelled/expired (in shares) 0

Exercisable, end of period (in shares) 25,000

Expiration date Apr. 30, 2020

X

- Definition
Exercise price per share or per unit of warrants or rights outstanding.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(i)(4))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(i)(2))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(2)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of non-option equity instruments exercised by participants.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(2)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of shares under non-option equity instrument agreements that were either cancelled or expired.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(3)-(4)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of equity instruments other than options outstanding, including both vested and non-vested instruments.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(ii)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Date the warrants or rights are to expire, in CCYY-MM-DD format.
+ References
No definition available.
+ Details

Name: vhc_ClassOfWarrantOrRightExpirationDate

Namespace Prefix: vhc_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: vhc_InformationAboutWarrantsOutstandingAbstract

Namespace Prefix: vhc_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_WarrantMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ClassOfWarrantOrRightAxis=vhc_AdvisorWarrantsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 39 R27.htm IDEA: XBRL DOCUMENT v3.10.0.1

Litigation (Details) - Positive Outcome of Litigation [Member]

Apr. 12, 2018

USD ($)

Sep. 29, 2017

USD ($)

Sep. 30, 2016

USD ($)

Patent

Nov. 06, 2012

USD ($)

Patent

VirnetX Inc. v. Cisco Systems, Inc. et al. (Case 6:10-CV-00417-LED) ("Apple I") [Member]

Litigation [Abstract]

Amount of damages awarded in patent infringement case $ 439,700,000 $ 302,400,000

Number of patents allegedly infringed upon by Apple, Inc. | Patent 4 4

Enhanced damages 41,300,000

Additional amount granted in agreed bill of costs, attorney fees, and prejudgment interest (96,000,000)

VirnetX Inc. v. Cisco Systems, Inc. et al. (Case 6:10-CV-00417-LED) ("Apple I") [Member] | Minimum [Member]

Litigation [Abstract]

Amount of damages awarded in patent infringement case $ 368,000,000

Royalty rate per device used in calculating infringement damages 1.20

VirnetX Inc. v. Cisco Systems, Inc. et al. (Case 6:10-CV-00417-LED) ("Apple I") [Member] | Maximum [Member]

Litigation [Abstract]

Royalty rate per device used in calculating infringement damages $ 1.80

VirnetX Inc. v. Apple, Inc. (Case 6:12-CV-00855-LED) ("Apple II") [Member]

Litigation [Abstract]

Amount of damages awarded in patent infringement case $ 502,600,000

X

- Definition
Number of entity's patents that another entity was found to have infringed.
+ References
No definition available.
+ Details

Name: us-gaap_GainContingencyPatentsFoundInfringedUponNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_GainContingencyQuantitiesPatentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of damages awarded to the plaintiff in the legal matter.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 9
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=82911808&loc=d3e14557-108349

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=82911808&loc=d3e14435-108349

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=82911808&loc=d3e14326-108349
+ Details

Name: us-gaap_LossContingencyDamagesAwardedValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Expense (income) directly attributable to litigation settlement interest, bill of costs and attorney fees.
+ References
No definition available.
+ Details

Name: vhc_LitigationSettlementInterestBillOfCostsAndAttorneyFees

Namespace Prefix: vhc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of damages awarded to the plaintiff in the legal matter.
+ References
No definition available.
+ Details

Name: vhc_LossContingencyEnhancedDamagesAwardedValue

Namespace Prefix: vhc_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Royalty rate per device used in calculating infringement damages by the court.
+ References
No definition available.
+ Details

Name: vhc_RoyaltyRatePerDeviceUsedInInfringementDamages

Namespace Prefix: vhc_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_GainContingenciesByNatureAxis=us-gaap_PositiveOutcomeOfLitigationMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_LitigationCaseAxis=vhc_VirnetXIncVCiscoSystemsIncEtAlCase610CV00417LEDAppleIMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_RangeAxis=srt_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_RangeAxis=srt_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_LitigationCaseAxis=vhc_VirnetXIncVAppleIncCase612CV00855LEDAppleIIMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 40 R28.htm IDEA: XBRL DOCUMENT v3.10.0.1

Effects of Adopting ASU Topic 606, Balance Sheet Highlights (Details) - USD ($)
$ in Thousands

Jun. 30, 2018

Dec. 31, 2017

Current liabilities [Abstract]

Deferred revenue, current portion $ 0 $ 1,500

Total current liabilities 3,584 4,482

Deferred revenue, non-current portion 0 1,000

Other liabilities 140 140

Total liabilities 3,724 5,622

Accumulated deficit (187,070) (175,516)

Total stockholders' equity 3,647 1,553

Pre-Topic 606 [Member]

Current liabilities [Abstract]

Deferred revenue, current portion 1,500

Total current liabilities 5,084

Deferred revenue, non-current portion 250

Other liabilities 140

Total liabilities 5,474

Accumulated deficit (188,820)

Total stockholders' equity 1,897

Effects of Adopting Topic 606 [Member] | ASU Topic 606 [Member]

Current liabilities [Abstract]

Deferred revenue, current portion (1,500) (1,500)

Total current liabilities (1,500) (1,500)

Deferred revenue, non-current portion (250) (1,000)

Other liabilities 0 0

Total liabilities (1,750) (2,500)

Accumulated deficit 1,750 2,500

Total stockholders' equity $ 1,750 2,500

Post-Topic 606 [Member]

Current liabilities [Abstract]

Deferred revenue, current portion 0

Total current liabilities 2,982

Deferred revenue, non-current portion 0

Other liabilities 140

Total liabilities 3,122

Accumulated deficit (173,016)

Total stockholders' equity $ 4,053

X

- Definition
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=82913815&loc=SL49130532-203044

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=82913815&loc=SL49130531-203044

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 8
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130549-203045
+ Details

Name: us-gaap_ContractWithCustomerLiabilityCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 8
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130549-203045

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=82913815&loc=SL49130532-203044

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=82913815&loc=SL49130531-203044
+ Details

Name: us-gaap_ContractWithCustomerLiabilityNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19-26)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_Liabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.21)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_LiabilitiesCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.24)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_OtherLiabilitiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The cumulative amount of the reporting entity's undistributed earnings or deficit.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30)(a)(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(23)(a)(4))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis=us-gaap_CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis=us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis=vhc_CalculatedUnderRevenueGuidanceInEffectAfterTopic606Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 41 R29.htm IDEA: XBRL DOCUMENT v3.10.0.1

Effects of Adopting ASU Topic 606, Income Statement Highlights (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended

Jun. 30, 2018

Jun. 30, 2017

Jun. 30, 2018

Jun. 30, 2017

Income Statement Highlights [Abstract]

Revenue $ 16 $ 396 $ 22 $ 771

Loss from operations (6,462) (3,811) (14,070) (7,717)

Interest income, net 12 13 20 31

Loss before taxes (6,450) (3,798) (14,050) (7,686)

Provision for income taxes 0 0 (5) (5)

Net loss (6,450) $ (3,798) (14,055) $ (7,691)

Pre-Topic 606 [Member]

Income Statement Highlights [Abstract]

Revenue 391 772

Loss from operations (6,087) (13,320)

Interest income, net 12 20

Loss before taxes (6,075) (13,300)

Provision for income taxes (5)

Net loss (6,075) (13,305)

Effects of Adopting Topic 606 [Member] | ASU Topic 606 [Member]

Income Statement Highlights [Abstract]

Revenue (375) (750)

Loss from operations (375) (750)

Interest income, net 0 0

Loss before taxes (375) (750)

Provision for income taxes 0

Net loss $ (375) $ (750)

X

- Definition
Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h)(1)(i))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeStatementAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (h)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 20
-Section 45
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324
+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The net amount of operating interest income (expense).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04.10)
-URI http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260
+ Details

Name: us-gaap_InterestIncomeExpenseNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669619-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669625-108580

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=114873790&loc=SL114874131-224263

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The net result for the period of deducting operating expenses from operating revenues.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130543-203045

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130539-203045

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130545-203045
+ Details

Name: us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis=us-gaap_CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis=us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 42 R30.htm IDEA: XBRL DOCUMENT v3.10.0.1

Effects of Adopting ASU Topic 606, Cash Flow Statement Highlights (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended

Jun. 30, 2018

Jun. 30, 2017

Jun. 30, 2018

Jun. 30, 2017

Cash Flow Statement Highlights [Abstract]

Net loss $ (6,450) $ (3,798) $ (14,055) $ (7,691)

Adjustments to reconcile net loss to net cash used in operating activities [Abstract]

Deferred revenue 0 (750)

Net cash used in operating activities (11,484) $ (9,390)

Pre-Topic 606 [Member]

Cash Flow Statement Highlights [Abstract]

Net loss (6,075) (13,305)

Adjustments to reconcile net loss to net cash used in operating activities [Abstract]

Deferred revenue (750)

Net cash used in operating activities (11,484)

Effects of Adopting Topic 606 [Member] | ASU Topic 606 [Member]

Cash Flow Statement Highlights [Abstract]

Net loss $ (375) (750)

Adjustments to reconcile net loss to net cash used in operating activities [Abstract]

Deferred revenue 750

Net cash used in operating activities $ 0

X

- References
No definition available.
+ Details

Name: us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInContractWithCustomerLiability

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3536-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3521-108585

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669619-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669625-108580

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=114873790&loc=SL114874131-224263

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_StatementOfCashFlowsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis=us-gaap_CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis=us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 43 R31.htm IDEA: XBRL DOCUMENT v3.10.0.1

Subsequent Events (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 6 Months Ended

Jul. 08, 2018

Aug. 06, 2018

Jun. 30, 2018

Restricted Stock Units (RSUs) [Member]

Stock Transactions [Abstract]

New shares of common stock issued as a result of vesting RSUs (in shares) 168,219

ATM Agreement [Member] | Common Stock [Member]

Stock Transactions [Abstract]

Number of shares of common stock sold (in shares) 3,072,610

Average sales price per common share (in dollars per share) $ 3.91

Aggregate proceeds from sales of common stock $ 12,000

Sales commissions, fees and other costs associated with issuance of common stock $ 360

Subsequent Event [Member] | Restricted Stock Units (RSUs) [Member]

Stock Transactions [Abstract]

New shares of common stock issued as a result of vesting RSUs (in shares) 31,865

Subsequent Event [Member] | ATM Agreement [Member] | Common Stock [Member]

Stock Transactions [Abstract]

Number of shares of common stock sold (in shares) 297,652

Average sales price per common share (in dollars per share) $ 3.48

Aggregate proceeds from sales of common stock $ 1,036

Sales commissions, fees and other costs associated with issuance of common stock $ 31

X

- Definition
Number of share instruments newly issued under a share-based compensation plan.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of new stock issued during the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_StockTransactionsParentheticalDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Represents aggregate proceeds from sale agreement of shares of common stock.
+ References
No definition available.
+ Details

Name: vhc_AggregateProceedsFromSaleAgreementOfSharesOfCommonStock

Namespace Prefix: vhc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Average price of a single share of common stock issued during the period.
+ References
No definition available.
+ Details

Name: vhc_CommonStockIssuedDuringPeriodAveragePricePerShare

Namespace Prefix: vhc_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Cost associated with sale of common stock.
+ References
No definition available.
+ Details

Name: vhc_StockIssuanceCost

Namespace Prefix: vhc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_SubsidiarySaleOfStockAxis=vhc_ATMAgreementMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

EXCEL 44 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 45 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 46 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 48 FilingSummary.xml IDEA: XBRL DOCUMENT 3.10.0.1 html 95 156 1 false 38 0 false 6 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://virnetx.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 010000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) Sheet http://virnetx.com/role/CondensedConsolidatedBalanceSheetsUnaudited CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) Statements 2 false false R3.htm 010100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) Sheet http://virnetx.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) Statements 3 false false R4.htm 020000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) Sheet http://virnetx.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) Statements 4 false false R5.htm 030000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited) Sheet http://virnetx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited) Statements 5 false false R6.htm 040000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Sheet http://virnetx.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Statements 6 false false R7.htm 060100 - Disclosure - Business Description Sheet http://virnetx.com/role/BusinessDescription Business Description Notes 7 false false R8.htm 060200 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies Sheet http://virnetx.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies Basis of Presentation and Summary of Significant Accounting Policies Notes 8 false false R9.htm 060300 - Disclosure - Income Taxes Sheet http://virnetx.com/role/IncomeTaxes Income Taxes Notes 9 false false R10.htm 060400 - Disclosure - Commitments and Related Party Transactions Sheet http://virnetx.com/role/CommitmentsAndRelatedPartyTransactions Commitments and Related Party Transactions Notes 10 false false R11.htm 060500 - Disclosure - Stock-Based Compensation Sheet http://virnetx.com/role/StockbasedCompensation Stock-Based Compensation Notes 11 false false R12.htm 060600 - Disclosure - Equity Sheet http://virnetx.com/role/Equity Equity Notes 12 false false R13.htm 060700 - Disclosure - Litigation Sheet http://virnetx.com/role/Litigation Litigation Notes 13 false false R14.htm 060800 - Disclosure - Effects of Adopting ASU Topic 606 Sheet http://virnetx.com/role/EffectsOfAdoptingAsuTopic606 Effects of Adopting ASU Topic 606 Notes 14 false false R15.htm 060900 - Disclosure - Subsequent Events Sheet http://virnetx.com/role/SubsequentEvents Subsequent Events Notes 15 false false R16.htm 070200 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies) Sheet http://virnetx.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies Basis of Presentation and Summary of Significant Accounting Policies (Policies) Policies http://virnetx.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies 16 false false R17.htm 080200 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables) Sheet http://virnetx.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables Basis of Presentation and Summary of Significant Accounting Policies (Tables) Tables http://virnetx.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies 17 false false R18.htm 080600 - Disclosure - Equity (Tables) Sheet http://virnetx.com/role/EquityTables Equity (Tables) Tables http://virnetx.com/role/Equity 18 false false R19.htm 080800 - Disclosure - Effects of Adopting ASU Topic 606 (Tables) Sheet http://virnetx.com/role/EffectsOfAdoptingAsuTopic606Tables Effects of Adopting ASU Topic 606 (Tables) Tables http://virnetx.com/role/EffectsOfAdoptingAsuTopic606 19 false false R20.htm 090100 - Disclosure - Business Description (Details) Sheet http://virnetx.com/role/BusinessDescriptionDetails Business Description (Details) Details http://virnetx.com/role/BusinessDescription 20 false false R21.htm 090200 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details) Sheet http://virnetx.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails Basis of Presentation and Summary of Significant Accounting Policies (Details) Details http://virnetx.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables 21 false false R22.htm 090300 - Disclosure - Income Taxes (Details) Sheet http://virnetx.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://virnetx.com/role/IncomeTaxes 22 false false R23.htm 090400 - Disclosure - Commitments and Related Party Transactions (Details) Sheet http://virnetx.com/role/CommitmentsAndRelatedPartyTransactionsDetails Commitments and Related Party Transactions (Details) Details http://virnetx.com/role/CommitmentsAndRelatedPartyTransactions 23 false false R24.htm 090500 - Disclosure - Stock-Based Compensation (Details) Sheet http://virnetx.com/role/StockbasedCompensationDetails Stock-Based Compensation (Details) Details http://virnetx.com/role/StockbasedCompensation 24 false false R25.htm 090600 - Disclosure - Equity, Common Stock (Details) Sheet http://virnetx.com/role/EquityCommonStockDetails Equity, Common Stock (Details) Details 25 false false R26.htm 090602 - Disclosure - Equity, Warrants (Details) Sheet http://virnetx.com/role/EquityWarrantsDetails Equity, Warrants (Details) Details 26 false false R27.htm 090700 - Disclosure - Litigation (Details) Sheet http://virnetx.com/role/LitigationDetails Litigation (Details) Details http://virnetx.com/role/Litigation 27 false false R28.htm 090800 - Disclosure - Effects of Adopting ASU Topic 606, Balance Sheet Highlights (Details) Sheet http://virnetx.com/role/EffectsOfAdoptingAsuTopic606BalanceSheetHighlightsDetails Effects of Adopting ASU Topic 606, Balance Sheet Highlights (Details) Details 28 false false R29.htm 090802 - Disclosure - Effects of Adopting ASU Topic 606, Income Statement Highlights (Details) Sheet http://virnetx.com/role/EffectsOfAdoptingAsuTopic606IncomeStatementHighlightsDetails Effects of Adopting ASU Topic 606, Income Statement Highlights (Details) Details 29 false false R30.htm 090806 - Disclosure - Effects of Adopting ASU Topic 606, Cash Flow Statement Highlights (Details) Sheet http://virnetx.com/role/EffectsOfAdoptingAsuTopic606CashFlowStatementHighlightsDetails Effects of Adopting ASU Topic 606, Cash Flow Statement Highlights (Details) Details 30 false false R31.htm 090900 - Disclosure - Subsequent Events (Details) Sheet http://virnetx.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://virnetx.com/role/SubsequentEvents 31 false false All Reports Book All Reports vhc-20180630.xml vhc-20180630.xsd vhc-20180630_cal.xml vhc-20180630_def.xml vhc-20180630_lab.xml vhc-20180630_pre.xml http://fasb.org/srt/2018-01-31 http://xbrl.sec.gov/dei/2018-01-31 http://xbrl.sec.gov/country/2017-01-31 http://fasb.org/us-gaap/2018-01-31 true true ZIP 50 0001140361-18-036080-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001140361-18-036080-xbrl.zip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�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end

Document and Entity Information - shares	6 Months Ended
Document and Entity Information - shares	Jun. 30, 2018	Aug. 06, 2018
Document and Entity Information [Abstract]
Entity Registrant Name	VirnetX Holding Corp
Entity Central Index Key	0001082324
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		62,622,325
Document Fiscal Year Focus	2018
Document Fiscal Period Focus	Q2
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2018

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Thousands	Jun. 30, 2018	Dec. 31, 2017
Current assets:
Cash and cash equivalents	$ 3,968	$ 3,135
Accounts receivables	2	0
Investments available for sale	724	1,453
Prepaid expenses and other current assets	864	591
Total current assets	5,558	5,179
Prepaid expenses, non-current	1,796	1,989
Property and equipment, net	17	7
Total assets	7,371	7,175
Current liabilities:
Accounts payable and accrued liabilities	2,966	414
Accrued payroll and related expenses	219	2,175
Income tax liability	399	393
Deferred revenue, current portion	0	1,500
Total current liabilities	3,584	4,482
Deferred revenue, non-current portion	0	1,000
Other liabilities	140	140
Total liabilities	3,724	5,622
Commitments and contingencies (Note 4)
Stockholders' equity:
Preferred stock, par value $0.0001 per share Authorized: 10,000,000 shares at June 30, 2018 and December 31, 2017, Issued and outstanding: 0 shares at June 30, 2018 and December 31, 2017	0	0
Common stock, par value $0.0001 per share: Authorized: 100,000,000 shares at June 30, 2018 and December 31, 2017, Issued and outstanding: 62,292,808 shares and 59,051,978 shares, at June 30, 2018 and December 31, 2017, respectively	6	6
Additional paid-in capital	190,724	177,076
Accumulated deficit	(187,070)	(175,516)
Accumulated other comprehensive loss	(13)	(13)
Total stockholders' equity	3,647	1,553
Total liabilities and stockholders' equity	$ 7,371	$ 7,175

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares	Jun. 30, 2018	Dec. 31, 2017
Stockholders' equity:
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	10,000,000	10,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	100,000,000	100,000,000
Common stock, shares issued (in shares)	62,292,808	59,051,978
Common stock, shares outstanding (in shares)	62,292,808	59,051,978

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) [Abstract]
Revenue	$ 16	$ 396	$ 22	$ 771
Operating expense:
Research and development	1,186	957	2,191	1,873
Selling, general and administrative	5,292	3,250	11,901	6,615
Total operating expense	6,478	4,207	14,092	8,488
Loss from operations	(6,462)	(3,811)	(14,070)	(7,717)
Interest income, net	12	13	20	31
Loss before taxes	(6,450)	(3,798)	(14,050)	(7,686)
Provision for income tax	0	0	(5)	(5)
Net loss	$ (6,450)	$ (3,798)	$ (14,055)	$ (7,691)
Basic and diluted loss per share (in dollars per share)	$ (0.10)	$ (0.07)	$ (0.23)	$ (0.13)
Weighted average shares outstanding basic and diluted (in shares)	61,532	58,195	60,835	58,170

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Cash flows from operating activities:
Net loss	$ (14,055)	$ (7,691)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	10	15
Stock-based compensation	2,008	1,715
Changes in assets and liabilities:
Prepaid expenses and other assets	(80)	(13)
Accounts payable and accrued liabilities	2,552	(1,362)
Accrued payroll and related expenses	(1,923)	(1,303)
Accounts receivables	(2)	0
Income tax liability	6	(1)
Deferred revenue	0	(750)
Net cash used in operating activities	(11,484)	(9,390)
Cash flows from investing activities:
Purchase of investments	(924)	(756)
Proceeds from sale or maturity of investments	1,635	5,760
Net cash provided by investing activities	711	5,004
Cash flows from financing activities:
Proceeds from sale of common stock	11,639	0
Payments of taxes on restricted stock units	(33)	(29)
Net cash provided by (used in) financing activities	11,606	(29)
Net change in cash and cash equivalents	833	(4,415)
Cash and cash equivalents, beginning of period	3,135	6,627
Cash and cash equivalents, end of period	3,968	2,212
ASU Topic 606 [Member]
Non-cash transactions
Deferred revenue reclassified to retained earnings - ASC 606 adoption	$ 2,500	$ 0

Business Description	6 Months Ended
Business Description	Jun. 30, 2018
Business Description [Abstract]
Business Description	Note 1 — Business Description VirnetX Holding Corporation, which we refer to as “we”, “us”, “our”, “the Company” or “VirnetX”, is engaged in the business of commercializing a portfolio of patents. We seek to license our technology, including GABRIEL Connection Technology™, to various original equipment manufacturers, or OEMs, that use our technologies in the development and manufacturing of their own products within the IP-telephony, mobility, fixed-mobile convergence and unified communications markets. Since 2012 we had revenues from settlements of patent infringement disputes whereby we received consideration for past sales of licensees that utilized our technology, where there was no prior patent license agreement, as well as license agreement revenues from settlements providing licensing for the continued use of our technology (see “Revenue Recognition”). Our portfolio of intellectual property is the foundation of our business model. We currently own approximately 185 total patents and pending applications, including 70 U.S. patents/patent applications and 115 foreign patents/validations/pending applications. Our patent portfolio is primarily focused on securing real-time communications over the Internet, as well as related services such as the establishment and maintenance of a secure domain name registry. Our patented methods also have additional applications in the key areas of device operating systems and network security for Cloud services, Machine-to-Machine (“M2M”), communications in areas including “Smart City,” “Connected Car” and “Connected Home.” All our U.S. and foreign patents and pending patent applications relate generally to securing communications over the internet and as such, cover all our technology and other products. Our issued U.S. and foreign patents expire at various times during the period from 2019 to 2024. Some of our issued patents and pending patent applications were acquired by our principal operating subsidiary, VirnetX, Inc., from Leidos, Inc. (“Leidos”) (f/k/a Science Applications International Corporation, or SAIC) in 2006 and we are required to make payments to Leidos based on cash or certain other values generated from those patents in certain circumstances. The amount of such payments depends upon the type of value generated and certain categories are subject to maximums and other limitations.

Income Taxes	6 Months Ended
Income Taxes	Jun. 30, 2018
Income Taxes [Abstract]
Income Taxes	Note 3 - Income Taxes We had income tax expense of $0 and $5 for the three and six-months ended June 30, 2018 and 2017, respectively, as a result of minimum tax payments. During the three and six-month period ended June 30, 2018 and 2017, we had net operating losses (“NOLs”) which generated deferred tax assets for NOL carryforwards. We provided valuation allowances against the net deferred tax assets including the deferred tax assets for NOL carryforwards. Valuation allowances provided for our net deferred tax assets increased by approximately $7,400 and $3,747 for the six months ended June 30, 2018 and 2017, respectively. In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of the deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Based on the available objective evidence, management believes it is more likely than not that the net deferred tax assets at June 30, 2018 will not be fully realizable. Accordingly, management has maintained a full valuation allowance against its net deferred tax assets at June 30, 2018. The valuation allowance carried against our net deferred tax assets was approximately $41,000 and $34,000 at June 30, 2018 and December 31, 2017, respectively. At June 30, 2018, we have federal and state net operating loss carryforwards of approximately $103,000 and $117,000, respectively, expiring beginning in 2027 and 2028, respectively. In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers, (“Topic 606”) which amends revenue recognition principles and provides a single set of criteria for revenue recognition among all industries. We adopted the new standard effective January 1, 2018 under the modified retrospective method. Under the modified retrospective method, we recognized deferred revenue of $2,500 through retained earnings. The tax provision is prepared based on the assumption that the Company will file accounting method change form 3115 with 2018 tax return to reflect the adoption of Topic 606. Our tax years for 2005 and forward are subject to examination by the U.S. tax authority and various state tax authorities. These years are open due to net operating losses and tax credits remaining unutilized from such years. Our policy is to recognize interest and penalties accrued on uncertain tax positions as a component of income tax expense. As of June 30, 2018, we had accrued immaterial amounts of interest and penalties related to the uncertain tax positions.

Commitments and Related Party Transactions	6 Months Ended
Commitments and Related Party Transactions	Jun. 30, 2018
Commitments and Related Party Transactions [Abstract]
Commitments and Related Party Transactions	Note 4 — Commitments and Related Party Transactions We lease our offices under an operating lease with a third party expiring in October 2019. We recognize rent expense on a straight-line basis over the term of the lease. We lease the use of an aircraft from K2 Investment Fund LLC (“LLC”) for business travel for employees of the Company. We incurred approximately $75 and $683 compared to $213 and $472 in rental fees and reimbursements to the LLC during the three and six months ended June 30, 2018 and 2017, respectively. Our Chief Executive Officer and Chief Administrative Officer are the managing partners and control the equity interests of the LLC. We entered into a 12-month non-exclusive lease with LLC for use of the plane at a rate of $8 per flight hour, with no minimum usage requirement. The agreement contains other terms and conditions normal in such transactions and can be cancelled by either us or LLC with 30 days’ notice. The lease renews on an annual basis unless terminated by the lessor or lessee. Neither party has exercised their termination rights.

Stock-Based Compensation	6 Months Ended
Stock-Based Compensation	Jun. 30, 2018
Stock-Based Compensation [Abstract]
Stock-Based Compensation	Note 5 — Stock-Based Compensation We have a stock incentive plan for employees and others called the VirnetX Holding Corporation 2013 Equity Incentive Plan (the “Plan”), which has been approved by our stockholders. In May 2017, the Board approved an amendment and restatement of the Plan to, among other things, increase the shares reserved under the Plan by 2,500,000 shares (the “Plan Amendment”). Our stockholders approved of the Plan Amendment at the 2017 Annual Meeting of Stockholders held on June 1, 2017. The Plan provides for grants of 16,624,469 shares of our common stock, including stock options and restricted stock units (“RSUs”), and will expire in 2023. As of June 30, 2018, 1,780,315 shares remained available for grant under the Plan. During the three months ended June 30, 2018, we granted options for a total of 336,000 shares with a weighted average grant date fair value of $2.31 per options. During the three months ended June 30, 2017, we granted options totaling 331,000 shares with a weighted average grant date fair value of $2.72. During the six months ended June 30, 2018, we granted options for a total of 1,006,000 shares. The weighted average fair value at the grant dates for options issued during the six months ended June 30, 2018 was $2.52 per option. The fair values of options at the grant date were estimated utilizing the Black-Scholes valuation model with the following weighted average assumptions for the six months ended June 30, 2018 (i) dividend yield on our common stock of 0 percent (ii) expected stock price volatility of 85 percent (iii) a risk-free interest rate of 2.65 percent and (iv) and expected option term of 6 years. During the six months ended June 30, 2017, we granted options for a total of 356,000 shares with a weighted average grant date fair value of $2.65. The fair values of options at the grant date were estimated utilizing the Black-Scholes valuation model with the following weighted average assumptions for the six months ended June 30, 2017 (i) dividend yield on our common stock of 0 percent (ii) expected stock price volatility of 84 percent (iii) a risk-free interest rate average of 1.94 percent and (iv) an expected option term of 6 years. During the three months ended June 30, 2018 and 2017, we granted 223,997 and 220,664 RSUs, respectively. The weighted average fair values at the grant dates for RSUs issued during the three months ended June 30, 2018 and 2017 were $3.19 and $3.83 per RSU, respectively. RSUs, which are subject to forfeiture if service terminates prior to the shares vesting, are expensed ratably over the vesting period. During the three months ended June 30, 2018 and 2017, we paid $33 and $29 in withholding taxes on shares issued upon conversion of RSUs. The underlying shares were canceled. These amounts are reflected as financing costs in the accompanying statement of cash flows. During the six months ended June 30, 2018 and 2017, we granted 243,997 and 220,664 RSUs, respectively. The weighted average fair values at the grant dates for RSUs issued during the six months ended June 30, 2018 and 2017 were $3.28 and $3.83 per RSU, respectively. RSUs, which are subject to forfeiture if service terminates prior to the shares vesting, are expensed ratably over the vesting period. During the six months ended June 30, 2018 and 2017, we paid $33 and $29 in withholding taxes on shares issued upon conversion of RSUs. The underlying shares were canceled. These amounts are reflected as financing costs in the accompanying statement of cash flows. Stock-based compensation expense included in general and administrative expense was $467 and $855 and in research and development expense was $655 and $1,154 for the three and six months ended June 30, 2018, respectively, and $442 and $834 for general and administrative and $440 and $881 for research and development for the three and six months ended June 30, 2017, respectively. As of June 30, 2018, the unrecognized stock-based compensation expense related to non-vested stock options and RSUs was $7,160 and $2,001, respectively, which will be amortized over an estimated weighted average period of approximately 3.08 and 2.72 years, respectively. During the six-month period ended June 30, 2018 we issued 168,219 new shares of common stock as a result of vesting RSUs. No shares of common stock were issued as a result of stock options exercised during the period.

Subsequent Events	6 Months Ended
Subsequent Events	Jun. 30, 2018
Subsequent Events [Abstract]
Subsequent Events	Note 9 — Subsequent Events Between July 1, 2018 and August 6, 2018, we sold 297,652 shares of common stock under the ATM program. The average sales price per common share sold was $3.48 and the aggregate proceeds from the sales totaled $1,036. Sales commissions, fees and other costs associated with the ATM transactions totaled $31. On July 8, 2018 we issued 31,865 new shares of common stock as a result of vesting RSUs.

Business Description (Details) - Patents [Member]	Jun. 30, 2018 Patent
Business Description [Abstract]
Number of patents and pending applications	185
U.S. [Member]
Business Description [Abstract]
Number of patents and pending applications	70
Foreign [Member]
Business Description [Abstract]
Number of patents and pending applications	115

Basis of Presentation and Summary of Significant Accounting Policies (Details) $ in Thousands	3 Months Ended	6 Months Ended		12 Months Ended
	Jun. 30, 2017 USD ($)	Jun. 30, 2018 USD ($) Institution	Jun. 30, 2017 USD ($)	Dec. 31, 2017 USD ($)	Dec. 31, 2016 USD ($)
Concentration of Credit Risk and Others Risks and Uncertainties [Abstract]
Number of financial institutions holding company's cash \| Institution		2
Prepaid Expenses [Abstract]
Prepayment of facility lease for corporate promotional and marketing purposes		$ 4,000
Lease term		10 years
Cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category [Abstract]
Adjusted Cost	$ 2,212	$ 3,968	$ 2,212	$ 3,135	$ 6,627
Adjusted Cost		2,635		2,617
Unrealized Gains		1		0
Unrealized Losses		0		(1)
Fair Value		2,636		2,616
Adjusted Cost		4,691		4,589
Fair Value		4,692		4,588
Investments Available for Sale		2,636		2,616
Cash [Member]
Cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category [Abstract]
Adjusted Cost		2,056		1,972
Fair Value		2,056		1,972
Cash and Cash Equivalents		2,056		1,972
Mutual Funds [Member]
Cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category [Abstract]
Adjusted Cost		1,087		616
Unrealized Gains		0		0
Unrealized Losses		0		0
Fair Value		1,087		616
Investments Available for Sale		1,087		616
U.S. Government Securities [Member]
Cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category [Abstract]
Adjusted Cost		80
Unrealized Gains		0
Unrealized Losses		0
Fair Value		80
Investments Available for Sale		80
U.S. Agency Securities [Member]
Cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category [Abstract]
Adjusted Cost		1,468		2,001
Unrealized Gains		1		0
Unrealized Losses		0		(1)
Fair Value		1,469		2,000
Investments Available for Sale		1,469		2,000
Recurring [Member]
Cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category [Abstract]
Fair Value		3,968		3,135
Fair Value		724		1,453
Cash and Cash Equivalents		3,968		3,135
Investments Available for Sale		724		1,453
Recurring [Member] \| Cash [Member]
Cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category [Abstract]
Fair Value		2,056		1,972
Cash and Cash Equivalents		2,056		1,972
Recurring [Member] \| Level 1 [Member]
Cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category [Abstract]
Fair Value		1,912		1,163
Fair Value		724		1,453
Cash and Cash Equivalents		1,912		1,163
Investments Available for Sale		724		1,453
Recurring [Member] \| Level 1 [Member] \| Mutual Funds [Member]
Cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category [Abstract]
Fair Value		1,087		616
Fair Value		0
Cash and Cash Equivalents		1,087		616
Investments Available for Sale		0
Recurring [Member] \| Level 1 [Member] \| U.S. Government Securities [Member]
Cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category [Abstract]
Fair Value		0
Fair Value		80
Cash and Cash Equivalents		0
Investments Available for Sale		80
Recurring [Member] \| Level 1 [Member] \| U.S. Agency Securities [Member]
Cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category [Abstract]
Fair Value		825		547
Fair Value		644		1,453
Cash and Cash Equivalents		825		547
Investments Available for Sale		644		1,453
2013 to 2016 Contract [Member]
Deferred Revenue [Abstract]
Total contractual payments received		$ 10,000
Revenue recognized	$ 375		$ 750
ASU 2014-09 [Member]
Deferred Revenue [Abstract]
Revenue recognized				2,500
ASU 2014-09 [Member] \| Retained Earnings [Member]
New Accounting Pronouncements [Abstract]
Cumulative effect adjustments				(2,500)
ASU 2014-09 [Member] \| Deferred Revenue [Member]
New Accounting Pronouncements [Abstract]
Cumulative effect adjustments				$ (2,500)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
Income Taxes (Details) - USD ($) $ in Thousands	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017	Dec. 31, 2017
Income Taxes [Abstract]
Income tax expense	$ 0	$ 0	$ 5	$ 5
Net change in valuation allowance			7,400	$ 3,747
Valuation allowance carried against net deferred tax assets	41,000		41,000		$ 34,000
ASU 2014-09 [Member]
Income Taxes [Abstract]
Deferred revenue recognized					$ 2,500
Federal [Member]
Income Taxes [Abstract]
Net operating loss carryforwards	103,000		$ 103,000
Federal [Member] \| Earliest Tax Year [Member]
Income Taxes [Abstract]
Operating loss carryforwards, expiration dates			Dec. 31, 2027
State [Member]
Income Taxes [Abstract]
Net operating loss carryforwards	$ 117,000		$ 117,000
State [Member] \| Earliest Tax Year [Member]
Income Taxes [Abstract]
Operating loss carryforwards, expiration dates			Dec. 31, 2028

Stock-Based Compensation (Details) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended	3 Months Ended		6 Months Ended
	May 31, 2017	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Share-based Compensation [Abstract]
Withholding taxes paid on shares issued upon conversion of RSUs				$ 33	$ 29
Stock-based compensation expense				2,008	1,715
General and Administrative Expense [Member]
Share-based Compensation [Abstract]
Stock-based compensation expense		$ 467	$ 442	855	834
Research and Development Expense [Member]
Share-based Compensation [Abstract]
Stock-based compensation expense		$ 655	$ 440	$ 1,154	$ 881
Stock Options [Member]
Share-based Compensation [Abstract]
Options granted (in shares)		336,000	331,000	1,006,000	356,000
Options granted, weighted average grant date fair value (in dollars per share)		$ 2.31	$ 2.72	$ 2.52	$ 2.65
Dividend yield				0.00%	0.00%
Expected stock price volatility				85.00%	84.00%
Risk-free interest rate				2.65%	1.94%
Expected option term				6 years	6 years
Unrecognized stock-based compensation expense expected to be recognized related to non-vested stock options		$ 7,160		$ 7,160
Weighted average amortization period				3 years 29 days
Options exercised (in shares)				0
Restricted Stock Units (RSUs) [Member]
Share-based Compensation [Abstract]
RSUs granted (in shares)		223,997	220,664	243,997	220,664
Weighted average grant date fair value of RSU's granted (in dollars per share)		$ 3.19	$ 3.83	$ 3.28	$ 3.83
Withholding taxes paid on shares issued upon conversion of RSUs		$ 33	$ 29	$ 33	$ 29
Unrecognized stock-based compensation expense expected to be recognized related to non-vested RSUs		$ 2,001		$ 2,001
Weighted average amortization period				2 years 8 months 19 days
New shares of common stock issued as a result of vesting RSUs (in shares)				168,219
2013 Plan [Member]
Share-based Compensation [Abstract]
Additional shares authorized for issuance (in shares)	2,500,000
Shares authorized for issuance (in shares)		16,624,469		16,624,469
Shares available for grant (in shares)		1,780,315		1,780,315

Equity, Common Stock (Details) - Common Stock [Member] - USD ($) $ / shares in Units, $ in Thousands	6 Months Ended
	Jun. 30, 2018	Mar. 08, 2018	Aug. 21, 2015	Aug. 20, 2015
Universal Shelf Registration Statement [Member]
Common Stock [Abstract]
Securities offered for sale, aggregate value			$ 100,000
ATM Agreement [Member]
Common Stock [Abstract]
Securities offered for sale, aggregate value		$ 50,000		$ 35,000
Number of shares of common stock sold (in shares)	3,072,610
Average sales price per common share (in dollars per share)	$ 3.91
Aggregate proceeds from sales of common stock	$ 12,000
Sales commissions, fees and other costs associated with issuance of common stock	$ 360

Equity, Warrants (Details) - Warrants [Member]	6 Months Ended
Equity, Warrants (Details) - Warrants [Member]	Jun. 30, 2018 $ / shares shares
Information about warrants outstanding [Abstract]
Exercisable, beginning of period (in shares)	25,000
Became exercisable (in shares)	0
Exercised (in shares)	0
Terminated/cancelled/expired (in shares)	0
Exercisable, end of period (in shares)	25,000
Advisor Warrants [Member]
Information about warrants outstanding [Abstract]
Original number of warrants issued (in shares)	25,000
Exercise price per common share (in dollars per share) \| $ / shares	$ 7.00
Exercisable, beginning of period (in shares)	25,000
Became exercisable (in shares)	0
Exercised (in shares)	0
Terminated/cancelled/expired (in shares)	0
Exercisable, end of period (in shares)	25,000
Expiration date	Apr. 30, 2020

Litigation (Details) - Positive Outcome of Litigation [Member]	Apr. 12, 2018 USD ($)	Sep. 29, 2017 USD ($)	Sep. 30, 2016 USD ($) Patent	Nov. 06, 2012 USD ($) Patent
VirnetX Inc. v. Cisco Systems, Inc. et al. (Case 6:10-CV-00417-LED) ("Apple I") [Member]
Litigation [Abstract]
Amount of damages awarded in patent infringement case		$ 439,700,000	$ 302,400,000
Number of patents allegedly infringed upon by Apple, Inc. \| Patent			4	4
Enhanced damages		41,300,000
Additional amount granted in agreed bill of costs, attorney fees, and prejudgment interest		(96,000,000)
VirnetX Inc. v. Cisco Systems, Inc. et al. (Case 6:10-CV-00417-LED) ("Apple I") [Member] \| Minimum [Member]
Litigation [Abstract]
Amount of damages awarded in patent infringement case				$ 368,000,000
Royalty rate per device used in calculating infringement damages		1.20
VirnetX Inc. v. Cisco Systems, Inc. et al. (Case 6:10-CV-00417-LED) ("Apple I") [Member] \| Maximum [Member]
Litigation [Abstract]
Royalty rate per device used in calculating infringement damages		$ 1.80
VirnetX Inc. v. Apple, Inc. (Case 6:12-CV-00855-LED) ("Apple II") [Member]
Litigation [Abstract]
Amount of damages awarded in patent infringement case	$ 502,600,000

Effects of Adopting ASU Topic 606, Balance Sheet Highlights (Details) - USD ($) $ in Thousands	Jun. 30, 2018	Dec. 31, 2017
Current liabilities [Abstract]
Deferred revenue, current portion	$ 0	$ 1,500
Total current liabilities	3,584	4,482
Deferred revenue, non-current portion	0	1,000
Other liabilities	140	140
Total liabilities	3,724	5,622
Accumulated deficit	(187,070)	(175,516)
Total stockholders' equity	3,647	1,553
Pre-Topic 606 [Member]
Current liabilities [Abstract]
Deferred revenue, current portion	1,500
Total current liabilities	5,084
Deferred revenue, non-current portion	250
Other liabilities	140
Total liabilities	5,474
Accumulated deficit	(188,820)
Total stockholders' equity	1,897
Effects of Adopting Topic 606 [Member] \| ASU Topic 606 [Member]
Current liabilities [Abstract]
Deferred revenue, current portion	(1,500)	(1,500)
Total current liabilities	(1,500)	(1,500)
Deferred revenue, non-current portion	(250)	(1,000)
Other liabilities	0	0
Total liabilities	(1,750)	(2,500)
Accumulated deficit	1,750	2,500
Total stockholders' equity	$ 1,750	2,500
Post-Topic 606 [Member]
Current liabilities [Abstract]
Deferred revenue, current portion		0
Total current liabilities		2,982
Deferred revenue, non-current portion		0
Other liabilities		140
Total liabilities		3,122
Accumulated deficit		(173,016)
Total stockholders' equity		$ 4,053

Subsequent Events (Details) - USD ($) $ / shares in Units, $ in Thousands		1 Months Ended	6 Months Ended
	Jul. 08, 2018	Aug. 06, 2018	Jun. 30, 2018
Restricted Stock Units (RSUs) [Member]
Stock Transactions [Abstract]
New shares of common stock issued as a result of vesting RSUs (in shares)			168,219
ATM Agreement [Member] \| Common Stock [Member]
Stock Transactions [Abstract]
Number of shares of common stock sold (in shares)			3,072,610
Average sales price per common share (in dollars per share)			$ 3.91
Aggregate proceeds from sales of common stock			$ 12,000
Sales commissions, fees and other costs associated with issuance of common stock			$ 360
Subsequent Event [Member] \| Restricted Stock Units (RSUs) [Member]
Stock Transactions [Abstract]
New shares of common stock issued as a result of vesting RSUs (in shares)	31,865
Subsequent Event [Member] \| ATM Agreement [Member] \| Common Stock [Member]
Stock Transactions [Abstract]
Number of shares of common stock sold (in shares)		297,652
Average sales price per common share (in dollars per share)		$ 3.48
Aggregate proceeds from sales of common stock		$ 1,036
Sales commissions, fees and other costs associated with issuance of common stock		$ 31